THE MEDICAL COLLEGE OF WISCONSIN INC
Reduce your risk when donating: see where the money actually goes.
Cite this
Plain text THE MEDICAL COLLEGE OF WISCONSIN INC. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/the-medical-college-of-wisconsin-inc-390806261. Retrieved 2026-11-05.
APA furp.org. (n.d.). THE MEDICAL COLLEGE OF WISCONSIN INC [Nonprofit organization profile; tax years 2009–2024]. Retrieved November 5, 2026, from https://furp.org/org/the-medical-college-of-wisconsin-inc-390806261
MLA “THE MEDICAL COLLEGE OF WISCONSIN INC.” furp.org, tax years 2009–2024, https://furp.org/org/the-medical-college-of-wisconsin-inc-390806261. Accessed 5 Nov. 2026.
Retrieved 2026-11-05; covers tax years 2009–2024. Data: furp.org, CC BY 4.0.
Related institution: Medical College of Wisconsin Exact
2024 · Form 990 · revenue $1.76B · expenses $1.68B · assets $3.47B
- EIN
- 39-0806261
- Address
- 8701 WATERTOWN PLANK RD, MILWAUKEE, WI 53226-3548
- Website
- http://www.mcw.edu
- NTEE code
- B430
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- November 1968 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- School
- Cross-check
- ProPublica Nonprofit Explorer
Mission
THE MEDICAL COLLEGE OF WISCONSIN (MCW) IS A DISTINGUISHED LEADER AND INNOVATOR IN THE EDUCATION AND DEVELOPMENT OF THE NEXT GENERATION OF PHYSICIANS, (CONTINUED IN SCHEDULE O)
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
85 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| John R Raymond Sr Md | TRUSTEE/PRESIDENT AND CEO | 2010-2024 | $1,947,303 | $21,141,951 | 5 |
| Joseph E Kerschner Md | SEE SCHEDULE O FOR TITLE | 2010-2024 | $1,776,799 | $13,551,658 | 7 |
| Max C Lee Md | ASST PROF-NEUROSURGERY | 2020-2024 | $2,581,006 | $13,427,259 | 1 |
| Michael Edward Mitchell Md | CHIEF, PROF-PED CARDIAC SURG | 2010-2024 | $2,015,466 | $10,930,082 | 1 |
| Roy L Silverstein Md | SEE SCHEDULE O FOR TITLE | 2011-2024 | $486,064 | $9,268,614 | 1 |
| Abdel Alqwasmi Md | PHYSICIAN-HEMATOLOGY/ONCOLOGY | 2019-2024 | $1,876,647 | $7,963,496 | 1 |
| Cheryl A Maurana Phd | SEE SCHEDULE O FOR TITLE | 2012-2024 | $848,654 | $7,668,891 | 1 |
| David Hotchkiss | VP-INFORMATION SERVICES, CIO | 2012-2024 | $571,380 | $5,067,118 | 1 |
| Gregory Wesley | SEE SCHEDULE O FOR TITLE | 2009-2024 | $522,378 | $4,926,405 | 18 |
| John T Newsome Jd | FMR SR VP-GEN COUNSEL/ASST SEC | 2014-2024 | $140,563 | $4,738,994 | 1 |
| Mara Lord Phd | SR VP-CHF STRATEGY & GRWTH OFF | 2015-2024 | $728,472 | $4,685,723 | 1 |
| George Mackinnon Iii Phd | DEAN, SCHOOL OF PHARMACY | 2015-2024 | $427,799 | $3,938,118 | 1 |
| Saman Shabani Md | ASST PROF-NEUROSURGERY | 2023-2024 | $1,940,879 | $3,523,599 | 1 |
| Ravindra P Misra Phd | FMR DEAN, SCHOOL OF GRAD STUD | 2009-2024 | $244,429 | $3,252,801 | 1 |
| Jeffrey Bornemann | VP-FACILITIES & OP TO 3/2/25 | 2016-2024 | $429,243 | $2,979,125 | 2 |
| David A Margolis Md | SEE SCHEDULE O FOR TITLE | 2020-2024 | $687,682 | $2,818,989 | 1 |
| C Greer Jordan | VP-ANCHOR PARTNERSHIPS | 2016-2024 | $405,626 | $2,719,581 | 2 |
| David King Md | TRUSTEE | 2023-2024 | $1,252,097 | $2,376,235 | 1 |
| Shelisa Dalton | CHIEF FINANCIAL OFFICER | 2021-2024 | $702,360 | $2,288,877 | 2 |
| Matthew Lester | EXEC VP-FINANCE & ADMIN, COO | 2022-2024 | $1,010,278 | $2,286,971 | 1 |
| Adrienne Mitchell | SR VP-HR, CHIEF PEOPLE OFFICER | 2020-2024 | $664,482 | $2,266,918 | 1 |
| Kimara Ellefson | FORMER INTERIM VP-HR | 2019-2024 | $341,171 | $1,895,773 | 1 |
| Matthew Cooper Md | CHIEF, PROF-TRANSPLANT SURGERY | 2024 | $1,587,542 | $1,587,542 | 1 |
| Tennille Sifuentes | VP-CORP COMPLIANCE/RISK MGT | 2021-2024 | $429,376 | $1,343,313 | 1 |
| Kevin M Eide | VP-FIN PLANNING/DATA ANALYTICS | 2022-2024 | $470,631 | $1,334,379 | 1 |
| Pamela J Stanick | VP-FINANCE & TREASURY | 2022-2024 | $445,126 | $1,299,696 | 1 |
| Jason E Kraiss | VP-INST ADVANCEMENT, CDO | 2022-2024 | $549,743 | $1,153,145 | 1 |
| M Aileen Shinaman Jd | SR VP-GENERAL COUNSEL/ASST SEC | 2023-2024 | $748,197 | $1,064,750 | 1 |
| Susan Melcher | VP-TOTAL REWARDS/HR ANALYTICS | 2022-2024 | $416,146 | $928,011 | 1 |
| Deborah M Costakos Md | SEE SCHEDULE O FOR TITLE | 2024 | $910,634 | $910,634 | 1 |
| Nathan Berken | VP-GOVERNMENT RELATIONS | 2022-2024 | $357,522 | $848,328 | 1 |
| Mary Reinke | VP-MARKETING & COMMUNICATIONS | 2022-2024 | $313,839 | $820,654 | 1 |
| Daisy Sahoo Phd | DEAN, SCHOOL OF GRAD STUDIES | 2023-2024 | $401,555 | $720,092 | 1 |
| Kevin R Regner Md | SEE SCHEDULE O FOR TITLE | 2024 | $595,432 | $595,432 | 1 |
| Curt D Sigmund Phd | TRUSTEE | 2024 | $515,314 | $515,314 | 1 |
| Jennifer S Bultman | SEE SCHEDULE O FOR TITLE | 2024 | $299,372 | $299,372 | 1 |
| Shekar N Kurpad Md (former) | CHAIR, PROF-NEUROSURGERY | 2009-2023 | $1,444,684 | $17,237,217 | 1 |
| Dennis Maiman Md Phd (former) | PROF OF NEUROSURGERY,FMR CHAIR | 2009-2015 | $1,797,256 | $14,223,199 | 1 |
| James S Tweddell Md (former) | PROF & CHIEF OF CARDIO SURGERY | 2009-2014 | $1,847,093 | $11,359,260 | 2 |
| Viktor Hraska Md (former) | CHIEF, PROF-PED CARDIAC SURG | 2017-2021 | $2,909,540 | $10,360,220 | 1 |
| Douglas B Evans Md (former) | CHAIR, PROF-SURGERY | 2017-2022 | $1,569,306 | $8,957,589 | 1 |
| John G Thometz Md (former) | PROF OF ORTHOPAEDIC SURGERY | 2009-2015 | $1,291,939 | $8,379,899 | 1 |
| J Channing Tassone Md (former) | PROF OF ORTHOPAEDIC SURGERY | 2013-2017 | $1,346,297 | $7,007,099 | 1 |
| Christopher P Kops (former) | SEE SCHEDULE O FOR TITLE | 2015-2022 | $871,117 | $5,798,257 | 1 |
| Joseph E Kerschnermd (former) | TRUSTEE/PROVOST& EXEC VP, DEAN | 2018-2021 | $1,777,670 | $5,790,564 | 1 |
| Ronald K Woods Md (former) | PROF OF PED CARDIAC SURGERY | 2015-2017 | $1,543,161 | $4,347,375 | 1 |
| Robert Lane Md (former) | CHAIR, PROF-PEDIATRICS | 2013-2019 | $689,948 | $4,217,114 | 1 |
| Robert M Kliegman Md (former) | PROF/FORMER CHAIR DEPT OF PEDS | 2009-2016 | $260,482 | $4,185,218 | 3 |
| Sherri Ducharme-White (former) | FORMER VP-HR | 2009-2020 | $201,140 | $4,080,430 | 1 |
| Daniel Wickeham (former) | VP-COMP & RISK MGT TO 10/1/21 | 2009-2021 | $309,413 | $3,846,134 | 1 |
| Kathryn Kuhn (former) | SEE SCHEDULE O FOR TITLE | 2010-2022 | $351,469 | $3,769,897 | 2 |
| Ann Nattinger Md Mph (former) | PROF/FORMER INT CHAIR DEPT MED | 2009-2016 | $457,291 | $3,226,667 | 1 |
| Marjorie Spencer (former) | CFO UNTIL 7/8/16 | 2009-2016 | $370,449 | $3,103,123 | 1 |
| Mark S Ruttum Md (former) | PROF OF OPHTHALMOLOGY | 2011-2012 | $1,369,305 | $2,777,244 | 1 |
| Kurt L Janavitz (former) | FORMER SR VP-HLTHCARE PSHIP | 2016-2021 | $546,594 | $2,613,125 | 1 |
| Jonathan I Ravdin Md (former) | FORMER TRUSTEE/DEAN & EXEC VP | 2009-2013 | $206,316 | $2,588,276 | 1 |
| Alice Archabal (former) | VP-DEVELOPMENT/CDO TO 11/16/18 | 2013-2018 | $533,690 | $2,566,292 | 1 |
| Johnny C Hong Md (former) | CHIEF, PROF TRANSPLANT SURG | 2013-2018 | $1,340,848 | $2,466,431 | 1 |
| Sarah D Cohn Jd (former) | FORMER VP-GEN COUNSEL/ASST SEC | 2009-2015 | $351,985 | $2,427,789 | 1 |
| T Michael Bolger JD (former) | PRESIDENT EMERITUS | 2009-2012 | $786,688 | $2,257,541 | 3 |
| Barclay Ferguson (former) | CFO TO 7/9/21 | 2016-2021 | $338,916 | $2,240,936 | 1 |
| Joseph D Chabot Do (former) | ASST PROF-NEUROSURGERY | 2022 | $2,138,317 | $2,138,317 | 1 |
| G Allen Bolton Jr (former) | SENIOR VP AND COO TO 9/15/14 | 2011-2014 | $654,168 | $2,079,505 | 1 |
| Mitchell Beckman (former) | FORMER VP-DEVELOPMENT, CDO | 2019-2023 | $501,736 | $2,026,593 | 1 |
| Douglas R Campbell (former) | FORMER SENIOR VP AND COO | 2009-2011 | $501,450 | $1,725,685 | 1 |
| Vincent P Mathews Md (former) | TRUSTEE | 2018-2019 | $878,804 | $1,665,640 | 1 |
| Michael J Dunn MD (former) | PROF MEDICINE/DEAN EMERITUS | 2009-2012 | $154,009 | $1,571,362 | 1 |
| Cynthia A Lien Md (former) | TRUSTEE | 2022-2023 | $736,944 | $1,502,767 | 1 |
| James W Heald (former) | VP - INST ADVANCE TO 7/28/13 | 2009-2013 | $215,349 | $1,411,680 | 1 |
| Madhuri Trivedi Md (former) | PHYSICIAN-GASTROENTEROLOGY | 2019 | $1,375,900 | $1,375,900 | 1 |
| J Channing Tassonemd (former) | PROF OF ORTHOPAEDIC SURGERY | 2018 | $1,341,188 | $1,341,188 | 1 |
| Scott C Hicks Md (former) | ORTHOPAEDIC SURGEON | 2016 | $1,276,825 | $1,276,825 | 1 |
| David Warltier Md Phd (former) | TRUSTEE | 2010-2011 | $579,793 | $1,137,448 | 1 |
| Kevin J Kelly Md (former) | INT CHAIR PEDS/PROF TO 1/27/13 | 2011-2013 | $190,418 | $1,137,350 | 1 |
| Christopher Wolfla MD (former) | ASSOC. PROFESSOR, NEUROSURGEON | 2009 | $1,055,334 | $1,055,334 | 1 |
| Stephen Hargarten Md (former) | TRUSTEE | 2014-2015 | $538,442 | $1,046,447 | 1 |
| Anne M Brown Jd (former) | FORMER INTERIM GEN COUNSEL | 2021-2023 | $151,302 | $863,049 | 1 |
| Tye Minckler (former) | VP - Operations UNTIL 7/2012 | 2009-2012 | $162,285 | $847,485 | 1 |
| Allen Cowley Jr Phd (former) | TRUSTEE | 2012-2013 | $422,852 | $839,576 | 1 |
| G Richard Olds MD (former) | Chair, Dept Med until 12/15/09 | 2009 | $762,922 | $762,922 | 1 |
| John R Kirby Phd (former) | TRUSTEE | 2020-2021 | $337,540 | $656,659 | 1 |
| Owen Griffith PhD (former) | PROFESSOR, BIOCHEMISTRY | 2009-2010 | $167,047 | $379,049 | 1 |
| Joseph C Besharse PhD (former) | Trustee | 2009 | $308,707 | $308,707 | 1 |
| Carlos Brown (former) | SEE SCHEDULE O FOR TITLE | 2021-2022 | $278,596 | $278,596 | 1 |
| Julia A Uihlein Phd (former) | TRUSTEE | 2009-2014 | $5,783 | $58,253 | 1 |
Officers and directors, no compensation reported
63 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Ted Kellner | TRUSTEE | 2009-2024 | 1 | $0 reported | 14 |
| Nancy Hernandez | TRUSTEE | 2023-2024 | 1 | $0 reported | 7 |
| Austin Ramirez | TRUSTEE | 2021-2024 | 1 | $0 reported | 14 |
| David Lubar | TRUSTEE | 2018-2024 | 1 | $0 reported | 16 |
| Jacqueline Herd-Barber | TRUSTEE/SECRETARY | 2016-2024 | 1 | $0 reported | 11 |
| Philip B Flynn | TRUSTEE/IMMEDIATE PAST CHAIR | 2012-2024 | 1 | $0 reported | 4 |
| Elizabeth Brenner | TRUSTEE/CHAIR | 2009-2024 | 3 | $0 reported | 8 |
| Jon D Hammes | TRUSTEE/TREASURER | 2009-2024 | 1 | $0 reported | 9 |
| Christy L Brown | TRUSTEE | 2019-2024 | 1 | $0 reported | 1 |
| Barbara Calkins Md | TRUSTEE | 2023-2024 | 1 | $0 reported | 1 |
| John Donofrio | TRUSTEE/VICE CHAIR | 2018-2024 | 2 | $0 reported | 1 |
| Linda G Gorens-Levey | TRUSTEE | 2017-2024 | 1 | $0 reported | 1 |
| Paul W Griepentrog | TRUSTEE | 2014-2024 | 1 | $0 reported | 1 |
| John M Grogan | TRUSTEE | 2019-2024 | 1 | $0 reported | 1 |
| Gregory Marcus | TRUSTEE | 2021-2024 | 1 | $0 reported | 7 |
| Anthony Mchenry | TRUSTEE | 2022-2024 | 1 | $0 reported | 5 |
| Chris Miskel | TRUSTEE | 2018-2024 | 1 | $0 reported | 9 |
| Justin L Mortara Phd | TRUSTEE | 2017-2024 | 1 | $0 reported | 8 |
| Janis M Orlowski Md | TRUSTEE | 2014-2024 | 1 | $0 reported | 2 |
| Warren D Pierson | TRUSTEE | 2022-2024 | 1 | $0 reported | 1 |
| R Jan Pirozzolo-Mellowes | TRUSTEE | 2018-2024 | 1 | $0 reported | 1 |
| Kristina M Ropella Phd | TRUSTEE | 2015-2024 | 1 | $0 reported | 2 |
| Rich Tennessen | TRUSTEE | 2023-2024 | 1 | $0 reported | 1 |
| Peggy Troy | TRUSTEE TO 8/11/24 | 2021-2024 | 1 | $0 reported | 8 |
| Gil Peri | TRUSTEE AS OF 8/12/24 | 2024 | 1 | $0 reported | 2 |
| Steve Schwab Md | TRUSTEE | 2024 | 1 | $0 reported | 1 |
| Brian S Cowperthwaite | VP-FACILITIES &OP AS OF 3/3/24 | 2024 | 40 | $0 reported | 1 |
| David Gay (former) | TRUSTEE TO 8/26/22 | 2017-2022 | 1 | $0 reported | 6 |
| Mary Ellen Stanek (former) | TRUSTEE/TREASURER | 2009-2022 | 1 | $0 reported | 12 |
| Jay Williams (former) | TRUSTEE/IMMEDIATE PAST CHAIR | 2009-2022 | 2 | $0 reported | 4 |
| Marie Nakata Md (former) | TRUSTEE | 2020-2022 | 1 | $0 reported | 2 |
| Cory Nettles (former) | TRUSTEE/IMMEDIATE PAST CHAIR | 2009-2021 | 2 | $0 reported | 13 |
| Wayne C Oldenburg (former) | TRUSTEE | 2009-2021 | 1 | $0 reported | 4 |
| Thomas L Spero (former) | TRUSTEE/TREASURER | 2009-2020 | 1 | $0 reported | 7 |
| Paul E Hankwitz Md (former) | TRUSTEE | 2017-2019 | 1 | $0 reported | 1 |
| Mr Owen J Sullivan (former) | TRUSTEE UNTIL 9/21/18 | 2009-2018 | 1 | $0 reported | 4 |
| Stephen Roell (former) | TRUSTEE/CHAIRMAN | 2009-2017 | 1 | $0 reported | 8 |
| Ricardo Diaz (former) | TRUSTEE | 2013-2017 | 1 | $0 reported | 2 |
| Susan A Feith (former) | TRUSTEE UNTIL 1/19/18 | 2009-2017 | 1 | $0 reported | 1 |
| Steven Bergin Md (former) | TRUSTEE | 2014-2016 | 0 | $0 reported | 1 |
| Joseph E Geenen Md (former) | TRUSTEE | 2009-2016 | 0 | $0 reported | 1 |
| P Michael Mahoney (former) | TRUSTEE/TREASURER | 2009-2015 | 0 | $0 reported | 7 |
| Gale E Klappa (former) | TRUSTEE UNTIL 4/22/16 | 2009-2015 | 0 | $0 reported | 5 |
| John Byrnes (former) | TRUSTEE UNTIL 4/22/16 | 2009-2015 | 0 | $0 reported | 1 |
| Harold Gus Frank (former) | TRUSTEE UNTIL 4/22/16 | 2014-2015 | 0 | $0 reported | 1 |
| Cynthia Laconte (former) | TRUSTEE UNTIL 11/20/15 | 2015 | 0 | $0 reported | 1 |
| John S Shiely (former) | TRUSTEE | 2009-2014 | 0 | $0 reported | 7 |
| Curt S Culver (former) | TRUSTEE | 2009-2014 | 0 | $0 reported | 7 |
| Carlene Ziegler (former) | TRUSTEE | 2009-2013 | 0 | $0 reported | 3 |
| Edward Zore (former) | TRUSTEE/IMMEDIATE PAST CHAIR | 2009-2013 | 0 | $0 reported | 6 |
| Paul F Knoebel (former) | TRUSTEE | 2009-2013 | 0 | $0 reported | 1 |
| Thomas Wittmann Md (former) | TRUSTEE | 2011-2013 | 0 | $0 reported | 1 |
| Agustin A Ramirez (former) | Trustee | 2009-2012 | 0 | $0 reported | 2 |
| Linda Mellowes (former) | IMMEDIATE PAST CHAIRMAN | 2009-2011 | 0 | $0 reported | 9 |
| Timothy Sullivan (former) | Trustee Until 7/2011 | 2009-2011 | 0 | $0 reported | 7 |
| Sheldon B Lubar (former) | Trustee | 2009-2010 | 0 | $0 reported | 3 |
| Christopher Abele (former) | Trustee UNTIL 4/11 | 2009-2010 | 0 | $0 reported | 1 |
| Cynthia Bauer MD (former) | Trustee | 2009-2010 | 0 | $0 reported | 1 |
| Dennis J Kuester (former) | Trustee UNTIL 2/11 | 2009-2010 | 0 | $0 reported | 1 |
| Jill J Morin (former) | Trustee UNTIL 11/10 | 2009-2010 | 0 | $0 reported | 2 |
| Sheldon A Wasserman (former) | Trustee UNTIL 11/10 | 2009-2010 | 0 | $0 reported | 1 |
| Steven J Smith (former) | Immediate past chairman | 2009 | 0 | $0 reported | 3 |
| Timothy E Hoeksema (former) | Trustee until 3/11/10 | 2009 | 0 | $0 reported | 1 |
People by year
2024 · 63 people listed · 36 paid, $29.6M · 8,196 employees · 26 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MAX C LEE MD | ASST PROF-NEUROSURGERY | 40 | $2,518,112 | $0 | $62,894 | $2,581,006 | 1 |
| MICHAEL EDWARD MITCHELL MD | CHIEF, PROF-PED CARDIAC SURG | 1 | $1,951,025 | $0 | $64,441 | $2,015,466 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $1,637,184 | $0 | $310,119 | $1,947,303 | 5 |
| SAMAN SHABANI MD | ASST PROF-NEUROSURGERY | 40 | $1,872,699 | $0 | $68,180 | $1,940,879 | 1 |
| ABDEL ALQWASMI MD | PHYSICIAN-HEMATOLOGY/ONCOLOGY | 40 | $1,808,484 | $0 | $68,163 | $1,876,647 | 1 |
| JOSEPH E KERSCHNER MD | SEE SCHEDULE O FOR TITLE | 39 | $1,583,187 | $0 | $193,612 | $1,776,799 | 7 |
| MATTHEW COOPER MD | CHIEF, PROF-TRANSPLANT SURGERY | 40 | $1,523,101 | $0 | $64,441 | $1,587,542 | 1 |
| DAVID KING MD | TRUSTEE | 40 | $1,190,917 | $0 | $61,180 | $1,252,097 | 1 |
| MATTHEW LESTER | EXEC VP-FINANCE & ADMIN, COO | 40 | $859,882 | $0 | $150,396 | $1,010,278 | 1 |
| DEBORAH M COSTAKOS MD | SEE SCHEDULE O FOR TITLE | 35 | $858,747 | $0 | $51,887 | $910,634 | 1 |
| CHERYL A MAURANA PHD | SEE SCHEDULE O FOR TITLE | 40 | $757,864 | $0 | $90,790 | $848,654 | 1 |
| M AILEEN SHINAMAN JD | SR VP-GENERAL COUNSEL/ASST SEC | 40 | $679,078 | $0 | $69,119 | $748,197 | 1 |
| MARA LORD PHD | SR VP-CHF STRATEGY & GRWTH OFF | 40 | $616,416 | $0 | $112,056 | $728,472 | 1 |
| SHELISA DALTON | CHIEF FINANCIAL OFFICER | 40 | $589,325 | $0 | $113,035 | $702,360 | 2 |
| DAVID A MARGOLIS MD | SEE SCHEDULE O FOR TITLE | 30 | $632,913 | $0 | $54,769 | $687,682 | 1 |
| ADRIENNE MITCHELL | SR VP-HR, CHIEF PEOPLE OFFICER | 40 | $542,368 | $0 | $122,114 | $664,482 | 1 |
| KEVIN R REGNER MD | SEE SCHEDULE O FOR TITLE | 40 | $546,960 | $0 | $48,472 | $595,432 | 1 |
| DAVID HOTCHKISS | VP-INFORMATION SERVICES, CIO | 40 | $465,702 | $0 | $105,678 | $571,380 | 1 |
| JASON E KRAISS | VP-INST ADVANCEMENT, CDO | 40 | $448,637 | $0 | $101,106 | $549,743 | 1 |
| GREGORY M WESLEY JD | SEE SCHEDULE O FOR TITLE | 40 | $457,558 | $0 | $64,820 | $522,378 | 18 |
| CURT D SIGMUND PHD | TRUSTEE | 40 | $463,687 | $0 | $51,627 | $515,314 | 1 |
| ROY L SILVERSTEIN MD | SEE SCHEDULE O FOR TITLE | 40 | $432,359 | $0 | $53,705 | $486,064 | 1 |
| KEVIN M EIDE | VP-FIN PLANNING/DATA ANALYTICS | 40 | $374,496 | $0 | $96,135 | $470,631 | 1 |
| PAMELA J STANICK | VP-FINANCE & TREASURY | 40 | $372,586 | $0 | $72,540 | $445,126 | 1 |
| TENNILLE SIFUENTES | VP-CORP COMPLIANCE/RISK MGT | 40 | $334,354 | $0 | $95,022 | $429,376 | 1 |
| JEFFREY BORNEMANN | VP-FACILITIES & OP TO 3/2/25 | 40 | $339,891 | $0 | $89,352 | $429,243 | 2 |
| GEORGE MACKINNON III PHD | DEAN, SCHOOL OF PHARMACY | 40 | $371,682 | $0 | $56,117 | $427,799 | 1 |
| SUSAN MELCHER | VP-TOTAL REWARDS/HR ANALYTICS | 40 | $346,708 | $0 | $69,438 | $416,146 | 1 |
| C GREER JORDAN PHD | VP-ANCHOR PARTNERSHIPS | 40 | $335,642 | $0 | $69,984 | $405,626 | 2 |
| DAISY SAHOO PHD | DEAN, SCHOOL OF GRAD STUDIES | 40 | $339,099 | $0 | $62,456 | $401,555 | 1 |
| NATHAN BERKEN | VP-GOVERNMENT RELATIONS | 40 | $268,773 | $0 | $88,749 | $357,522 | 1 |
| KIMARA ELLEFSON | FORMER INTERIM VP-HR | 40 | $288,454 | $0 | $52,717 | $341,171 | 1 |
| MARY REINKE | VP-MARKETING & COMMUNICATIONS | 40 | $268,622 | $0 | $45,217 | $313,839 | 1 |
| JENNIFER S BULTMAN | SEE SCHEDULE O FOR TITLE | 40 | $243,548 | $0 | $55,824 | $299,372 | 1 |
| RAVINDRA P MISRA PHD | FMR DEAN, SCHOOL OF GRAD STUD | 40 | $212,683 | $0 | $31,746 | $244,429 | 1 |
| JOHN T NEWSOME JD | FMR SR VP-GEN COUNSEL/ASST SEC | 10 | $140,563 | $0 | $0 | $140,563 | 1 |
| ELIZABETH BRENNER | TRUSTEE/CHAIR | 3 | $0 | $0 | $0 | $0 | 8 |
| PHILIP B FLYNN | TRUSTEE/IMMEDIATE PAST CHAIR | 1 | $0 | $0 | $0 | $0 | 4 |
| JOHN DONOFRIO | TRUSTEE/VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 1 |
| JACQUELINE HERD-BARBER | TRUSTEE/SECRETARY | 1 | $0 | $0 | $0 | $0 | 11 |
| JON D HAMMES | TRUSTEE/TREASURER | 1 | $0 | $0 | $0 | $0 | 9 |
| CHRISTY L BROWN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BARBARA CALKINS MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LINDA G GORENS-LEVEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN M GROGAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| NANCY HERNANDEZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| TED D KELLNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| DAVID LUBAR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 16 |
| GREGORY S MARCUS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| ANTHONY MCHENRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| CHRIS MISKEL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| JUSTIN L MORTARA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| JANIS M ORLOWSKI MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| GIL PERI | TRUSTEE AS OF 8/12/24 | 1 | $0 | $0 | $0 | $0 | 2 |
| WARREN D PIERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| R JAN PIROZZOLO-MELLOWES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AUSTIN RAMIREZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| KRISTINA M ROPELLA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| STEVE SCHWAB MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| RICH TENNESSEN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PEGGY TROY | TRUSTEE TO 8/11/24 | 1 | $0 | $0 | $0 | $0 | 8 |
| BRIAN S COWPERTHWAITE | VP-FACILITIES &OP AS OF 3/3/24 | 40 | $0 | $0 | $0 | $0 | 1 |
2023 · 59 people listed · 35 paid, $25.8M · 8,103 employees · 26 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MAX C LEE MD | ASST PROF-NEUROSURGERY | 40 | $2,418,193 | $0 | $59,235 | $2,477,428 | 1 |
| MICHAEL EDWARD MITCHELL MD | CHIEF, PROF-PED CARDIAC SURG | 3 | $1,945,478 | $0 | $61,337 | $2,006,815 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $1,428,199 | $0 | $296,446 | $1,724,645 | 5 |
| JOSEPH E KERSCHNER MD | TRUSTEE/PROVOST& EXEC VP, DEAN | 39 | $1,398,843 | $0 | $197,497 | $1,596,340 | 7 |
| ABDEL ALQWASMI MD | PHYSICIAN-HEMATOLOGY/ONCOLOGY | 40 | $1,523,256 | $0 | $65,130 | $1,588,386 | 1 |
| SAMAN SHABANI MD | ASST PROF-NEUROSURGERY | 40 | $1,543,068 | $0 | $39,652 | $1,582,720 | 1 |
| SHEKAR N KURPAD MD | CHAIR, PROF-NEUROSURGERY | 40 | $1,397,196 | $0 | $47,488 | $1,444,684 | 1 |
| DAVID KING MD | TRUSTEE AS OF 1/26/24 | 40 | $1,065,863 | $0 | $58,275 | $1,124,138 | 1 |
| MATTHEW LESTER | EXEC VP-FINANCE & ADMIN, COO | 40 | $737,166 | $0 | $143,752 | $880,918 | 1 |
| ROY L SILVERSTEIN MD | CHAIR, PROF-MEDICINE | 40 | $731,319 | $0 | $51,513 | $782,832 | 1 |
| CYNTHIA A LIEN MD | TRUSTEE | 40 | $675,957 | $0 | $60,987 | $736,944 | 1 |
| GREGORY M WESLEY JD | SR VP-STRAT ALLIANCES/BUS DEV | 40 | $615,914 | $0 | $88,840 | $704,754 | 18 |
| CHERYL A MAURANA PHD | SR VP-STRAT ACADEM PARTNERSHIP | 40 | $604,351 | $0 | $85,849 | $690,200 | 1 |
| SHELISA DALTON | CHIEF FINANCIAL OFFICER | 40 | $500,417 | $0 | $106,268 | $606,685 | 2 |
| MARA LORD PHD | SR VP-UNIV ENGMT/STRAT PLAN | 40 | $504,328 | $0 | $99,596 | $603,924 | 1 |
| DAVID A MARGOLIS MD | INTERIM CHAIR, PROF-PEDIATRICS | 22 | $538,568 | $0 | $52,175 | $590,743 | 1 |
| ADRIENNE MITCHELL | SR VP-HR, CHIEF PEOPLE OFFICER | 40 | $458,417 | $0 | $109,960 | $568,377 | 1 |
| DAVID HOTCHKISS | VP-INFORMATION SERVICES, CIO | 40 | $411,313 | $0 | $101,592 | $512,905 | 1 |
| MITCHELL BECKMAN | FORMER VP-DEVELOPMENT, CDO | 0 | $477,389 | $0 | $24,347 | $501,736 | 1 |
| PAMELA J STANICK | VP-FINANCE & TREASURY | 40 | $376,705 | $0 | $70,069 | $446,774 | 1 |
| GEORGE MACKINNON III PHD | DEAN, SCHOOL OF PHARMACY | 40 | $368,361 | $0 | $59,553 | $427,914 | 1 |
| KEVIN M EIDE | VP-FIN PLANNING/DATA ANALYTICS | 40 | $332,486 | $0 | $92,244 | $424,730 | 1 |
| JEFFREY BORNEMANN | VP-FACILITIES & OPERATIONS | 40 | $300,944 | $0 | $83,888 | $384,832 | 2 |
| TENNILLE SIFUENTES | VP-CORP COMPLIANCE/RISK MGT | 40 | $277,106 | $0 | $80,602 | $357,708 | 1 |
| C GREER JORDAN PHD | VP-INCLUSION/DIVERSITY, CDIO | 40 | $279,407 | $0 | $74,131 | $353,538 | 2 |
| SUSAN MELCHER | VP-TOTAL REWARDS/HR ANALYTICS | 40 | $300,254 | $0 | $48,127 | $348,381 | 1 |
| JASON E KRAISS | SEE SCHEDULE O FOR TITLE | 40 | $279,024 | $0 | $57,432 | $336,456 | 1 |
| KIMARA ELLEFSON | FORMER INTERIM VP-HR | 40 | $275,577 | $0 | $45,229 | $320,806 | 1 |
| DAISY SAHOO PHD | SEE SCHEDULE O FOR TITLE | 40 | $265,167 | $0 | $53,370 | $318,537 | 1 |
| M AILEEN SHINAMAN JD | SEE SCHEDULE O FOR TITLE | 40 | $282,530 | $0 | $34,023 | $316,553 | 1 |
| NATHAN BERKEN | SEE SCHEDULE O FOR TITLE | 40 | $221,670 | $0 | $64,283 | $285,953 | 1 |
| MARY REINKE | VP-MARKETING & COMMUNICATIONS | 40 | $221,589 | $0 | $39,017 | $260,606 | 1 |
| RAVINDRA P MISRA PHD | SEE SCHEDULE O FOR TITLE | 40 | $207,545 | $0 | $29,974 | $237,519 | 1 |
| ANNE M BROWN JD | FORMER INTERIM GEN COUNSEL | 0 | $136,263 | $0 | $15,039 | $151,302 | 1 |
| JOHN T NEWSOME JD | FMR SR VP-GEN COUNSEL/ASST SEC | 10 | $140,563 | $0 | $0 | $140,563 | 1 |
| PHILIP B FLYNN | TRUSTEE/CHAIR OF THE BOARD | 2 | $0 | $0 | $0 | $0 | 4 |
| ELIZABETH BRENNER | TRUSTEE/VICE CHAIR | 2 | $0 | $0 | $0 | $0 | 8 |
| JACQUELINE HERD-BARBER | TRUSTEE/SECRETARY | 1 | $0 | $0 | $0 | $0 | 11 |
| JON D HAMMES | TRUSTEE/TREASURER AS OF 7/1/23 | 1 | $0 | $0 | $0 | $0 | 9 |
| CHRISTY L BROWN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| BARBARA CALKINS MD | TRUSTEE AS OF 7/1/23 | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN DONOFRIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| LINDA G GORENS-LEVEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN M GROGAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| NANCY HERNANDEZ | TRUSTEE AS OF 7/1/23 | 1 | $0 | $0 | $0 | $0 | 7 |
| TED D KELLNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| DAVID LUBAR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 16 |
| GREGORY S MARCUS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| ANTHONY MCHENRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| CHRIS MISKEL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| JUSTIN L MORTARA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| JANIS M ORLOWSKI MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WARREN D PIERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| R JAN PIROZZOLO-MELLOWES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AUSTIN RAMIREZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| KRISTINA M ROPELLA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| RICH TENNESSEN | TRUSTEE AS OF 7/1/23 | 1 | $0 | $0 | $0 | $0 | 1 |
| PEGGY TROY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
2022 · 60 people listed · 35 paid, $26.3M · 7,887 employees · 25 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MAX C LEE MD | ASST PROF-NEUROSURGERY | 40 | $2,784,751 | $0 | $55,674 | $2,840,425 | 1 |
| JOSEPH D CHABOT DO | ASST PROF-NEUROSURGERY | 40 | $2,080,630 | $0 | $57,687 | $2,138,317 | 1 |
| MICHAEL EDWARD MITCHELL MD | CHIEF, PROF-PED CARDIAC SURG | 5 | $1,914,091 | $0 | $57,687 | $1,971,778 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $1,718,522 | $0 | $171,528 | $1,890,050 | 5 |
| JOSEPH E KERSCHNER MD | TRUSTEE/PROVOST& EXEC VP, DEAN | 39 | $1,515,267 | $0 | $191,242 | $1,706,509 | 7 |
| DOUGLAS B EVANS MD | CHAIR, PROF-SURGERY | 40 | $1,523,262 | $0 | $46,044 | $1,569,306 | 1 |
| SHEKAR N KURPAD MD | CHAIR, PROF-NEUROSURGERY | 40 | $1,456,899 | $0 | $46,249 | $1,503,148 | 1 |
| CHRISTOPHER P KOPS | SEE SCHEDULE O FOR TITLE | 40 | $832,743 | $0 | $38,374 | $871,117 | 1 |
| ROY L SILVERSTEIN MD | CHAIR, PROF-MEDICINE | 40 | $748,074 | $0 | $47,529 | $795,603 | 1 |
| CYNTHIA A LIEN MD | TRUSTEE | 1 | $708,386 | $0 | $57,437 | $765,823 | 1 |
| GREGORY M WESLEY JD | SR VP-STRAT ALLIANCES/BUS DEV | 40 | $611,229 | $0 | $84,835 | $696,064 | 18 |
| CHERYL MAURANA PHD | SR VP-STRAT ACADEM PARTNERSHIP | 40 | $604,635 | $0 | $82,411 | $687,046 | 1 |
| DAVID A MARGOLIS MD | INTERIM CHAIR, PROF-PEDIATRICS | 20 | $526,317 | $0 | $48,940 | $575,257 | 1 |
| SHELISA DALTON | CHIEF FINANCIAL OFFICER | 40 | $497,530 | $0 | $77,705 | $575,235 | 2 |
| MARA LORD PHD | SR VP-UNIV ENGMT/STRAT PLAN | 40 | $471,015 | $0 | $99,523 | $570,538 | 1 |
| ADRIENNE MITCHELL | VP-CHIEF PEOPLE OFFICER | 40 | $462,207 | $0 | $80,819 | $543,026 | 1 |
| DAVID HOTCHKISS | VP-INFORMATION SERVICES, CIO | 40 | $431,677 | $0 | $78,505 | $510,182 | 1 |
| MITCHELL BECKMAN | SEE SCHEDULE O FOR TITLE | 40 | $418,270 | $0 | $74,793 | $493,063 | 1 |
| GEORGE MACKINNON III PHD | DEAN, SCHOOL OF PHARMACY | 40 | $424,027 | $0 | $55,992 | $480,019 | 1 |
| KEVIN M EIDE | VP-FIN PLANNING/DATA ANALYTICS | 40 | $366,303 | $0 | $72,715 | $439,018 | 1 |
| PAMELA J STANICK | VP-FINANCE & TREASURY | 40 | $355,665 | $0 | $52,131 | $407,796 | 1 |
| MATTHEW LESTER | SEE SCHEDULE O FOR TITLE | 40 | $325,431 | $0 | $70,344 | $395,775 | 1 |
| JEFFREY BORNEMANN | VP-FACILITIES & OPERATIONS | 40 | $316,032 | $0 | $67,433 | $383,465 | 2 |
| JOHN T NEWSOME ESQ | FMR SR VP-GEN COUNSEL/ASST SEC | 10 | $334,334 | $0 | $47,702 | $382,036 | 1 |
| ANNE M BROWN JD | INTERIM GEN COUNSEL TO 3/3/23 | 40 | $337,056 | $0 | $36,640 | $373,696 | 1 |
| C GREER JORDAN PHD | VP-INCLUSION/DIVERSITY, CDIO | 40 | $285,069 | $0 | $68,204 | $353,273 | 2 |
| KATHRYN KUHN | SEE SCHEDULE O FOR TITLE | 40 | $315,680 | $0 | $35,789 | $351,469 | 2 |
| TENNILLE SIFUENTES | SEE SCHEDULE O FOR TITLE | 40 | $276,454 | $0 | $54,336 | $330,790 | 1 |
| KIMARA ELLEFSON | FORMER INTERIM VP-HR | 40 | $261,553 | $0 | $46,724 | $308,277 | 1 |
| CARLOS BROWN | SEE SCHEDULE O FOR TITLE | 40 | $263,759 | $0 | $14,837 | $278,596 | 1 |
| JASON E KRAISS | SEE SCHEDULE O FOR TITLE | 40 | $226,062 | $0 | $40,884 | $266,946 | 1 |
| MARY REINKE | VP-MARKETING & COMMUNICATIONS | 40 | $218,295 | $0 | $27,914 | $246,209 | 1 |
| RAVINDRA P MISRA PHD | DEAN, SCHOOL OF GRAD STUDIES | 40 | $214,575 | $0 | $29,744 | $244,319 | 1 |
| NATHAN BERKEN | SEE SCHEDULE O FOR TITLE | 40 | $155,489 | $0 | $49,364 | $204,853 | 1 |
| SUSAN MELCHER | VP-TOTAL REWARDS/HR ANALYTICS | 40 | $145,062 | $0 | $18,422 | $163,484 | 1 |
| PHILIP B FLYNN | TRUSTEE/CHAIRMAN | 2 | $0 | $0 | $0 | $0 | 4 |
| JAY B WILLIAMS | TRUSTEE/IMMEDIATE PAST CHAIR | 2 | $0 | $0 | $0 | $0 | 4 |
| ELIZABETH BRENNER | TRUSTEE/VICE CHAIRMAN | 2 | $0 | $0 | $0 | $0 | 8 |
| JACQUELINE HERD-BARBER | TRUSTEE/SECRETARY | 1 | $0 | $0 | $0 | $0 | 11 |
| MARY ELLEN STANEK | TRUSTEE/TREASURER | 1 | $0 | $0 | $0 | $0 | 12 |
| CHRISTY L BROWN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN DONOFRIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID GAY | TRUSTEE TO 8/26/22 | 1 | $0 | $0 | $0 | $0 | 6 |
| LINDA G GORENS-LEVEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN M GROGAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JON D HAMMES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| TED D KELLNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| DAVID LUBAR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 16 |
| GREGORY S MARCUS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| ANTHONY MCHENRY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 5 |
| CHRIS MISKEL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| JUSTIN L MORTARA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| MARIE NAKATA MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| JANIS M ORLOWSKI MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WARREN D PIERSON | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| R JAN PIROZZOLO-MELLOWES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AUSTIN RAMIREZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| KRISTINA ROPELLA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PEGGY TROY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
2021 · 56 people listed · 30 paid, $25.7M · 7,385 employees · 26 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MAX C LEE MD | ASST PROF-NEUROSURGERY | 40 | $2,996,895 | $0 | $53,522 | $3,050,417 | 1 |
| VIKTOR HRASKA MD | CHIEF, PROF-PED CARDIAC SURG | 2 | $2,867,036 | $0 | $42,504 | $2,909,540 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $2,066,220 | $0 | $118,400 | $2,184,620 | 5 |
| JOSEPH E KERSCHNERMD | TRUSTEE/PROVOST& EXEC VP, DEAN | 39 | $1,600,660 | $0 | $177,010 | $1,777,670 | 1 |
| SHEKAR N KURPAD MD | CHAIR, PROF-NEUROSURGERY | 40 | $1,518,050 | $0 | $42,611 | $1,560,661 | 1 |
| DOUGLAS B EVANS MD | CHAIR, PROF-SURGERY | 40 | $1,514,811 | $0 | $44,221 | $1,559,032 | 1 |
| ABDEL ALQWASMI MD | PHYSICIAN-HEMATOLOGY/MED ONCOL | 40 | $1,466,159 | $0 | $54,139 | $1,520,298 | 1 |
| CHRISTOPHER P KOPS | EXEC VP-FINANCE & ADMIN, COO | 40 | $823,055 | $0 | $101,875 | $924,930 | 1 |
| ROY L SILVERSTEIN MD | CHAIR, PROF-MEDICINE | 40 | $858,259 | $0 | $45,252 | $903,511 | 1 |
| CHERYL MAURANA PHD | SR VP-STRAT ACADEM PARTNERSHIP | 40 | $775,925 | $0 | $78,201 | $854,126 | 1 |
| GREGORY M WESLEY JD | SR VP-STRAT ALLIANCES/BUS DEV | 40 | $614,443 | $0 | $80,832 | $695,275 | 18 |
| JOHN T NEWSOME ESQ | SEE SCHEDULE O FOR TITLE | 40 | $561,969 | $0 | $110,081 | $672,050 | 1 |
| MARA LORD | SR VP-UNIV ENGMT/STRAT PLAN | 40 | $520,347 | $0 | $101,682 | $622,029 | 1 |
| KURT L JANAVITZ | FORMER SR VP-HLTHCARE PSHIP | 40 | $527,402 | $0 | $19,192 | $546,594 | 1 |
| DAVID A MARGOLIS MD | INTERIM CHAIR, PROF-PEDIATRICS | 20 | $469,737 | $0 | $46,864 | $516,601 | 1 |
| ADRIENNE MITCHELL | VP-CHIEF PEOPLE OFFICER | 40 | $437,727 | $0 | $53,306 | $491,033 | 1 |
| DAVID HOTCHKISS | VP-INFORMATION SERVICES, CIO | 40 | $424,388 | $0 | $57,109 | $481,497 | 1 |
| MITCHELL BECKMAN | VP-DEVELOPMENT, CDO | 40 | $399,398 | $0 | $54,258 | $453,656 | 1 |
| GEORGE MACKINNON III PHD | DEAN, PHARMACY SCHOOL | 40 | $379,488 | $0 | $53,645 | $433,133 | 1 |
| SHELISA DALTON | CFO FROM 11/15/21 | 40 | $352,088 | $0 | $52,509 | $404,597 | 2 |
| KATHRYN KUHN | VP-GOVT & COMMUNITY RELATIONS | 40 | $314,387 | $0 | $35,102 | $349,489 | 2 |
| JEFFREY BORNEMANN | VP-FACILITIES & OPERATIONS | 40 | $291,348 | $0 | $51,169 | $342,517 | 2 |
| BARCLAY FERGUSON | CFO TO 7/9/21 | 40 | $312,178 | $0 | $26,738 | $338,916 | 1 |
| ANNE M BROWN JD | SEE SCHEDULE O FOR TITLE | 40 | $303,463 | $0 | $34,588 | $338,051 | 1 |
| JOHN R KIRBY PHD | TRUSTEE | 40 | $303,850 | $0 | $33,690 | $337,540 | 1 |
| C GREER JORDAN PHD | VP-INCLUSION/DIVERSITY, CDIO | 40 | $278,859 | $0 | $55,224 | $334,083 | 2 |
| DANIEL WICKEHAM | VP-COMP & RISK MGT TO 10/1/21 | 40 | $262,994 | $0 | $46,419 | $309,413 | 1 |
| KIMARA ELLEFSON | FORMER INTERIM VP-HR | 40 | $258,553 | $0 | $44,372 | $302,925 | 1 |
| TENNILLE SIFUENTES | SEE SCHEDULE O FOR TITLE | 40 | $188,888 | $0 | $36,551 | $225,439 | 1 |
| RAVINDRA P MISRA PHD | DEAN, GRADUATE SCHOOL | 40 | $196,777 | $0 | $28,623 | $225,400 | 1 |
| JAY B WILLIAMS | TRUSTEE/CHAIRMAN | 2 | $0 | $0 | $0 | $0 | 4 |
| CORY L NETTLES | TRUSTEE/IMMEDIATE PAST CHAIR | 2 | $0 | $0 | $0 | $0 | 13 |
| PHILIP B FLYNN | TRUSTEE/VICE CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 4 |
| JACQUELINE HERD-BARBER | TRUSTEE/SECRETARY | 1 | $0 | $0 | $0 | $0 | 11 |
| MARY ELLEN STANEK | TRUSTEE/TREASURER | 1 | $0 | $0 | $0 | $0 | 12 |
| ELIZABETH BRENNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| CHRISTY L BROWN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN DONOFRIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID GAY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 6 |
| LINDA G GORENS-LEVEY | TRUSTEE | 2 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN M GROGAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JON D HAMMES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| TED D KELLNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| DAVID LUBAR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 16 |
| GREGORY S MARCUS | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 7 |
| CHRIS MISKEL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| JUSTIN L MORTARA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| MARIE NAKATA MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WAYNE C OLDENBURG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| JANIS M ORLOWSKI MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| R JAN PIROZZOLO-MELLOWES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| AUSTIN RAMIREZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| KRISTINA ROPELLA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| PEGGY TROY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| CARLOS BROWN | VP-COMP & RISK MGT FM 3/15/22 | 40 | $0 | $0 | $0 | $0 | 1 |
2020 · 51 people listed · 27 paid, $21.0M · 7,052 employees · 24 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| MAX C LEE MD | ASST PROF-NEUROSURGERY | 40 | $2,448,434 | $0 | $29,549 | $2,477,983 | 1 |
| VIKTOR HRASKA MD | CHIEF, PROF-PED CARDIAC SURG | 2 | $1,823,839 | $0 | $43,210 | $1,867,049 | 1 |
| SHEKAR N KURPAD MD | CHAIR, PROF-NEUROSURGERY | 40 | $1,426,450 | $0 | $40,735 | $1,467,185 | 1 |
| ABDEL ALQWASMI MD | PHYSICIAN-HEMATOLOGY/MED ONCOL | 40 | $1,398,811 | $0 | $53,086 | $1,451,897 | 1 |
| DOUGLAS B EVANS MD | CHAIR, PROF-SURGERY | 40 | $1,395,358 | $0 | $43,210 | $1,438,568 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $1,232,811 | $0 | $170,435 | $1,403,246 | 5 |
| JOSEPH E KERSCHNERMD | TRUSTEE/PROVOST& EXEC VP, DEAN | 38 | $1,202,846 | $0 | $162,989 | $1,365,835 | 1 |
| CHRISTOPHER P KOPS | EXEC VP-FINANCE & ADMIN, COO | 40 | $841,811 | $0 | $99,923 | $941,734 | 1 |
| ROY L SILVERSTEIN MD | CHAIR, PROF-MEDICINE | 40 | $739,332 | $0 | $44,410 | $783,742 | 1 |
| JOHN T NEWSOME ESQ | SR VP-GENERAL COUNSEL/ASST SEC | 40 | $631,536 | $0 | $81,038 | $712,574 | 1 |
| CHERYL MAURANA PHD | SR VP-STRAT ACADEM PARTNERSHIP | 40 | $534,878 | $0 | $105,186 | $640,064 | 1 |
| GREGORY M WESLEY | SR VP-STRAT ALLIANCES/BUS DEV | 40 | $537,735 | $0 | $78,970 | $616,705 | 18 |
| KURT L JANAVITZ | SRVP-HLTHCARE PSHIP TO 2/28/21 | 40 | $499,527 | $0 | $85,614 | $585,141 | 1 |
| MARA LORD | SR VP-UNIV ENGMT/STRAT PLAN | 40 | $476,008 | $0 | $101,279 | $577,287 | 1 |
| BARCLAY FERGUSON | CHIEF FINANCIAL OFFICER | 40 | $471,348 | $0 | $29,453 | $500,801 | 1 |
| GEORGE MACKINNON III PHD | DEAN, PHARMACY SCHOOL | 40 | $406,767 | $0 | $52,402 | $459,169 | 1 |
| DAVID A MARGOLIS MD | INT CHAIR,PROF-PEDS FM 1/20/20 | 20 | $399,547 | $0 | $49,159 | $448,706 | 1 |
| DAVID HOTCHKISS | VP-INFORMATION SERVICES, CIO | 40 | $387,747 | $0 | $55,793 | $443,540 | 1 |
| MITCHELL BECKMAN | VP-DEVELOPMENT, CDO | 40 | $353,525 | $0 | $52,503 | $406,028 | 1 |
| KIMARA ELLEFSON | INTERIM VP-HR TO 12/31/20 | 40 | $300,284 | $0 | $44,202 | $344,486 | 1 |
| DANIEL WICKEHAM | VP-CORP COMPLIANCE & RISK MGT | 40 | $291,563 | $0 | $51,753 | $343,316 | 1 |
| KATHRYN KUHN | VP-GOVT & COMMUNITY RELATIONS | 40 | $289,843 | $0 | $47,214 | $337,057 | 2 |
| JOHN R KIRBY PHD | TRUSTEE | 40 | $285,225 | $0 | $33,894 | $319,119 | 1 |
| C GREER JORDAN PHD | VP-INCLUSION/DIVERSITY, CDIO | 40 | $263,246 | $0 | $52,775 | $316,021 | 2 |
| JEFFREY BORNEMANN | VP-FACILITIES & OPERATIONS | 40 | $266,904 | $0 | $48,443 | $315,347 | 2 |
| RAVINDRA P MISRA PHD | DEAN, GRADUATE SCHOOL | 40 | $189,865 | $0 | $27,173 | $217,038 | 1 |
| SHERRI DUCHARME-WHITE | FORMER VP-HR | 0 | $201,140 | $0 | $0 | $201,140 | 1 |
| JAY B WILLIAMS | TRUSTEE/CHAIRMAN | 2 | $0 | $0 | $0 | $0 | 4 |
| CORY L NETTLES | TRUSTEE/IMMEDIATE PAST CHAIR | 2 | $0 | $0 | $0 | $0 | 13 |
| PHILIP B FLYNN | TRUSTEE/VICE CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 4 |
| MARY ELLEN STANEK | TRUSTEE/SECRETARY | 1 | $0 | $0 | $0 | $0 | 12 |
| THOMAS L SPERO | TRUSTEE/TREASURER | 1 | $0 | $0 | $0 | $0 | 7 |
| ELIZABETH BRENNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| CHRISTY L BROWN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN DONOFRIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| DAVID GAY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 6 |
| LINDA G GORENS-LEVEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN M GROGAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JON D HAMMES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| JACQUELINE HERD-BARBER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 11 |
| TED D KELLNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| DAVID LUBAR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 16 |
| CHRIS MISKEL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| JUSTIN L MORTARA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| MARIE NAKATA MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| WAYNE C OLDENBURG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| JANIS M ORLOWSKI MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| R JAN PIROZZOLO-MELLOWES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KRISTINA ROPELLA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| ADRIENNE MITCHELL | VP-CHIEF PEOPLE OFF FM 1/1/21 | 40 | $0 | $0 | $0 | $0 | 1 |
2019 · 50 people listed · 27 paid, $20.3M · 7,232 employees · 24 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| VIKTOR HRASKA MD | CHIEF, PROF-PED CARDIAC SURG | 2 | $1,823,985 | $0 | $41,907 | $1,865,892 | 1 |
| ABDEL ALQWASMI MD | PHYSICIAN-HEMATOLOGY/MED ONCOL | 40 | $1,477,964 | $0 | $48,304 | $1,526,268 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $1,288,333 | $0 | $169,025 | $1,457,358 | 5 |
| SHEKAR N KURPAD MD | CHAIR, PROF-NEUROSURGERY | 40 | $1,398,263 | $0 | $33,142 | $1,431,405 | 1 |
| JOSEPH E KERSCHNERMD | TRUSTEE/PROVOST& EXEC VP, DEAN | 38 | $1,258,311 | $0 | $161,462 | $1,419,773 | 1 |
| MADHURI TRIVEDI MD | PHYSICIAN-GASTROENTEROLOGY | 40 | $1,334,108 | $0 | $41,792 | $1,375,900 | 1 |
| DOUGLAS B EVANS MD | CHAIR, PROF-SURGERY | 40 | $1,331,035 | $0 | $41,907 | $1,372,942 | 1 |
| VINCENT P MATHEWS MD | TRUSTEE | 40 | $834,231 | $0 | $44,573 | $878,804 | 1 |
| CHRISTOPHER P KOPS | EXEC VP-FINANCE & ADMIN, COO | 40 | $676,079 | $0 | $99,968 | $776,047 | 1 |
| ROY L SILVERSTEIN MD | CHAIR, PROF-MEDICINE | 40 | $695,479 | $0 | $42,917 | $738,396 | 1 |
| ROBERT LANE MD | CHAIR, PROF-PEDIATRICS | 40 | $637,575 | $0 | $52,373 | $689,948 | 1 |
| CHERYL MAURANA PHD | SR VP-ACADEMIC PARTNERSHIPS | 40 | $533,994 | $0 | $103,858 | $637,852 | 1 |
| JOHN T NEWSOME ESQ | SR VP-GENERAL COUNSEL/ASST SEC | 40 | $530,781 | $0 | $52,307 | $583,088 | 1 |
| GREGORY M WESLEY | SR VP-STRAT ALLIANCES/BUS DEV | 40 | $503,116 | $0 | $78,414 | $581,530 | 18 |
| KURT L JANAVITZ | SR VP-HEALTHCARE PARTNERSHIPS | 40 | $488,856 | $0 | $85,588 | $574,444 | 1 |
| SHERRI DUCHARME-WHITE | VP-HR TO 8/31/19 | 40 | $493,991 | $0 | $52,904 | $546,895 | 1 |
| BARCLAY FERGUSON | CHIEF FINANCIAL OFFICER | 40 | $470,121 | $0 | $32,902 | $503,023 | 1 |
| MARA LORD | SEE SCHEDULE O FOR TITLE | 40 | $429,028 | $0 | $65,280 | $494,308 | 1 |
| DAVID HOTCHKISS | VP-INFORMATION SERVICES, CIO | 40 | $379,383 | $0 | $54,070 | $433,453 | 1 |
| GEORGE MACKINNON III PHD | DEAN, PHARMACY SCHOOL | 40 | $361,644 | $0 | $50,907 | $412,551 | 1 |
| DANIEL WICKEHAM | VP-CORP COMPLIANCE & RISK MGT | 40 | $295,551 | $0 | $50,113 | $345,664 | 1 |
| KATHRYN KUHN | VP-GOVT & COMMUNITY RELATIONS | 40 | $292,705 | $0 | $49,928 | $342,633 | 2 |
| C GREER JORDAN PHD | CHIEF DIVERSITY OFFICER | 40 | $259,336 | $0 | $51,589 | $310,925 | 2 |
| JEFFREY BORNEMANN | VP-FACILITIES & OPERATIONS | 40 | $263,118 | $0 | $47,144 | $310,262 | 2 |
| KIMARA ELLEFSON | INTERIM VP-HR FM 12/1/19 | 40 | $237,358 | $0 | $40,750 | $278,108 | 1 |
| RAVINDRA P MISRA PHD | DEAN, GRADUATE SCHOOL | 40 | $189,886 | $0 | $27,220 | $217,106 | 1 |
| MITCHELL BECKMAN | VP-DEVELOPMENT/CDO FM 9/16/19 | 40 | $164,950 | $0 | $7,160 | $172,110 | 1 |
| CORY L NETTLES | TRUSTEE/CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 13 |
| MARY ELLEN STANEK | TRUSTEE/IMMEDIATE PAST CHAIR | 1 | $0 | $0 | $0 | $0 | 12 |
| JAY B WILLIAMS | TRUSTEE/VICE CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 4 |
| JACQUELINE HERD-BARBER | TRUSTEE/SECRETARY | 1 | $0 | $0 | $0 | $0 | 11 |
| THOMAS L SPERO | TRUSTEE/TREASURER | 1 | $0 | $0 | $0 | $0 | 7 |
| ELIZABETH BRENNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| CHRISTY L BROWN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN DONOFRIO | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP B FLYNN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| DAVID GAY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 6 |
| LINDA G GORENS-LEVEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JOHN M GROGAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JON D HAMMES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| PAUL E HANKWITZ MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TED D KELLNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| DAVID LUBAR | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 16 |
| CHRIS MISKEL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| JUSTIN L MORTARA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| WAYNE C OLDENBURG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| JANIS M ORLOWSKI MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| R JAN PIROZZOLO-MELLOWES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KRISTINA ROPELLA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
2018 · 48 people listed · 26 paid, $19.8M · 7,018 employees · 23 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| VIKTOR HRASKA MD | CHIEF, PROF PED CARDIAC SURG | 3 | $1,823,032 | $0 | $42,014 | $1,865,046 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $1,623,057 | $0 | $110,930 | $1,733,987 | 5 |
| SHEKAR N KURPAD MD | CHAIR, PROF DEPT OF NEUROSURG | 40 | $1,454,496 | $0 | $33,422 | $1,487,918 | 1 |
| DOUGLAS B EVANS MD | CHAIR, PROF DEPT OF SURGERY | 40 | $1,324,321 | $0 | $42,015 | $1,366,336 | 1 |
| J CHANNING TASSONEMD | PROF OF ORTHOPAEDIC SURGERY | 1 | $1,299,202 | $0 | $41,986 | $1,341,188 | 1 |
| JOHNNY C HONG MD | CHIEF, PROF TRANSPLANT SURG | 40 | $1,288,047 | $0 | $52,801 | $1,340,848 | 1 |
| JOSEPH E KERSCHNERMD | TRUSTEE/PROVOST& EXEC VP, DEAN | 38 | $1,069,346 | $0 | $157,940 | $1,227,286 | 1 |
| VINCENT P MATHEWS MD | TRUSTEE | 40 | $742,017 | $0 | $44,819 | $786,836 | 1 |
| CHRISTOPHER P KOPS | EXEC VP-FINANCE & ADMIN, COO | 40 | $660,326 | $0 | $98,142 | $758,468 | 1 |
| ROY L SILVERSTEIN MD | CHAIR, PROF DEPT OF MEDICINE | 40 | $688,061 | $0 | $43,137 | $731,198 | 1 |
| ROBERT LANE MD | CHAIR, PROF DEPT OF PEDIATRICS | 40 | $605,608 | $0 | $52,601 | $658,209 | 1 |
| CHERYL MAURANA PHD | SR VP-ACADEMIC PARTNERSHIPS | 40 | $560,979 | $0 | $76,455 | $637,434 | 1 |
| JOHN T NEWSOME ESQ | SR VP-GENERAL COUNSEL/ASST SEC | 40 | $535,802 | $0 | $52,886 | $588,688 | 1 |
| KURT L JANAVITZ | SR VP-HEALTHCARE PARTNERSHIPS | 40 | $478,857 | $0 | $75,928 | $554,785 | 1 |
| GREGORY M WESLEY | SR VP-STRATEGIC ALLIANCES | 40 | $495,555 | $0 | $54,551 | $550,106 | 18 |
| ALICE ARCHABAL | VP-DEVELOPMENT/CDO TO 11/16/18 | 40 | $443,331 | $0 | $90,359 | $533,690 | 1 |
| BARCLAY FERGUSON | CHIEF FINANCIAL OFFICER | 40 | $454,440 | $0 | $52,206 | $506,646 | 1 |
| SHERRI DUCHARME-WHITE | VP-HR & FACULTY AFFAIRS | 40 | $405,360 | $0 | $55,521 | $460,881 | 1 |
| DAVID HOTCHKISS | VP-INFORMATION SERVICES, CIO | 40 | $371,861 | $0 | $53,899 | $425,760 | 1 |
| GEORGE MACKINNON III PHD | DEAN, PHARMACY SCHOOL | 40 | $360,065 | $0 | $51,531 | $411,596 | 1 |
| DANIEL WICKEHAM | VP-CORP COMPLIANCE & RISK MGT | 40 | $294,131 | $0 | $50,678 | $344,809 | 1 |
| KATHRYN KUHN | VP-GOVT & COMMUNITY RELATIONS | 40 | $286,683 | $0 | $50,651 | $337,334 | 2 |
| C GREER JORDAN PHD | CHIEF DIVERSITY OFFICER | 40 | $274,556 | $0 | $51,678 | $326,234 | 2 |
| MARA LORD | VP-COMMUNICATIONS, INTERIM CDO | 40 | $268,672 | $0 | $51,337 | $320,009 | 1 |
| JEFFREY BORNEMANN | VP-FACILITIES & OPERATIONS | 40 | $246,547 | $0 | $45,595 | $292,142 | 2 |
| RAVINDRA P MISRA PHD | DEAN, GRADUATE SCHOOL | 40 | $188,542 | $0 | $27,209 | $215,751 | 1 |
| CORY L NETTLES | TRUSTEE/CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 13 |
| MARY ELLEN STANEK | TRUSTEE/IMMEDIATE PAST CHAIR | 1 | $0 | $0 | $0 | $0 | 12 |
| JAY B WILLIAMS | TRUSTEE/VICE CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 4 |
| JACQUELINE HERD-BARBER | TRUSTEE/SECRETARY | 1 | $0 | $0 | $0 | $0 | 11 |
| THOMAS L SPERO | TRUSTEE/TREASURER | 1 | $0 | $0 | $0 | $0 | 7 |
| ELIZABETH BRENNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| JOHN DONOFRIO | TRUSTEE AS OF 9/21/18 | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP B FLYNN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| DAVID GAY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 6 |
| LINDA G GORENS-LEVEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JON D HAMMES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| PAUL E HANKWITZ MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| TED D KELLNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| DAVID LUBAR | TRUSTEE AS OF 9/21/18 | 1 | $0 | $0 | $0 | $0 | 16 |
| CHRIS MISKEL | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| JUSTIN L MORTARA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| WAYNE C OLDENBURG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| JANIS M ORLOWSKI MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| R JAN PIROZZOLO-MELLOWES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| KRISTINA ROPELLA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| OWEN J SULLIVAN | TRUSTEE UNTIL 9/21/18 | 1 | $0 | $0 | $0 | $0 | 4 |
2017 · 46 people listed · 25 paid, $18.5M · 6,651 employees · 22 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| VIKTOR HRASKA MD | CHIEF, PROF PED CARDIAC SURG | 3 | $1,833,199 | $0 | $19,494 | $1,852,693 | 1 |
| DOUGLAS B EVANS MD | CHAIR, PROF DEPT OF SURGERY | 40 | $1,610,311 | $0 | $41,094 | $1,651,405 | 1 |
| RONALD K WOODS MD | PROF OF PED CARDIAC SURGERY | 1 | $1,491,481 | $0 | $51,680 | $1,543,161 | 1 |
| SHEKAR N KURPAD MD | CHAIR, PROF OF NEUROSURGERY | 40 | $1,456,077 | $0 | $30,759 | $1,486,836 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $1,260,637 | $0 | $165,271 | $1,425,908 | 5 |
| J CHANNING TASSONE MD | PROF OF ORTHOPAEDIC SURGERY | 1 | $1,305,172 | $0 | $41,125 | $1,346,297 | 1 |
| JOSEPH KERSCHNER MD | TRUSTEE/PROVOST& EXEC VP, DEAN | 40 | $1,044,973 | $0 | $146,978 | $1,191,951 | 7 |
| CHRISTOPHER P KOPS | EXEC VP-FINANCE & ADMIN, COO | 40 | $688,860 | $0 | $98,041 | $786,901 | 1 |
| ROY L SILVERSTEIN MD | TRUSTEE | 40 | $633,127 | $0 | $42,338 | $675,465 | 1 |
| JOHN T NEWSOME ESQ | SR VP-GENERAL COUNSEL/ASST SEC | 40 | $624,781 | $0 | $50,358 | $675,139 | 1 |
| ROBERT LANE MD | CHAIR, PROF DEPT OF PEDIATRICS | 38 | $565,784 | $0 | $51,456 | $617,240 | 1 |
| GREGORY M WESLEY | SR VP-STRATEGIC ALLIANCES | 40 | $483,475 | $0 | $56,421 | $539,896 | 18 |
| CHERYL MAURANA PHD | SR VP-ACADEMIC PARTNERSHIPS | 40 | $476,885 | $0 | $45,317 | $522,202 | 1 |
| ALICE ARCHABAL | VP-DEVELOPMENT | 40 | $396,318 | $0 | $88,312 | $484,630 | 1 |
| SHERRI DUCHARME-WHITE | VP-HR & FACULTY AFFAIRS | 40 | $371,236 | $0 | $52,782 | $424,018 | 1 |
| GEORGE MACKINNON III PHD | DEAN, PHARMACY SCHOOL | 40 | $351,368 | $0 | $49,834 | $401,202 | 1 |
| BARCLAY FERGUSON | CHIEF FINANCIAL OFFICER | 40 | $358,076 | $0 | $33,474 | $391,550 | 1 |
| DAVID HOTCHKISS | VP-INFORMATION SERVICES, CIO | 40 | $338,064 | $0 | $51,912 | $389,976 | 1 |
| KURT L JANAVITZ | SR VP-HEALTHCARE PARTNERSHIPS | 40 | $292,650 | $0 | $59,511 | $352,161 | 1 |
| DANIEL WICKEHAM | VP-CORP COMPLIANCE & RISK MGT | 40 | $282,290 | $0 | $49,431 | $331,721 | 1 |
| C GREER JORDAN PHD | CHIEF DIVERSITY OFFICER | 40 | $270,974 | $0 | $48,907 | $319,881 | 2 |
| KATHRYN A KUHN | VP-GOVT & COMMUNITY RELATIONS | 40 | $262,127 | $0 | $48,457 | $310,584 | 2 |
| JEFFREY BORNEMANN | VP-FACILITIES & OPERATIONS | 40 | $238,018 | $0 | $43,616 | $281,634 | 2 |
| MARA LORD | VP-COMMUNICATIONS | 40 | $233,372 | $0 | $48,140 | $281,512 | 1 |
| RAVINDRA P MISRA PHD | DEAN, GRADUATE SCHOOL | 40 | $186,281 | $0 | $26,680 | $212,961 | 1 |
| STEPHEN ROELL | TRUSTEE/CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 8 |
| MARY ELLEN STANEK | TRUSTEE/IMMEDIATE PAST CHAIR | 1 | $0 | $0 | $0 | $0 | 12 |
| CORY L NETTLES | TRUSTEE/VICE CHAIRMAN | 1 | $0 | $0 | $0 | $0 | 13 |
| JAY B WILLIAMS | TRUSTEE/SECRETARY | 1 | $0 | $0 | $0 | $0 | 4 |
| THOMAS L SPERO | TRUSTEE/TREASURER | 1 | $0 | $0 | $0 | $0 | 7 |
| ELIZABETH BRENNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| RICARDO DIAZ | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| SUSAN A FEITH | TRUSTEE UNTIL 1/19/18 | 1 | $0 | $0 | $0 | $0 | 1 |
| PHILIP B FLYNN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| DAVID GAY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 6 |
| LINDA G GORENS-LEVEY | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JON D HAMMES | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 9 |
| PAUL E HANKWITZ MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 1 |
| JACQUELINE HERD-BARBER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 11 |
| TED D KELLNER | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 14 |
| JUSTIN L MORTARA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 8 |
| WAYNE C OLDENBURG | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
| JANIS M ORLOWSKI MD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| KRISTINA ROPELLA PHD | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 2 |
| OWEN J SULLIVAN | TRUSTEE | 1 | $0 | $0 | $0 | $0 | 4 |
2016 · 47 people listed · 25 paid, $17.2M · 6,314 employees · 20 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JOSEPH KERSCHNER MD | TRUSTEE/PROVOST& EXEC VP, DEAN | 40 | $1,503,889 | $0 | $91,878 | $1,595,767 | 7 |
| RONALD K WOODS MD | PROF OF PED CARDIAC SURGERY | 7 | $1,491,919 | $0 | $47,201 | $1,539,120 | 1 |
| J CHANNING TASSONE MD | ASSOC PROF OF ORTHO SURGERY | 1 | $1,441,707 | $0 | $43,202 | $1,484,909 | 1 |
| MICHAEL E MITCHELL MD | PROF OF PED CARDIAC SURGERY | 4 | $1,433,627 | $0 | $46,826 | $1,480,453 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $1,230,467 | $0 | $222,871 | $1,453,338 | 5 |
| SHEKAR N KURPAD MD | CHAIR, PROF OF NEUROSURGERY | 40 | $1,273,706 | $0 | $29,728 | $1,303,434 | 1 |
| SCOTT C HICKS MD | ORTHOPAEDIC SURGEON | 40 | $1,229,549 | $0 | $47,276 | $1,276,825 | 1 |
| CHRISTOPHER P KOPS | SR VP-FINANCE & ADMIN, COO | 40 | $654,415 | $0 | $84,645 | $739,060 | 1 |
| ROY L SILVERSTEIN MD | TRUSTEE | 40 | $619,865 | $0 | $41,337 | $661,202 | 1 |
| ROBERT LANE MD | CHAIR, PROF DEPT OF PEDIATRICS | 37 | $548,304 | $0 | $49,136 | $597,440 | 1 |
| JOHN T NEWSOME JD | VP-GENERAL COUNSEL, ASST SEC | 40 | $463,695 | $0 | $46,853 | $510,548 | 1 |
| ALICE ARCHABAL | VP-DEVELOPMENT | 40 | $381,022 | $0 | $103,437 | $484,459 | 1 |
| ANN NATTINGER MD MPH | PROF/FORMER INT CHAIR DEPT MED | 40 | $407,796 | $0 | $49,495 | $457,291 | 1 |
| CHERYL MAURANA PHD | VP-ACADEMIC OUTREACH | 40 | $413,553 | $0 | $42,013 | $455,566 | 1 |
| SHERRI DUCHARME-WHITE | VP-HR AND FACULTY AFFAIRS | 40 | $350,931 | $0 | $49,475 | $400,406 | 1 |
| GEORGE MACKINNON III PHD | DEAN, PHARMACY SCHOOL | 40 | $338,042 | $0 | $46,277 | $384,319 | 1 |
| MARJORIE SPENCER | CFO UNTIL 7/8/16 | 40 | $338,856 | $0 | $31,593 | $370,449 | 1 |
| DAVID HOTCHKISS | VP-INFO SERVICES, CIO | 40 | $314,609 | $0 | $49,107 | $363,716 | 1 |
| DANIEL WICKEHAM | VP-COMPLIANCE AND RISK MGMT | 40 | $297,257 | $0 | $46,974 | $344,231 | 1 |
| KATHRYN A KUHN | VP-GOVT AND COMM RELATIONS | 40 | $256,781 | $0 | $46,289 | $303,070 | 2 |
| MARA LORD | VP-COMMUNICATIONS | 40 | $220,969 | $0 | $44,558 | $265,527 | 1 |
| ROBERT M KLIEGMAN MD | PROF/FORMER CHAIR DEPT OF PEDS | 40 | $223,659 | $0 | $36,823 | $260,482 | 3 |
| JEFFREY BORNEMANN | VP-FACILITIES& OP AS OF 2/1/17 | 40 | $201,147 | $0 | $38,536 | $239,683 | 2 |
| RAVINDRA P MISRA PHD | DEAN, GRADUATE SCHOOL | 40 | $176,038 | $0 | $22,951 | $198,989 | 1 |
| GREGORY M WESLEY | TRUSTEE UNTIL 9/23/16 | 40 | $19,697 | $0 | $0 | $19,697 | 18 |
| STEPHEN ROELL | TRUSTEE/CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 8 |
| MARY ELLEN STANEK | TRUSTEE/IMMEDIATE PAST CHAIR | 0 | $0 | $0 | $0 | $0 | 12 |
| CORY L NETTLES | TRUSTEE/VICE CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 13 |
| JAY B WILLIAMS | TRUSTEE/SECRETARY | 0 | $0 | $0 | $0 | $0 | 4 |
| JON D HAMMES | TRUSTEE/TREASURER | 0 | $0 | $0 | $0 | $0 | 9 |
| STEVEN BERGIN MD | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH BRENNER | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 8 |
| RICARDO DIAZ | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 2 |
| SUSAN A FEITH | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP B FLYNN | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 4 |
| JOSEPH E GEENEN MD | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| JACQUELINE HERD-BARBER | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 11 |
| TED D KELLNER | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 14 |
| WAYNE C OLDENBURG | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 4 |
| JANIS M ORLOWSKI MD | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 2 |
| KRISTINA ROPELLA PHD | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 2 |
| THOMAS L SPERO | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 7 |
| OWEN J SULLIVAN | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 4 |
| KURT L JANAVITZ | SR VP-HEALTHCARE PARTNERSHIPS | 40 | $0 | $0 | $0 | $0 | 1 |
| C GREER JORDAN PHD | CHIEF DIVERSITY OFFICER 1/3/17 | 40 | $0 | $0 | $0 | $0 | 2 |
| BARCLAY FERGUSON | CFO AS OF 1/9/17 | 40 | $0 | $0 | $0 | $0 | 1 |
2015 · 49 people listed · 24 paid, $16.3M · 6,120 employees · 25 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DENNIS MAIMAN MD PHD | PROF OF NEUROSURGERY,FMR CHAIR | 40 | $1,747,789 | $0 | $49,467 | $1,797,256 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $1,616,958 | $0 | $49,849 | $1,666,807 | 5 |
| J CHANNING TASSONE MD | ASSOC PROF OF ORTHO SURGERY | 1 | $1,510,377 | $0 | $46,691 | $1,557,068 | 1 |
| JOHN G THOMETZ MD | PROF OF ORTHOPAEDIC SURGERY | 2 | $1,247,239 | $0 | $44,700 | $1,291,939 | 1 |
| RONALD K WOODS MD | ASSOC PROF OF PED CARDIAC SURG | 11 | $1,216,452 | $0 | $48,642 | $1,265,094 | 1 |
| MICHAEL E MITCHELL MD | PROF OF PED CARDIAC SURGERY | 5 | $1,161,919 | $0 | $46,469 | $1,208,388 | 1 |
| JOSEPH KERSCHNER MD | TRUSTEE/DEAN AND EXEC VP | 40 | $980,887 | $0 | $129,208 | $1,110,095 | 7 |
| ROY L SILVERSTEIN MD | CHAIR, PROF DEPT OF MEDICINE | 40 | $597,735 | $0 | $47,988 | $645,723 | 1 |
| ROBERT LANE MD | CHAIR, PROF DEPT OF PEDIATRICS | 36 | $521,618 | $0 | $48,391 | $570,009 | 1 |
| STEPHEN HARGARTEN MD | TRUSTEE | 40 | $490,474 | $0 | $47,968 | $538,442 | 1 |
| MARJORIE SPENCER | CHIEF FINANCIAL OFFICER | 40 | $479,484 | $0 | $44,565 | $524,049 | 1 |
| CHERYL MAURANA PHD | VP-ACADEMIC OUTREACH | 40 | $399,954 | $0 | $49,735 | $449,689 | 1 |
| ALICE ARCHABAL | VP-DEVELOPMENT | 40 | $405,629 | $0 | $42,856 | $448,485 | 1 |
| ANN NATTINGER MD MPH | PROF/FORMER INT CHAIR DEPT MED | 40 | $359,206 | $0 | $49,135 | $408,341 | 1 |
| SHERRI DUCHARME-WHITE | VP-HR AND FACULTY AFFAIRS | 40 | $316,956 | $0 | $49,111 | $366,067 | 1 |
| SARAH D COHN JD | FORMER VP-GEN COUNSEL/ASST SEC | 40 | $323,970 | $0 | $28,015 | $351,985 | 1 |
| DANIEL WICKEHAM | VP-COMPLIANCE AND RISK MGT | 40 | $294,451 | $0 | $46,610 | $341,061 | 1 |
| JOHN T NEWSOME JD | VP-GENERAL COUNSEL/ASST SEC | 40 | $299,725 | $0 | $34,020 | $333,745 | 1 |
| DAVID HOTCHKISS | VP-INFO SERVICES/CIO | 40 | $277,599 | $0 | $48,795 | $326,394 | 1 |
| KATHRYN A KUHN | VP-GOVT AND COMM RELATIONS | 40 | $246,454 | $0 | $44,644 | $291,098 | 2 |
| ROBERT M KLIEGMAN MD | PROF/FORMER CHAIR DEPT OF PEDS | 40 | $210,694 | $0 | $42,094 | $252,788 | 3 |
| MARA LORD | VP-COMMUNICATIONS AT 11/20/15 | 40 | $180,547 | $0 | $41,570 | $222,117 | 1 |
| RAVINDRA P MISRA PHD | DEAN, GRADUATE SCHOOL | 40 | $170,851 | $0 | $23,270 | $194,121 | 1 |
| GEORGE MACKINNON III PHD | DEAN, PHARMACY SCHOOL 10/1/15 | 40 | $89,069 | $0 | $11,347 | $100,416 | 1 |
| MARY ELLEN STANEK | TRUSTEE/CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 12 |
| JON D HAMMES | TRUSTEE/IMMEDIATE PAST CHAIR | 0 | $0 | $0 | $0 | $0 | 9 |
| STEPHEN ROELL | TRUSTEE/VICE CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 8 |
| JAY B WILLIAMS | TRUSTEE/SECRETARY | 0 | $0 | $0 | $0 | $0 | 4 |
| P MICHAEL MAHONEY | TRUSTEE/TREASURER | 0 | $0 | $0 | $0 | $0 | 7 |
| STEVEN BERGIN MD | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH BRENNER | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 8 |
| JOHN BYRNES | TRUSTEE UNTIL 4/22/16 | 0 | $0 | $0 | $0 | $0 | 1 |
| RICARDO DIAZ | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 2 |
| SUSAN A FEITH | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP B FLYNN | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 4 |
| HAROLD GUS FRANK | TRUSTEE UNTIL 4/22/16 | 0 | $0 | $0 | $0 | $0 | 1 |
| JOSEPH E GEENEN MD | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| TED D KELLNER | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 14 |
| GALE E KLAPPA | TRUSTEE UNTIL 4/22/16 | 0 | $0 | $0 | $0 | $0 | 5 |
| CYNTHIA LACONTE | TRUSTEE UNTIL 11/20/15 | 0 | $0 | $0 | $0 | $0 | 1 |
| CORY L NETTLES | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 13 |
| WAYNE C OLDENBURG | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 4 |
| JANIS M ORLOWSKI MD | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 2 |
| KRISTINA ROPELLA PHD | TRUSTEE AS OF 11/20/15 | 0 | $0 | $0 | $0 | $0 | 2 |
| THOMAS L SPERO | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 7 |
| OWEN J SULLIVAN | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 4 |
| GREGORY M WESLEY | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 18 |
| CHRISTOPHER P KOPS | SR VP AND COO AS OF 2/15/16 | 40 | $0 | $0 | $0 | $0 | 1 |
2014 · 48 people listed · 23 paid, $15.6M · 6,146 employees · 25 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| DENNIS MAIMAN MD PHD | PROF & CHAIR OF NEUROSURGERY | 40 | $1,799,688 | $0 | $48,124 | $1,847,812 | 1 |
| JAMES S TWEDDELL MD | PROF & CHIEF OF CARDIO SURGERY | 5 | $1,801,783 | $0 | $45,310 | $1,847,093 | 2 |
| J CHANNING TASSONE MD | ASSOC PROF OF ORTHO SURGERY | 2 | $1,332,330 | $0 | $45,897 | $1,378,227 | 1 |
| JOHN G THOMETZ MD | PROF OF ORTHOPAEDIC SURGERY | 2 | $1,153,536 | $0 | $45,924 | $1,199,460 | 1 |
| MICHAEL E MITCHELL MD | PROF OF PED CARDIAC SURGERY | 8 | $1,090,812 | $0 | $48,215 | $1,139,027 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $906,759 | $0 | $137,007 | $1,043,766 | 5 |
| JOSEPH KERSCHNER MD | TRUSTEE/DEAN AND EXEC VP | 40 | $887,662 | $0 | $129,970 | $1,017,632 | 7 |
| G ALLEN BOLTON JR | SENIOR VP AND COO TO 9/15/14 | 40 | $611,026 | $0 | $43,142 | $654,168 | 1 |
| ROY L SILVERSTEIN MD | CHAIR DEPT OF MEDICINE/PROF | 40 | $571,233 | $0 | $47,129 | $618,362 | 1 |
| ROBERT LANE MD | CHAIR DEPT OF PEDS/PROF | 36 | $514,791 | $0 | $47,323 | $562,114 | 1 |
| STEPHEN HARGARTEN MD | TRUSTEE | 40 | $460,290 | $0 | $47,715 | $508,005 | 1 |
| ALICE ARCHABAL | VP - INST ADVANCEMENT | 40 | $440,040 | $0 | $26,276 | $466,316 | 1 |
| MARJORIE SPENCER | CHIEF FINANCIAL OFFICER | 40 | $416,384 | $0 | $45,796 | $462,180 | 1 |
| CHERYL MAURANA PHD | VP - ACADEMIC OUTREACH | 40 | $374,498 | $0 | $47,594 | $422,092 | 1 |
| SARAH D COHN JD | VP-GEN CSL/ASST SEC TO 5/31/15 | 40 | $373,843 | $0 | $30,700 | $404,543 | 1 |
| ANN NATTINGER MD MPH | PROF/FORMER INT CHAIR DEPT MED | 40 | $345,876 | $0 | $48,334 | $394,210 | 1 |
| SHERRI DUCHARME-WHITE | VP - HUMAN RESOURCES | 40 | $299,403 | $0 | $48,296 | $347,699 | 1 |
| DAVID HOTCHKISS | VP - INFO SERVICES/CIO | 40 | $245,010 | $0 | $46,446 | $291,456 | 1 |
| DANIEL WICKEHAM | VP - COMPLIANCE/INTERIM COO | 40 | $244,957 | $0 | $44,175 | $289,132 | 1 |
| KATHRYN A KUHN | VP - GOVT/COMM RELATIONS | 40 | $232,593 | $0 | $45,314 | $277,907 | 2 |
| ROBERT M KLIEGMAN MD | PROF/FORMER CHAIR DEPT OF PEDS | 40 | $204,764 | $0 | $41,430 | $246,194 | 3 |
| RAVINDRA P MISRA PHD | DEAN OF GRADUATE SCHOOL | 40 | $165,487 | $0 | $23,930 | $189,417 | 1 |
| JULIA A UIHLEIN PHD | TRUSTEE | 8 | $5,783 | $0 | $0 | $5,783 | 1 |
| MARY ELLEN STANEK | TRUSTEE/CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 12 |
| JON D HAMMES | TRUSTEE/IMMEDIATE PAST CHAIR | 0 | $0 | $0 | $0 | $0 | 9 |
| STEPHEN ROELL | TRUSTEE/VICE CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 8 |
| JAY B WILLIAMS | TRUSTEE/SECRETARY | 0 | $0 | $0 | $0 | $0 | 4 |
| P MICHAEL MAHONEY | TRUSTEE/TREASURER | 0 | $0 | $0 | $0 | $0 | 7 |
| STEVEN BERGIN MD | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| ELIZABETH BRENNER | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 8 |
| JOHN BYRNES | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| CURT S CULVER | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 7 |
| RICARDO DIAZ | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 2 |
| SUSAN A FEITH | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| PHILIP B FLYNN | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 4 |
| HAROLD FRANK | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| JOSEPH E GEENEN MD | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| PAUL W GRIEPENTROG | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 1 |
| TED D KELLNER | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 14 |
| GALE E KLAPPA | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 5 |
| CORY L NETTLES | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 13 |
| WAYNE C OLDENBURG | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 4 |
| JANIS M ORLOWSKI MD | TRUSTEE AS OF 11/21/14 | 0 | $0 | $0 | $0 | $0 | 2 |
| JOHN S SHIELY | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 7 |
| THOMAS L SPERO | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 7 |
| OWEN J SULLIVAN | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 4 |
| GREGORY M WESLEY | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 18 |
| JOHN T NEWSOME JD | VP-GEN CSL/ASST SEC AT 6/1/15 | 40 | $0 | $0 | $0 | $0 | 1 |
2013 · 50 people listed · 26 paid, $15.2M · 6,166 employees · 80 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| JAMES S TWEDDELL MD | PROF & CHIEF OF CARDIO SURGERY | 2 | $1,892,701 | - | $45,408 | $1,938,109 | 2 |
| DENNIS MAIMAN MD PHD | PROF & CHAIR OF NEUROSURGERY | 40 | $1,680,919 | - | $46,125 | $1,727,044 | 1 |
| J CHANNING TASSONE MD | ASSOC PROF OF ORTHO SURGERY | - | $1,194,755 | - | $45,843 | $1,240,598 | 1 |
| JOHN G THOMETZ MD | PROF OF ORTHOPAEDIC SURGERY | - | $1,154,425 | - | $45,690 | $1,200,115 | 1 |
| JOHNNY C HONG MD | ASSOC PROF& CHIEF TRANSPL SURG | 40 | $1,079,965 | - | $45,618 | $1,125,583 | 1 |
| JOSEPH KERSCHNER MD | TRUSTEE/DEAN AND EXEC VP | 40 | $836,040 | - | $129,746 | $965,786 | 7 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRESIDENT AND CEO | 40 | $808,744 | - | $125,597 | $934,341 | 5 |
| ROY L SILVERSTEIN MD | CHAIR DEPT OF MEDICINE/PROF | 40 | $568,646 | - | $45,735 | $614,381 | 1 |
| G ALLEN BOLTON JR | SENIOR VP AND COO | 40 | $496,505 | - | $96,116 | $592,621 | 1 |
| ROBERT LANE MD | CHAIR DEPT PEDS/PROF 1/28/13 | 40 | $479,349 | - | $42,805 | $522,154 | 1 |
| ALLEN COWLEY JR PHD | TRUSTEE | 40 | $375,472 | - | $47,380 | $422,852 | 1 |
| CHERYL MAURANA PHD | VP - STRATEGIC OUTREACH | 40 | $370,350 | - | $46,664 | $417,014 | 1 |
| ANN NATTINGER MD MPH | PROF/FORMER INT CHAIR DEPT MED | 40 | $350,855 | - | $48,077 | $398,932 | 1 |
| MARJORIE SPENCER | CHIEF FINANCIAL OFFICER | 40 | $339,701 | - | $45,746 | $385,447 | 1 |
| SARAH D COHN JD | VP - GENERAL COUNSEL/ASST SEC | 40 | $333,406 | - | $30,683 | $364,089 | 1 |
| SHERRI DUCHARME-WHITE | VP - HUMAN RESOURCES | 40 | $250,760 | - | $48,246 | $299,006 | 1 |
| ROBERT M KLIEGMAN MD | PROF/FORMER CHAIR DEPT OF PEDS | 13 | $237,494 | - | $44,319 | $281,813 | 3 |
| DAVID HOTCHKISS | VP - INFO SERVICES/CIO | 40 | $221,392 | - | $49,484 | $270,876 | 1 |
| DANIEL WICKEHAM | VP - CORPORATE COMPLIANCE | 40 | $214,925 | - | $42,785 | $257,710 | 1 |
| KATHRYN A KUHN | VP - GOVT/COMM RELATIONS | 40 | $199,317 | - | $42,613 | $241,930 | 2 |
| JAMES W HEALD | VP - INST ADVANCE TO 7/28/13 | 40 | $183,229 | - | $32,120 | $215,349 | 1 |
| JONATHAN I RAVDIN MD | FORMER TRUSTEE/DEAN & EXEC VP | 0 | $206,316 | - | $0 | $206,316 | 1 |
| KEVIN J KELLY MD | INT CHAIR PEDS/PROF TO 1/27/13 | 5 | $166,448 | - | $23,970 | $190,418 | 1 |
| RAVINDRA P MISRA PHD | DEAN OF GRADUATE SCHOOL | 40 | $163,077 | - | $23,824 | $186,901 | 1 |
| ALICE ARCHABAL | VP - INST ADVANCE AT 7/29/13 | 40 | $140,290 | - | $8,422 | $148,712 | 1 |
| JULIA A UIHLEIN PHD | TRUSTEE | 8 | $8,960 | - | $0 | $8,960 | 1 |
| JON D HAMMES | TRUSTEE/CHAIRMAN | 0 | $0 | - | $0 | $0 | 9 |
| EDWARD J ZORE | TRUSTEE/IMMEDIATE PAST CHAIR | 0 | $0 | - | $0 | $0 | 6 |
| MARY ELLEN STANEK | TRUSTEE/VICE CHAIRMAN | 0 | $0 | - | $0 | $0 | 12 |
| STEPHEN ROELL | TRUSTEE/SECRETARY | 0 | $0 | - | $0 | $0 | 8 |
| P MICHAEL MAHONEY | TRUSTEE/TREASURER | 0 | $0 | - | $0 | $0 | 7 |
| ELIZABETH BRENNER | TRUSTEE | 0 | $0 | - | $0 | $0 | 8 |
| JOHN BYRNES | TRUSTEE | 0 | $0 | - | $0 | $0 | 1 |
| CURT S CULVER | TRUSTEE | 0 | $0 | - | $0 | $0 | 7 |
| RICARDO DIAZ | TRUSTEE | 0 | $0 | - | $0 | $0 | 2 |
| SUSAN A FEITH | TRUSTEE | 0 | $0 | - | $0 | $0 | 1 |
| PHILIP B FLYNN | TRUSTEE | 0 | $0 | - | $0 | $0 | 4 |
| JOSEPH E GEENEN MD | TRUSTEE | 0 | $0 | - | $0 | $0 | 1 |
| TED D KELLNER | TRUSTEE | 0 | $0 | - | $0 | $0 | 14 |
| GALE E KLAPPA | TRUSTEE | 0 | $0 | - | $0 | $0 | 5 |
| PAUL F KNOEBEL | TRUSTEE | 0 | $0 | - | $0 | $0 | 1 |
| CORY L NETTLES | TRUSTEE | 0 | $0 | - | $0 | $0 | 13 |
| WAYNE C OLDENBURG | TRUSTEE | 0 | $0 | - | $0 | $0 | 4 |
| JOHN S SHIELY | TRUSTEE | 0 | $0 | - | $0 | $0 | 7 |
| THOMAS L SPERO | TRUSTEE | 0 | $0 | - | $0 | $0 | 7 |
| OWEN J SULLIVAN | TRUSTEE | 0 | $0 | - | $0 | $0 | 4 |
| GREGORY M WESLEY | TRUSTEE | 0 | $0 | $0 | $0 | $0 | 18 |
| JAY B WILLIAMS | TRUSTEE | 0 | $0 | - | $0 | $0 | 4 |
| THOMAS WITTMANN MD | TRUSTEE | 0 | $0 | - | $0 | $0 | 1 |
| CARLENE ZIEGLER | TRUSTEE | 0 | $0 | - | $0 | $0 | 3 |
2012 · 50 people listed · 26 paid, $16.5M · 6,355 employees · 80 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Dennis Maiman MD PhD | PROF & CHAIR OF NEUROSURGERY | 40 | $2,013,099 | $0 | $47,435 | $2,060,534 | 1 |
| James S Tweddell MD | PROF & CHIEF OF CARDIO SURGERY | 5 | $1,911,791 | $0 | $46,717 | $1,958,508 | 2 |
| MARK S RUTTUM MD | PROF OF OPHTHALMOLOGY | - | $1,323,750 | $0 | $45,555 | $1,369,305 | 1 |
| Shekar Kurpad MD PhD | ASSOC. PROF OF NEUROSURGERY | 40 | $1,170,406 | $0 | $32,419 | $1,202,825 | 1 |
| John G Thometz MD | PROF OF ORTHOPAEDIC SURGERY | - | $1,152,704 | $0 | $47,000 | $1,199,704 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRES/CEO | 40 | $820,990 | $0 | $126,235 | $947,225 | 5 |
| JOSEPH KERSCHNER MD | TRUSTEE/DEAN/EXEC. VP | 40 | $763,522 | $0 | $131,056 | $894,578 | 7 |
| Robert M Kliegman MD | PROF/FORMER CHAIR DEPT OF PEDS | 18 | $751,138 | $0 | $46,718 | $797,856 | 3 |
| T Michael Bolger JD | PRESIDENT EMERITUS | 0 | $786,688 | $0 | - | $786,688 | 3 |
| ROY L SILVERSTEIN MD | CHAIR DEPT OF MEDICINE/PROF | 40 | $554,002 | $0 | $47,045 | $601,047 | 1 |
| G ALLEN BOLTON JR | SENIOR VP AND COO | 40 | $490,755 | $0 | $96,946 | $587,701 | 1 |
| KEVIN J KELLY MD | INTERIM Chair Dept PEDS/PROF | 4 | $453,082 | $0 | $46,718 | $499,800 | 1 |
| ALLEN COWLEY JR PHD | TRUSTEE | 40 | $416,724 | $0 | $0 | $416,724 | 1 |
| CHERYL MAURANA PHD | VP - STRATEGIC OUTREACH | 40 | $360,178 | $0 | $46,774 | $406,952 | 1 |
| Ann Nattinger MD | PROF/FORMER INT CHAIR DEPT MED | 40 | $333,580 | $0 | $50,487 | $384,067 | 1 |
| Marjorie Spencer | Chief Financial Officer | 40 | $322,194 | $0 | $47,056 | $369,250 | 1 |
| Sarah D Cohn JD | VP - General Counsel/ASST SEC | 40 | $320,053 | $0 | $30,941 | $350,994 | 1 |
| James W Heald | VP - INSTITUTIONAL ADVANCEMENT | 40 | $270,473 | $0 | $47,956 | $318,429 | 1 |
| Sherri DuCharme-White | VP - HUMAN RESOURCES | 40 | $233,715 | $0 | $50,606 | $284,321 | 1 |
| Daniel Wickeham | VP - CORPORATE COMPLIANCE | 40 | $209,703 | $0 | $44,107 | $253,810 | 1 |
| KATHRYN A KUHN | VP - GOVT/COMM RELATIONS | 40 | $185,809 | $0 | $43,049 | $228,858 | 2 |
| Ravindra P Misra PhD | Dean OF Grad School | 40 | $160,063 | $0 | $24,549 | $184,612 | 1 |
| Tye Minckler | VP - Operations UNTIL 7/2012 | 40 | $133,734 | $0 | $28,551 | $162,285 | 1 |
| Michael J Dunn MD | PROF MEDICINE/DEAN EMERITUS | 25 | $117,657 | $0 | $36,352 | $154,009 | 1 |
| DAVID HOTCHKISS | VP - INFO SERV/CIO AS OF 10/12 | 40 | $43,606 | - | $2,377 | $45,983 | 1 |
| Julia A Uihlein PHD | Trustee | 8 | $11,229 | - | - | $11,229 | 1 |
| JON D HAMMES | TRUSTEE/CHAIRMAN | 0 | - | - | - | $0 | 9 |
| Edward J Zore | TRUSTEE/IMMEDIATE PAST CHAIR | 0 | - | - | - | $0 | 6 |
| Mary Ellen Stanek | TRUSTEE/VICE CHAIRMAN | 0 | - | - | - | $0 | 12 |
| STEPHEN ROELL | TRUSTEE/SECRETARY | 0 | - | - | - | $0 | 8 |
| P Michael Mahoney | TRUSTEE/TREASURER | 0 | - | - | - | $0 | 7 |
| Elizabeth Brenner | Trustee | 0 | - | - | - | $0 | 8 |
| John Byrnes | Trustee | 0 | - | - | - | $0 | 1 |
| Curt S Culver | Trustee | 0 | - | - | - | $0 | 7 |
| Susan A Feith | Trustee | 0 | - | - | - | $0 | 1 |
| PHILIP B FLYNN | TRUSTEE | 0 | - | - | - | $0 | 4 |
| Joseph E Geenen MD | Trustee | 0 | - | - | - | $0 | 1 |
| Ted D Kellner | Trustee | 0 | - | - | - | $0 | 14 |
| Gale E Klappa | Trustee | 0 | - | - | - | $0 | 5 |
| Paul F Knoebel | Trustee | 0 | - | - | - | $0 | 1 |
| Cory L Nettles | Trustee | 0 | - | - | - | $0 | 13 |
| Wayne C Oldenburg | Trustee | 0 | - | - | - | $0 | 4 |
| Agustin A Ramirez | Trustee | 0 | - | - | - | $0 | 2 |
| John S Shiely | Trustee | 0 | - | - | - | $0 | 7 |
| Thomas L Spero | Trustee | 0 | - | - | - | $0 | 7 |
| Owen J Sullivan | Trustee | 0 | - | - | - | $0 | 4 |
| Gregory M Wesley | Trustee | 0 | - | - | - | $0 | 18 |
| Jay B Williams | Trustee | 0 | - | - | - | $0 | 4 |
| Thomas Wittmann MD | Trustee | 0 | - | - | - | $0 | 1 |
| Carlene Ziegler | Trustee | 0 | - | - | - | $0 | 3 |
2011 · 50 people listed · 25 paid, $17.4M · 6,241 employees · 75 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Dennis Maiman MD PhD | PROF & CHAIR OF NEUROSURGERY | 40 | $2,118,493 | $0 | $46,288 | $2,164,781 | 1 |
| James S Tweddell MD | PROF & CHIEF OF CARDIO SURGERY | 40 | $1,950,556 | $0 | $45,568 | $1,996,124 | 2 |
| Shekar Kurpad MD PhD | ASSOC. PROF OF NEUROSURGERY | 40 | $1,676,946 | $0 | $46,078 | $1,723,024 | 1 |
| MARK S RUTTUM MD | PROF OF OPHTHALMOLOGY | 40 | $1,363,532 | $0 | $44,407 | $1,407,939 | 1 |
| John G Thometz MD | PROF OF ORTHOPAEDIC SURGERY | 40 | $1,227,081 | $0 | $45,851 | $1,272,932 | 1 |
| JOSEPH KERSCHNER MD | TRUSTEE/DEAN/EXEC. VP | 40 | $864,518 | $0 | $55,842 | $920,360 | 7 |
| Jonathan I Ravdin MD | FORMER Trustee/Dean/EXEC VP | 40 | $846,102 | $0 | $51,837 | $897,939 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRES/CEO | 40 | $723,431 | $0 | $124,293 | $847,724 | 5 |
| Robert M Kliegman MD | Chair Dept Pediatrics to 10/11 | 40 | $753,703 | $0 | $45,568 | $799,271 | 3 |
| Michael J Dunn MD | PROF MEDICINE/DEAN EMERITUS | 25 | $732,011 | $0 | $36,805 | $768,816 | 1 |
| DAVID WARLTIER MD PHD | TRUSTEE | 40 | $528,972 | $0 | $50,821 | $579,793 | 1 |
| Douglas R Campbell | FORMER SENIOR VP AND COO | 0 | $461,869 | $0 | $39,581 | $501,450 | 1 |
| KEVIN J KELLY MD | INTERIM Chair Dept Peds 10/11 | 40 | $401,564 | $0 | $45,568 | $447,132 | 1 |
| Ann Nattinger MD | INTERIM CHAIR DEPT MED TO 9/11 | 40 | $395,010 | $0 | $49,338 | $444,348 | 1 |
| Marjorie Spencer | Chief Financial Officer | 40 | $300,108 | $0 | $45,908 | $346,016 | 1 |
| Sarah D Cohn JD | VP - General Counsel | 40 | $305,574 | $0 | $30,250 | $335,824 | 1 |
| James W Heald | VP - INSTITUTIONAL ADVANCEMENT | 40 | $264,547 | $0 | $46,868 | $311,415 | 1 |
| Daniel Wickeham | VP - CORPORATE COMPLIANCE | 40 | $221,936 | $0 | $44,300 | $266,236 | 1 |
| Sherri DuCharme-White | VP - HUMAN RESOURCES | 40 | $214,465 | $0 | $48,294 | $262,759 | 1 |
| G ALLEN BOLTON JR | SENIOR VP AND COO AS OF 9/2011 | 40 | $205,966 | $0 | $39,049 | $245,015 | 1 |
| Tye Minckler | VP - Operations | 40 | $195,882 | $0 | $41,745 | $237,627 | 1 |
| ROY L SILVERSTEIN MD | CHAIR DEPT MEDICINE AS OF 9/11 | 40 | $208,294 | $0 | $22,794 | $231,088 | 1 |
| KATHRYN A KUHN | VP - GOVT/COMM RELATIONS | 40 | $172,892 | $0 | $40,898 | $213,790 | 2 |
| Ravindra P Misra PhD | Dean OF Grad School | 40 | $152,257 | $0 | $23,288 | $175,545 | 1 |
| Julia A Uihlein PHD | Trustee | 8 | $11,007 | $0 | $0 | $11,007 | 1 |
| Edward J Zore | CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 6 |
| Linda T Mellowes | IMMEDIATE PAST CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 9 |
| Jon D Hammes | VICE CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 9 |
| Mary Ellen Stanek | Secretary | 0 | $0 | $0 | $0 | $0 | 12 |
| P Michael Mahoney | TREASURER | 0 | $0 | $0 | $0 | $0 | 7 |
| Elizabeth Brenner | Trustee | 0 | $0 | $0 | $0 | $0 | 8 |
| John Byrnes | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Curt S Culver | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Susan A Feith | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Joseph E Geenen MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Ted D Kellner | Trustee | 0 | $0 | $0 | $0 | $0 | 14 |
| Gale E Klappa | Trustee | 0 | $0 | $0 | $0 | $0 | 5 |
| Paul F Knoebel | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Cory L Nettles | Trustee | 0 | $0 | $0 | $0 | $0 | 13 |
| Wayne C Oldenburg | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Agustin A Ramirez | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Stephen Roell | Trustee | 0 | $0 | $0 | $0 | $0 | 8 |
| John S Shiely | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Thomas L Spero | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Owen J Sullivan | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Timothy W Sullivan | Trustee Until 7/2011 | 0 | $0 | $0 | $0 | $0 | 7 |
| Gregory M Wesley | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Jay B Williams | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Thomas Wittmann MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Carlene Ziegler | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
2010 · 54 people listed · 24 paid, $15.5M · 6,124 employees · 94 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Dennis Maiman MD PhD | PROFESSOR, NEUROSURGEON | 40 | $2,359,856 | $0 | $45,232 | $2,405,088 | 1 |
| James S Tweddell MD | PROFESSOR, CHIEF OF CARDIO | 40 | $1,893,767 | $0 | $44,482 | $1,938,249 | 2 |
| Shekar Kurpad MD PhD | ASSOC. PROFESSOR, NEUROSURGEON | 40 | $1,325,389 | $0 | $51,222 | $1,376,611 | 1 |
| MICHAEL MITCHELL MD | PROF OF UROLOGIC SURGERY | 40 | $1,053,463 | $0 | $54,692 | $1,108,155 | 1 |
| John G Thometz MD | PROFESSOR, ORTHO SURGEON | 40 | $1,019,049 | $0 | $44,782 | $1,063,831 | 1 |
| Robert M Kliegman MD | Chairman, Dept. of Pediatrics | 40 | $751,980 | $0 | $44,487 | $796,467 | 3 |
| JOSEPH KERSCHNER MD | TRUSTEE/DEAN/EXECVP AS OF 1/11 | 40 | $731,359 | $0 | $44,482 | $775,841 | 7 |
| Jonathan I Ravdin MD | Trustee/Dean/EXEC VP TO 1/11 | 40 | $647,999 | $0 | $118,042 | $766,041 | 1 |
| T Michael Bolger JD | PRESIDENT EMERITUS | 40 | $656,037 | $0 | $69,536 | $725,573 | 3 |
| Douglas R Campbell | SENIOR VP AND COO UNTIL 1/11 | 40 | $515,901 | $0 | $104,482 | $620,383 | 1 |
| DAVID C WARLTIER MD | TRUSTEE AS OF 7/10 | 40 | $509,093 | $0 | $48,562 | $557,655 | 1 |
| JOHN R RAYMOND SR MD | TRUSTEE/PRES/CEO AS OF 7/10 | 40 | $412,259 | $0 | $69,374 | $481,633 | 5 |
| Ann Nattinger MD | INTERIM CHAIR, DEPT MEDICINE | 40 | $391,432 | $0 | $48,262 | $439,694 | 1 |
| Marjorie Spencer | Chief Financial Officer | 40 | $282,418 | $0 | $44,842 | $327,260 | 1 |
| Sarah D Cohn JD | VP - General Counsel | 40 | $286,340 | $0 | $29,741 | $316,081 | 1 |
| Michael J Dunn MD | PROF OF MEDICINE DEAN EMERITUS | 40 | $245,769 | $0 | $44,621 | $290,390 | 1 |
| James W Heald | VP - INSTITUTIONAL ADVANCEMENT | 40 | $255,753 | $0 | $31,961 | $287,714 | 1 |
| Sherri DuCharme-White | VP - HUMAN RESOURCES | 40 | $198,509 | $0 | $46,098 | $244,607 | 1 |
| Tye Minckler | Vice President - Operations | 40 | $187,026 | $0 | $39,987 | $227,013 | 1 |
| Daniel Wickeham | VP - CORPORATE COMPLIANCE | 40 | $175,579 | $0 | $39,509 | $215,088 | 1 |
| KATHRYN A KUHN | VP GOVERNMENT AFFAIRS | 40 | $146,568 | $0 | $38,110 | $184,678 | 2 |
| Owen Griffith PhD | PROFESSOR, BIOCHEMISTRY | 40 | $145,558 | $0 | $21,489 | $167,047 | 1 |
| Ravindra P Misra PhD | Dean, Grad School | 40 | $140,176 | $0 | $22,057 | $162,233 | 1 |
| Julia A Uihlein | Trustee | 8 | $10,792 | $0 | $0 | $10,792 | 1 |
| Edward J Zore | CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 6 |
| Linda T Mellowes | IMMEDIATE PAST CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 9 |
| Jon D Hammes | VICE CHAIRMAN | 0 | $0 | $0 | $0 | $0 | 9 |
| Mary Ellen Stanek | Secretary | 0 | $0 | $0 | $0 | $0 | 12 |
| P Michael Mahoney | TREASURER | 0 | $0 | $0 | $0 | $0 | 7 |
| Christopher Abele | Trustee UNTIL 4/11 | 0 | $0 | $0 | $0 | $0 | 1 |
| Cynthia Bauer MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Elizabeth Brenner | Trustee | 0 | $0 | $0 | $0 | $0 | 8 |
| John Byrnes | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Curt S Culver | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Susan A Feith | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Joseph E Geenen MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Ted D Kellner | Trustee | 0 | $0 | $0 | $0 | $0 | 14 |
| Gale E Klappa | Trustee | 0 | $0 | $0 | $0 | $0 | 5 |
| Paul F Knoebel | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Dennis J Kuester | Trustee UNTIL 2/11 | 0 | $0 | $0 | $0 | $0 | 1 |
| Sheldon B Lubar | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Jill J Morin | Trustee UNTIL 11/10 | 0 | $0 | $0 | $0 | $0 | 2 |
| Cory L Nettles | Trustee | 0 | $0 | $0 | $0 | $0 | 13 |
| Wayne C Oldenburg | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Agustin A Ramirez | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Stephen Roell | Trustee | 0 | $0 | $0 | $0 | $0 | 8 |
| John S Shiely | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Thomas L Spero | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Owen J Sullivan | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Timothy W Sullivan | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Sheldon A Wasserman | Trustee UNTIL 11/10 | 0 | $0 | $0 | $0 | $0 | 1 |
| Gregory M Wesley | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Jay B Williams | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Carlene Ziegler | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
2009 · 54 people listed · 22 paid, $13.8M · 6,012 employees · 102 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Dennis J Maiman MD PhD | PROFESSOR, NEUROSURGEON | 40 | $2,177,902 | $0 | $42,782 | $2,220,684 | 1 |
| James S Tweddell MD | PROFESSOR, CHIEF OF CARDIO | 6 | $1,639,145 | $0 | $42,032 | $1,681,177 | 2 |
| Shekar N Kurpad MD PhD | ASSOC. PROFESSOR, NEUROSURGEON | 40 | $1,198,914 | $0 | $50,572 | $1,249,486 | 1 |
| John G Thometz MD | PROFESSOR, ORTHO SURGEON | 1 | $1,109,586 | $0 | $42,332 | $1,151,918 | 1 |
| Christopher Wolfla MD | ASSOC. PROFESSOR, NEUROSURGEON | 40 | $1,009,762 | $0 | $45,572 | $1,055,334 | 1 |
| G Richard Olds MD | Chair, Dept Med until 12/15/09 | 40 | $720,709 | $0 | $42,213 | $762,922 | 1 |
| Robert M Kliegman MD | Chairman, Dept. of Pediatrics | 6 | $708,254 | $0 | $42,093 | $750,347 | 3 |
| T Michael Bolger JD | Trustee/President and CEO | 40 | $632,289 | $0 | $112,991 | $745,280 | 3 |
| Jonathan I Ravdin MD | Trustee/Dean and Exec VP | 40 | $606,588 | $0 | $111,392 | $717,980 | 1 |
| Douglas R Campbell | Senior Vice President & COO | 40 | $503,860 | $0 | $99,992 | $603,852 | 1 |
| Michael J Dunn MD | PROF OF MEDICINE DEAN EMERITUS | 40 | $315,976 | $0 | $42,171 | $358,147 | 1 |
| Marjorie Spencer | Chief Financial Officer | 39 | $276,080 | $0 | $42,392 | $318,472 | 1 |
| Joseph C Besharse PhD | Trustee | 0 | $264,516 | $0 | $44,191 | $308,707 | 1 |
| Sarah D Cohn JD | VP - General Counsel | 40 | $275,474 | $0 | $28,799 | $304,273 | 1 |
| Ann Nattinger MD | Chair, Dept Med as of 12/15/09 | 40 | $253,571 | $0 | $46,213 | $299,784 | 1 |
| James W Heald | VP - INSTITUTIONAL ADVANCEMENT | 40 | $249,474 | $0 | $29,299 | $278,773 | 1 |
| Sherri DuCharme-White | VP - HUMAN RESOURCES | 40 | $201,283 | $0 | $41,348 | $242,631 | 1 |
| Tye Minckler | Vice President - Operations | 40 | $182,968 | $0 | $37,592 | $220,560 | 1 |
| Owen Griffith PhD | Dean, Grad School until 5/1/10 | 40 | $185,950 | $0 | $26,052 | $212,002 | 1 |
| Daniel Wickeham | VP - CORPORATE COMPLIANCE | 40 | $167,551 | $0 | $36,392 | $203,943 | 1 |
| Ravindra P Misra PhD | Dean, Grad School as of 5/1/10 | 40 | $126,151 | $0 | $20,309 | $146,460 | 1 |
| Julia A Uihlein | Trustee | 0 | $10,482 | $0 | $0 | $10,482 | 1 |
| Linda T Mellowes | Chairman | 0 | $0 | $0 | $0 | $0 | 9 |
| Steven J Smith | Immediate past chairman | 0 | $0 | $0 | $0 | $0 | 3 |
| Edward J Zore | Vice Chairman | 0 | $0 | $0 | $0 | $0 | 6 |
| Mary Ellen Stanek | Secretary | 0 | $0 | $0 | $0 | $0 | 12 |
| P Michael Mahoney | TREASURER | 0 | $0 | $0 | $0 | $0 | 7 |
| Christopher Abele | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Cynthia Bauer MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Elizabeth Brenner | Trustee | 0 | $0 | $0 | $0 | $0 | 8 |
| John Byrnes | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Curt S Culver | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Susan A Feith | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Joseph E Geenen MD | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Jon D Hammes | Trustee | 0 | $0 | $0 | $0 | $0 | 9 |
| Timothy E Hoeksema | Trustee until 3/11/10 | 0 | $0 | $0 | $0 | $0 | 1 |
| Ted D Kellner | Trustee | 0 | $0 | $0 | $0 | $0 | 14 |
| Gale E Klappa | Trustee | 0 | $0 | $0 | $0 | $0 | 5 |
| Paul F Knoebel | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Dennis J Kuester | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Sheldon B Lubar | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
| Jill J Morin | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Cory L Nettles | Trustee | 0 | $0 | $0 | $0 | $0 | 13 |
| Wayne C Oldenburg | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Agustin A Ramirez | Trustee | 0 | $0 | $0 | $0 | $0 | 2 |
| Stephen Roell | Trustee | 0 | $0 | $0 | $0 | $0 | 8 |
| John S Shiely | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Thomas L Spero | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Owen J Sullivan | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Timothy W Sullivan | Trustee | 0 | $0 | $0 | $0 | $0 | 7 |
| Sheldon A Wasserman | Trustee | 0 | $0 | $0 | $0 | $0 | 1 |
| Gregory M Wesley | Trustee | 0 | $0 | $0 | $0 | $0 | 18 |
| Jay B Williams | Trustee | 0 | $0 | $0 | $0 | $0 | 4 |
| Carlene Ziegler | Trustee | 0 | $0 | $0 | $0 | $0 | 3 |
Highest-paid independent contractors
2024 · 5 contractors · $120.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| M A MORTENSON CO | MILWAUKEE, WI | CONSTRUCTION SERVICE | $59,103,256 |
| FROEDTERT HEALTH MEDICAL GROUP | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $17,527,730 |
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $16,438,925 |
| FROEDTERT MEMORIAL LUTHERAN HOSPITA | MILWAUKEE, WI | CONTRACTUAL SERVICES | $15,044,490 |
| FROEDTERT THEDACARE HEALTH INC | MILWAUKEE, WI | CONTRACTUAL SERVICES | $12,677,844 |
2023 · 5 contractors · $78.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| M A MORTENSON CO | MILWAUKEE, WI | CONSTRUCTION SERVICE | $24,241,811 |
| FROEDTERT HEALTH MEDICAL GROUP | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $17,304,856 |
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $14,365,549 |
| FROEDTERT THEDACARE HEALTH INC | MILWAUKEE, WI | CONTRACTUAL SERVICES | $11,121,668 |
| MEDICAL COLLEGE OF WI AFFIL HOSP | MILWAUKEE, WI | RESIDENT SERVICES | $10,965,299 |
2022 · 5 contractors · $61.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| FROEDTERT HEALTH MEDICAL GROUP | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $18,279,551 |
| FROEDTERT HEALTH INC | MILWAUKEE, WI | CONTRACTUAL SERVICES | $12,233,858 |
| NATL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $11,631,234 |
| MEDICAL COLLEGE OF WI AFFIL HOSP | MILWAUKEE, WI | RESIDENT SERVICES | $11,126,946 |
| MIRON CONSTRUCTION CO INC | GREEN BAY, WI | CONSTRUCTION SERVICE | $7,710,910 |
2021 · 5 contractors · $54.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| FROEDTERT HEALTH MEDICAL GROUP | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $15,012,525 |
| NATL MARROW DONOR PROGRAM | MENNEAPOLIS, MN | RESEARCH SUBCONTRACT | $14,507,012 |
| MEDICAL COLLEGE OF WI AFFIL HOSP | MILWAUKEE, WI | RESIDENT SERVICES | $9,981,116 |
| FROEDTERT HEALTH INC | MILWAUKEE, WI | CONTRACTUAL SERVICES | $8,313,456 |
| MIRON CONSTRUCTION CO INC | GREEN BAY, WI | CONSTRUCTION SERVICE | $6,296,942 |
2020 · 5 contractors · $48.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| FROEDTERT HEALTH MEDICAL GROUP | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $14,430,683 |
| NATL MARROW DONOR PROGRAM | MENNEAPOLIS, MN | RESEARCH SUBCONTRACT | $12,720,302 |
| MEDICAL COLLEGE OF WI AFFIL HOSP | MILWAUKEE, WI | RESIDENT SERVICES | $8,794,636 |
| AFFILIATED CONSTRUCTION SERVICES IN | MIDDLETON, WI | CONSTRUCTION SERVICE | $6,354,519 |
| FROEDTERT HEALTH INC | MILWAUKEE, WI | CONTRACTUAL SERVICES | $6,189,797 |
2019 · 5 contractors · $46.0M
| Name | Location | Service | Paid |
|---|---|---|---|
| FROEDTERT HEALTH MEDICAL GROUP | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $11,944,046 |
| AFFILIATED CONSTRUCTION SERVICES IN | MIDDLETON, WI | CONSTRUCTION SERVICE | $9,657,895 |
| MEDICAL COLLEGE OF WI AFFIL HOSP | MILWAUKEE, WI | RESIDENT SERVICES | $8,225,019 |
| NATL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $8,081,938 |
| FROEDTERT HEALTH INC | MILWAUKEE, WI | CONTRACTUAL SERVICES | $8,043,210 |
2018 · 5 contractors · $44.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| FROEDTERT HEALTH MEDICAL GROUP | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $12,877,080 |
| C G SCHMIDT INC | MILWAUKEE, WI | CONSTRUCTION SERVICE | $10,962,466 |
| NATL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $9,468,950 |
| MEDICAL COLLEGE OF WI AFFIL HOSP | MILWAUKEE, WI | RESIDENT SERVICES | $6,778,520 |
| CHILDRENS HOSPITAL OF WISCONSIN | MILWAUKEE, WI | CONTRACTUAL SERVICES | $4,371,035 |
2017 · 5 contractors · $95.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| C G SCHMIDT INC | MILWAUKEE, WI | CONSTRUCTION SERVICE | $67,170,548 |
| FROEDTERT HEALTH MEDICAL GROUP | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $10,221,099 |
| NATL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $8,298,633 |
| MEDICAL COLLEGE OF WI AFFIL HOSP | MILWAUKEE, WI | RESIDENT SERVICES | $5,732,291 |
| CHILDRENS HOSPITAL OF WISCONSIN | MILWAUKEE, WI | CONTRACTUAL SERVICES | $4,292,549 |
2016 · 5 contractors · $43.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| C G SCHMIDT INC | MILWAUKEE, WI | CONSTRUCTION SERVICE | $16,958,739 |
| FROEDTERT HEALTH MEDICAL GROUP | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $9,650,420 |
| NATL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $7,056,907 |
| MEDICAL COLLEGE OF WI AFFILIATED HO | MILWAUKEE, WI | RESIDENT SERVICES | $4,767,175 |
| CARDIOLOGY JOINT VENTURE LLC | MILWAUKEE, WI | PHYSICIAN SERVICES | $4,670,017 |
2015 · 5 contractors · $33.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $9,784,695 |
| Froedtert Health Medical Group | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $9,119,552 |
| CARDIOLOGY JOINT VENTURE LLC | MILWAUKEE, WI | Physician Services | $5,858,851 |
| Blood Center of Wisconsin Inc | MILWAUKEE, WI | RESEARCH/CONTRACTUAL | $4,717,569 |
| Medical College of WI Affiliated Ho | MILWAUKEE, WI | Resident Services | $4,456,938 |
2014 · 5 contractors · $34.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Froedtert Health Medical Group | MILWAUKEE, WI | PHYSICIAN/SHARED SVC | $9,962,991 |
| NATL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $8,512,716 |
| CARDIOLOGY JOINT VENTURE LLC | MILWAUKEE, WI | Physician Services | $6,631,993 |
| Dedicated Computing Enterprise Solu | MILWAUKEE, WI | Information Systems | $4,782,238 |
| Medical College of WI Affiliated Ho | MILWAUKEE, WI | RESIDENT SERVICES | $4,298,285 |
2013 · 5 contractors · $26.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATL MARROW DONOR PROGRAM | RESEARCH SUBCONTRACT | $7,026,279 | |
| Dedicated Computing Enterprise Solu | Information Systems | $6,171,787 | |
| CARDIOLOGY JOINT VENTURE LLC | Physician Services | $5,519,286 | |
| Medical College of WI Affiliated Ho | RESIDENT SERVICES | $4,286,142 | |
| FROEDTERT MEMORIAL LUTHERAN HOSPITA | SHARED SERVICES | $3,492,858 |
2012 · 5 contractors · $31.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $8,658,329 |
| FROEDTERT MEMORIAL LUTHERAN HOSPITA | MILWAUKEE, WI | SHARED SERVICES | $7,694,788 |
| TUSHAUS COMPUTER SERVICES LLC | MILWAUKEE, WI | INFORMATION SYSTEMS | $6,104,367 |
| C G SCHMIDT INC | MILWAUKEE, WI | CONSTRUCTION | $4,729,254 |
| Medical College of WI Affiliated Ho | MILWAUKEE, WI | RESIDENT SERVICES | $4,485,819 |
2011 · 5 contractors · $26.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $7,670,270 |
| DEDICATED COMP SVC DBA TUSHAUS COMP | MILWAUKEE, WI | INFORMATION SYSTEMS | $6,252,879 |
| Medical College of WI Affiliated Ho | MILWAUKEE, WI | resident services | $4,787,574 |
| FROEDTERT MEMORIAL LUTHERAN HOSPITA | MILWAUKEE, WI | SHARED SERVICES | $4,292,908 |
| PRINCIPAL LIFE INSURANCE CO | DES MOINES, IA | BENEFITS ADMIN | $3,170,440 |
2010 · 5 contractors · $26.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Affiliated Construction Services I | MADISON, WI | CONSTRUCTION | $6,632,586 |
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $5,515,274 |
| TUSHAUS COMPUTER SERVICES LLC | MILWAUKEE, WI | INFORMATION SYSTEMS | $5,154,076 |
| Medical College of WI Affiliated Ho | MILWAUKEE, WI | resident services | $5,096,929 |
| THE EMMES CORP | ROCKVILLE, MD | RESEARCH SUBCONTRACT | $3,799,385 |
2009 · 5 contractors · $21.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| NATIONAL MARROW DONOR PROGRAM | MINNEAPOLIS, MN | RESEARCH SUBCONTRACT | $6,302,610 |
| TUSHAUS COMPUTER SERVICES INC | MILWAUKEE, WI | INFORMATION SYSTEMS | $4,649,754 |
| Medical College of WI Affiliated Ho | MILWAUKEE, WI | resident services | $4,522,492 |
| THE EMMES CORP | ROCKVILLE, MD | RESEARCH SUBCONTRACT | $3,320,513 |
| Affiliated Construction Services I | MADISON, WI | construction | $3,123,823 |
Paid as a vendor by
Other organizations that listed this one among their highest-paid independent contractors. Contractor lists give no EIN, so these are matched on name and address; check the filing.
Who the money went to
Grants this organization reported paying: Schedule I Part II of the Form 990, or the grants-paid list on the 990-PF. Open a year for every recipient. Recipients link to their own page when the grant names an EIN we have (990-PF grants list no EIN, so those link only on an exact, unique name and state). Grants to individuals are counted; their names are not shown.
2024 · 205 grants to organizations · $65.0M
Listed grants add up to $64,978,323; the return's “grants paid” expense line says $65,670,189. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2023 · 205 grants to organizations · $46.4M
Listed grants add up to $46,394,781; the return's “grants paid” expense line says $64,474,204. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2022 · 192 grants to organizations · $43.3M
Listed grants add up to $43,260,992; the return's “grants paid” expense line says $59,390,524. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2021 · 155 grants to organizations · $40.5M
Listed grants add up to $40,530,214; the return's “grants paid” expense line says $56,555,097. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2020 · 163 grants to organizations · $39.1M
Listed grants add up to $39,129,892; the return's “grants paid” expense line says $52,645,496. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2019 · 146 grants to organizations · $34.4M
Listed grants add up to $34,410,412; the return's “grants paid” expense line says $47,156,362. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2018 · 145 grants to organizations · $28.3M
Listed grants add up to $28,256,934; the return's “grants paid” expense line says $40,544,988. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2017 · 155 grants to organizations · $29.7M
Listed grants add up to $29,716,200; the return's “grants paid” expense line says $40,710,283. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2016 · 144 grants to organizations · $28.9M
Listed grants add up to $28,945,470; the return's “grants paid” expense line says $38,712,784. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2015 · 135 grants to organizations · $25.3M
Listed grants add up to $25,287,072; the return's “grants paid” expense line says $34,918,016. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2014 · 146 grants to organizations · $28.8M
Listed grants add up to $28,834,959; the return's “grants paid” expense line says $37,797,830. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2013 · 143 grants to organizations · $28.8M
Listed grants add up to $28,783,752; the return's “grants paid” expense line says $38,138,093. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2012 · 130 grants to organizations · $26.5M
Listed grants add up to $26,453,889; the return's “grants paid” expense line says $36,227,542. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2011 · 125 grants to organizations · $25.7M
Listed grants add up to $25,697,443; the return's “grants paid” expense line says $35,121,338. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2010 · 126 grants to organizations · $25.7M
Listed grants add up to $25,660,002; the return's “grants paid” expense line says $35,655,716. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
2009 · 130 grants to organizations · $22.8M
Listed grants add up to $22,757,629; the return's “grants paid” expense line says $33,335,829. Returns can differ here (grants paid vs. accrued, items listed elsewhere); check the filing.
Negative amounts are returned or refunded grants; they are listed last and left out of the totals of grants paid.
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $1,758,334,139 | $1,682,301,948 | $3,469,802,142 | $2,669,199,970 | $226,082,409 | $1,399,529,898 | $18,970,453 | 8,196 | 26 |
| 2023 · Form 990 | ||||||||
| $1,607,441,142 | $1,584,630,058 | $3,274,618,395 | $2,456,863,549 | $222,011,817 | $1,305,967,100 | $17,341,763 | 8,103 | 26 |
| 2022 · Form 990 | ||||||||
| $1,485,866,745 | $1,459,941,335 | $3,048,459,625 | $2,205,784,204 | $214,545,386 | $1,196,087,794 | $14,899,962 | 7,887 | 25 |
| 2021 · Form 990 | ||||||||
| $1,613,951,767 | $1,375,096,323 | $2,894,883,838 | $2,011,631,913 | $224,509,895 | $1,145,495,436 | $12,980,417 | 7,385 | 26 |
| 2020 · Form 990 | ||||||||
| $1,363,134,190 | $1,287,814,092 | $3,131,610,164 | $2,341,803,071 | $240,236,197 | $1,058,801,872 | $13,343,108 | 7,052 | 24 |
| 2019 · Form 990 | ||||||||
| $1,286,151,484 | $1,217,951,862 | $2,541,731,692 | $1,804,859,631 | $207,371,004 | $995,530,737 | $12,714,624 | 7,232 | 24 |
| 2018 · Form 990 | ||||||||
| $1,258,883,721 | $1,179,626,265 | $2,456,134,363 | $1,821,686,451 | $187,393,808 | $993,408,242 | $12,275,864 | 7,018 | 23 |
| 2017 · Form 990 | ||||||||
| $1,216,120,532 | $1,116,060,114 | $2,324,075,644 | $1,767,691,614 | $152,950,270 | $953,168,825 | $10,863,933 | 6,651 | 22 |
| 2016 · Form 990 | ||||||||
| $1,144,930,712 | $1,061,080,967 | $2,231,331,527 | $1,658,238,226 | $171,540,243 | $891,071,981 | $9,843,072 | 6,314 | 20 |
| 2015 · Form 990 | ||||||||
| $1,052,471,372 | $993,553,543 | $1,984,855,763 | $1,438,920,196 | $151,693,606 | $838,919,429 | $8,701,645 | 6,120 | 25 |
| 2014 · Form 990 | ||||||||
| $1,036,038,159 | $928,128,669 | $1,898,080,641 | $1,469,345,530 | $153,455,335 | $806,543,087 | $7,769,946 | 6,146 | 25 |
| 2013 · Form 990 | ||||||||
| $990,874,258 | $915,251,004 | $1,828,250,839 | $1,401,080,335 | $148,438,376 | $782,600,595 | $6,949,049 | 6,166 | 80 |
| 2012 · Form 990 | ||||||||
| $950,823,140 | $902,540,629 | $1,603,116,222 | $1,210,461,210 | $150,411,593 | $752,674,825 | $6,504,074 | 6,355 | 80 |
| 2011 · Form 990 | ||||||||
| $949,759,390 | $901,934,512 | $1,447,446,882 | $1,086,942,866 | $163,033,071 | $745,912,385 | $7,435,650 | 6,241 | 75 |
| 2010 · Form 990 | ||||||||
| $936,188,529 | $872,807,244 | $1,439,703,234 | $1,078,177,170 | $172,601,206 | $713,287,506 | $6,276,610 | 6,124 | 94 |
| 2009 · Form 990 | ||||||||
| $839,096,199 | $818,319,669 | $1,247,019,757 | $912,517,688 | $157,918,543 | $675,377,861 | $6,131,774 | 6,012 | 102 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- UNITED WAY OF GREATER MILWAUKEE & WAUKESHA COUNTY INC Milwaukee, WI · 10 people in common (Austin Ramirez, David Lubar, Elizabeth Brenner)
- METROPOLITAN MILWAUKEE ASSOCIATION OF COMMERCE Milwaukee, WI · 10 people in common (Austin Ramirez, Chris Miskel, David Lubar)
- GREATER MILWAUKEE COMMITTEE FOR COMMUNITY DEVELOPMENT Milwaukee, WI · 6 people in common (Austin Ramirez, David Lubar, Elizabeth Brenner)
- MARQUETTE UNIVERSITY Milwaukee, WI · 5 people in common (Janis M Orlowski Md, Jon D Hammes, Kristina M Ropella Phd)
- UNITED PERFORMING ARTS FUND INC Milwaukee, WI · 5 people in common (Austin Ramirez, C Greer Jordan, David Lubar)
- YOUNG MENS CHRISTIAN ASSOCIATION OF METROPOLITAN MILWAUKEE Milwaukee, WI · 4 people in common (Austin Ramirez, Gregory Wesley, Jon D Hammes)
- VERSITI BLOOD HEALTH INC Milwaukee, WI · 3 people in common (Chris Miskel, John R Raymond Sr Md, Peggy Troy)
- BOYS AND GIRLS CLUB OF GREATER MILWAUKEE INC Milwaukee, WI · 3 people in common (Austin Ramirez, Elizabeth Brenner, Gregory Wesley)
- UWM FOUNDATION INC Milwaukee, WI · 3 people in common (David Lubar, Jacqueline Herd-Barber, Joseph E Kerschner Md)
- UNIVERSITY OF WISCONSIN FOUNDATION Madison, WI · 2 people in common (Jon D Hammes, Ted Kellner)
- CHILDRENS HOSPITAL AND HEALTH SYSTEM INC Milwaukee, WI · 2 people in common (Elizabeth Brenner, Joseph E Kerschner Md)
- CHILDRENS SPECIALTY GROUP INC Milwaukee, WI · 2 people in common (Joseph E Kerschner Md, Shelisa Dalton) · related organization (Schedule R)
- CHILDRENS HOSPITAL OF WISCONSIN FOUNDATION INC Boston, MA · 2 people in common (Jacqueline Herd-Barber, Ted Kellner)
- MILWAUKEE WORLD FESTIVAL INC Milwaukee, WI · 2 people in common (Jon D Hammes, Ted Kellner)
- VERSITI ILLINOIS INC Aurora, IL · 2 people in common (Chris Miskel, Peggy Troy)
- VERSITI BLOOD RESEARCH INSTITUTE FOUNDATION INC Milwaukee, WI · 2 people in common (Chris Miskel, John R Raymond Sr Md)
- CITY FORWARD COLLECTIVE INC Milwaukee, WI · 2 people in common (Austin Ramirez, Nancy Hernandez)
- BLACK ARTS MKE INC Milwaukee, WI · 2 people in common (Gregory Wesley, Jacqueline Herd-Barber)
- BADGER INSTITUTE INC Milwaukee, WI · 2 people in common (David Lubar, Jon D Hammes)
- GREATER MILWAUKEE HOLDINGS INC Milwaukee, WI · 2 people in common (Gregory Wesley, Jacqueline Herd-Barber)
Funders of this organization
300 grantors reported grants to this organization, $221,815,344 in all, tax years 2009 to 2025; the 25 largest shown (all 300). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Type | Match | Years given | Grants | Total | Latest year | Latest year's amount | Grants |
|---|---|---|---|---|---|---|---|---|
| MIDWEST ATHLETES AGAINST CHILDHOOD CANCER INC | Public charity | Exact | 2010-2022, 2024 | 21 | $30,168,800 | 2024 | $3,750,000 | show |
| THE ROBERT D AND PATRICIA E KERN FAMILY FOUNDATION INC | Private foundation | Fuzzy filed as “THE MEDICAL COLLEGE OF WISCONSIN INC” | 2020-2024 | 5 | $22,025,000 | 2024 | $7,500,000 | show |
| AMERICAN HEART ASSOCIATION INC | Public charity | Exact | 2010-2024 | 16 | $16,738,628 | 2024 | $565,140 | show |
| MARQUETTE UNIVERSITY | Public charity | Exact | 2009-2010, 2012-2017, 2019-2024 | 26 | $8,898,180 | 2024 | $867,342 | show |
| UNITED WAY OF GREATER MILWAUKEE & WAUKESHA COUNTY INC | Public charity | Exact | 2009-2013, 2015-2024 | 24 | $8,876,006 | 2024 | $347,571 | show |
| JOHNS HOPKINS UNIVERSITY | DAF sponsor | Exact | 2009-2011, 2013-2024 | 15 | $8,723,908 | 2024 | $193,040 | show |
| AMERICAN CANCER SOCIETY INC | Public charity | Exact | 2009-2011, 2013-2014, 2016-2018, 2020-2024 | 14 | $7,462,884 | 2024 | $22,234 | show |
| UNIVERSITY OF CHICAGO | Public charity | Exact | 2009-2024 | 16 | $6,289,733 | 2024 | $141,362 | show |
| CYSTIC FIBROSIS FOUNDATION | Public charity | Exact | 2010-2024 | 37 | $6,227,576 | 2024 | $802,162 | show |
| PAULA AND RODGER RINEY FOUNDATION | Private foundation | Fuzzy filed as “THE MEDICAL COLLEGE OF WISCONSIN” | 2022-2023 | 2 | $5,965,118 | 2023 | $2,982,559 | show |
| THE CHILDRENS HOSPITAL OF PHILADELPHIA | Public charity | Exact | 2010-2024 | 15 | $4,446,856 | 2024 | $154,773 | show |
| GREATER MILWAUKEE FOUNDATION INC | DAF sponsor | Exact | 2020-2024 | 5 | $4,172,540 | 2024 | $1,525,016 | show |
| WBCS INC | Public charity | Exact | 2010-2015, 2017-2019, 2022, 2024 | 11 | $3,610,000 | 2024 | $325,000 | show |
| AVALON NETWORK | Public charity | Exact | 2023-2024 | 2 | $3,500,000 | 2024 | $2,500,000 | show |
| FIDELITY INVESTMENTS CHARITABLE GIFT FUND | DAF sponsor | Exact | 2016-2024 | 9 | $3,304,499 | 2024 | $503,550 | show |
| BREAKTHROUGH T1D | Public charity | Exact | 2010, 2012, 2014-2015, 2017-2019, 2022-2024 | 10 | $3,268,966 | 2024 | $338,260 | show |
| NORTHWESTERN UNIVERSITY | DAF sponsor | Exact | 2009-2024 | 16 | $3,010,816 | 2024 | $436,013 | show |
| CEDAR STREET CHARITABLE FOUNDATION INC | DAF sponsor | Exact | 2011-2015, 2017-2025 | 16 | $2,749,400 | 2025 | $319,400 | show |
| American Diabetes Association Research Foundation Inc | Public charity | Exact | 2010, 2012-2016, 2018, 2020-2021 | 17 | $2,598,101 | 2021 | $680,116 | show |
| MORGAN STANLEY GLOBAL IMPACT FUNDING TRUST INC | DAF sponsor | Exact | 2018, 2022-2023 | 3 | $2,210,000 | 2023 | $1,100,000 | show |
| MAYO CLINIC | DAF sponsor | Exact | 2012-2016, 2018-2021, 2023-2024 | 11 | $2,006,006 | 2024 | $12,341 | show |
| VANDERBILT UNIVERSITY | DAF sponsor | Exact | 2009-2015, 2023 | 8 | $1,954,526 | 2023 | $35,172 | show |
| CHILDRENS HOSPITAL OF WISCONSIN INC | Public charity | Exact | 2010-2011, 2013-2024 | 27 | $1,836,919 | 2024 | $13,624 | show |
| TOPS CLUB INC | Public charity | Exact | 2010-2021 | 12 | $1,775,192 | 2021 | $100,000 | show |
| ASPIRUS HEALTH FOUNDATION INC | Public charity | Exact | 2016-2022 | 7 | $1,770,000 | 2022 | $240,000 | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| TRUSTEES OF DARTMOUTH COLLEGE | NH | B43 | $2,261,775,916 | $1,618,788,716 | Chief Executive Officer - Investment Office | $5,113,351 | Same NTEE code B43, revenue within 2x |
| SAVANNAH COLLEGE OF ART AND DESIGN INC | GA | B43 | $952,827,667 | $699,373,327 | President | $5,736,005 | Same NTEE code B43, revenue within 2x |
| BARD COLLEGE | NY | B43 | $930,316,002 | $408,373,029 | PRESIDENT/TRUSTEE | $689,293 | Same NTEE code B43, revenue within 2x |
| TRUSTEES OF TUFTS COLLEGE | MA | B43 | $1,556,567,693 | $1,476,698,115 | Trustee & University President | $1,356,483 | Same NTEE code B43, revenue within 2x |
| NOVA SOUTHEASTERN UNIVERSITY INC | FL | B43 | $1,062,017,634 | $998,250,087 | President/CEO through 1/1/2025 | $1,800,665 | Same NTEE code B43, revenue within 2x |
| LIBERTY UNIVERSITY INC | VA | B43 | $1,939,920,591 | $1,528,685,670 | Former Trustee/Officer | $9,781,223 | Same NTEE code B43, revenue within 2x |
| ROCHESTER INSTITUTE OF TECHNOLOGY | NY | B43 | $1,173,696,705 | $1,125,942,387 | PRESIDENT | $1,421,925 | Same NTEE code B43, revenue within 2x |
| BOSTON COLLEGE TRUSTEES | MA | B43 | $1,838,532,376 | $1,504,254,811 | HEAD COACH, FBALL (FROM 2/24) | $3,396,247 | Same NTEE code B43, revenue within 2x |
| TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUC | PA | B43 | $1,787,499,000 | $1,594,038,000 | Head Coach - Football (thru 11/24) | $1,733,911 | Same NTEE code B43, revenue within 2x |
| UNIVERSITY OF OTTAWA | B43 | $1,124,805,721 | $1,066,980,410 | Dean | $377,347 | Same NTEE code B43, revenue within 2x | |
| UNIVERSITY OF DAYTON | OH | B43 | $947,238,621 | $897,643,780 | HEAD COACH MEN'S BASKETBALL | $2,767,651 | Same NTEE code B43, revenue within 2x |
| DEPAUL UNIVERSITY | IL | B43 | $966,926,889 | $943,640,265 | MEN'S HEAD BASKETBALL COACH | $1,223,672 | Same NTEE code B43, revenue within 2x |
| FORDHAM UNIVERSITY | NY | B43 | $1,225,879,469 | $1,167,075,092 | PRESIDENT & TRUSTEE | $1,846,798 | Same NTEE code B43, revenue within 2x |
| SOUTHERN METHODIST UNIVERSITY | TX | B43 | $1,181,490,564 | $1,097,826,408 | Head Basketball Coach -Current | $7,606,787 | Same NTEE code B43, revenue within 2x |
| UNIVERSITY OF BRITISH COLUMBIA | B43 | $2,797,284,167 | $2,707,290,736 | Professor tenure Faculty of Medicine | $567,994 | Same NTEE code B43, revenue within 2x | |
| HOWARD UNIVERSITY | DC | B43 | $1,433,002,000 | $1,412,020,000 | FORMER PRESIDENT, RET 9/1/23 | $1,520,238 | Same NTEE code B43, revenue within 2x |
| BAYLOR UNIVERSITY | TX | B43 | $1,558,351,465 | $1,503,719,409 | HEAD MEN'S BASKETBALL COAC | $6,836,352 | Same NTEE code B43, revenue within 2x |
| THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND | LA | B43 | $1,943,508,000 | $1,755,227,000 | Head Football Coach | $3,081,000 | Same NTEE code B43, revenue within 2x |
| GEORGE WASHINGTON UNIVERSITY | VA | B43 | $2,041,697,367 | $2,032,943,695 | President - Ex Officio | $1,907,439 | Same NTEE code B43, revenue within 2x |
| TEXAS CHRISTIAN UNIVERSITY | TX | B43 | $1,250,018,653 | $1,091,646,077 | Head Football Coach | $6,386,809 | Same NTEE code B43, revenue within 2x |
| WILLIAM MARSH RICE UNIVERSITY | TX | B43 | $1,635,701,788 | $1,369,765,124 | Chief Investment Officer, Treasurer, Assistant Secretary | $2,975,212 | Same NTEE code B43, revenue within 2x |
| LOYOLA UNIVERSITY OF CHICAGO | IL | B43 | $1,058,054,182 | $1,021,633,063 | HEAD MEN'S BASKETBALL COACH | $1,360,375 | Same NTEE code B43, revenue within 2x |
| UNIVERSITY OF SASKATCHEWAN | B43 | $962,171,944 | $858,134,508 | Former Vice-President Research | $1,540,960 | Same NTEE code B43, revenue within 2x | |
| PRINCETON UNIVERSITY | NJ | B43 | $3,208,577,000 | $3,196,203,000 | President of PRINCO | $4,722,776 | Same NTEE code B43, revenue within 2x |
| YORK UNIVERSITY | B43 | $1,017,395,087 | $1,018,036,554 | Professor/Senior Advisor/Advisor/Endowed Chair | $493,410 | Same NTEE code B43, revenue within 2x |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $1,682,301,948 spent · pay $1,296,679,542 · grants $65,670,189 · events $10,781,686
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,059,342,926 | $1,009,634,934 | $45,456,979 | $4,251,013 | 63.0% | |
| Fees: other services | $99,920,426 | $88,519,976 | $10,584,866 | $815,584 | 5.9% | |
| Other employee benefits | $96,106,574 | $91,721,835 | $4,027,166 | $357,573 | 5.7% | |
| Payroll taxes | $59,172,598 | $55,503,753 | $3,365,904 | $302,941 | 3.5% | |
| Pension plan contributions | $58,842,846 | $55,644,736 | $2,923,579 | $274,531 | 3.5% | |
| Grants to US organizations and governments | $46,204,480 | $46,204,480 | - | - | 2.7% | |
| Occupancy | $41,197,144 | $38,065,825 | $3,079,302 | $52,017 | 2.4% | |
| Depreciation and depletion | $33,079,127 | $30,233,496 | $2,803,095 | $42,536 | 2.0% | |
| Information technology | $27,010,333 | $5,573,152 | $20,943,976 | $493,205 | 1.6% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $24,671,250 | $24,671,250 | - | - | 1.5% |
| Pay: officers, directors, trustees, key employees | $18,970,453 | $5,919,635 | $12,150,303 | $900,515 | 1.1% | |
| Grants to US individuals | $18,628,267 | $18,628,267 | - | - | 1.1% | |
| Other (as described) | RESIDENTS & FELLOWS | $13,140,395 | $13,140,395 | - | - | 0.8% |
| Other (as described) | DUES & SUBSCRIPTIONS | $10,874,508 | $9,824,552 | $1,039,613 | $10,343 | 0.6% |
| Conferences, conventions and meetings | $10,645,969 | $10,270,361 | $306,760 | $68,848 | 0.6% | |
| Fees: investment management | $10,594,691 | - | $10,594,691 | - | 0.6% | |
| Interest | $10,259,183 | $9,341,358 | $917,825 | - | 0.6% | |
| Travel | $9,678,714 | $9,187,461 | $328,829 | $162,424 | 0.6% | |
| All other expenses | $8,278,022 | $4,377,500 | $3,720,064 | $180,458 | 0.5% | |
| Office expenses | $7,286,822 | $5,908,419 | $1,234,883 | $143,520 | 0.4% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $5,085,901 | $4,813,634 | $267,244 | $5,023 | 0.3% |
| Pay: disqualified persons | $4,244,145 | $3,931,700 | $312,445 | - | 0.3% | |
| Advertising and promotion | $2,930,443 | $2,894,686 | - | $35,757 | 0.2% | |
| Fees: legal | $1,404,706 | $789,216 | $615,490 | - | 0.1% | |
| Insurance | $1,390,280 | $281,933 | $1,101,161 | $7,186 | 0.1% | |
| Royalties | $1,346,936 | $1,346,936 | - | - | 0.1% | |
| Grants outside the US | $837,442 | $837,442 | - | - | 0.0% | |
| Fees: accounting | $832,103 | - | $832,103 | - | 0.0% | |
| Fees: lobbying | $299,716 | $284,470 | $15,246 | - | 0.0% | |
| Fees: professional fundraisers | $25,548 | - | - | $25,548 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $60,638 | $135,717 | reported apart | |||
| Total | $1,682,301,948 | 100% |
2023 · Form 990 · $1,584,630,058 spent · pay $1,225,313,002 · grants $64,474,204 · events $11,395,091
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $1,000,078,498 | $952,297,388 | $44,008,760 | $3,772,350 | 63.1% | |
| Other employee benefits | $94,293,602 | $89,809,677 | $4,158,931 | $324,994 | 6.0% | |
| Fees: other services | $77,895,422 | $66,510,595 | $11,214,618 | $170,209 | 4.9% | |
| Payroll taxes | $55,527,566 | $51,990,082 | $3,264,281 | $273,203 | 3.5% | |
| Pension plan contributions | $54,948,776 | $51,839,541 | $2,869,870 | $239,365 | 3.5% | |
| Grants to US organizations and governments | $46,457,081 | $46,457,081 | - | - | 2.9% | |
| Occupancy | $37,216,124 | $31,936,740 | $5,229,085 | $50,299 | 2.3% | |
| Depreciation and depletion | $33,913,598 | $30,807,953 | $3,033,279 | $72,366 | 2.1% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $24,950,852 | $24,950,852 | - | - | 1.6% |
| Information technology | $23,947,663 | $4,154,283 | $19,214,016 | $579,364 | 1.5% | |
| Grants to US individuals | $17,470,602 | $17,470,602 | - | - | 1.1% | |
| Pay: officers, directors, trustees, key employees | $17,341,763 | $5,477,017 | $11,103,333 | $761,413 | 1.1% | |
| Other (as described) | RESIDENTS & FELLOWS | $11,809,913 | $11,809,913 | - | - | 0.7% |
| Conferences, conventions and meetings | $11,300,130 | $10,830,364 | $419,363 | $50,403 | 0.7% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $11,086,803 | $10,390,249 | $681,510 | $15,044 | 0.7% |
| Interest | $10,580,595 | $9,634,853 | $945,742 | - | 0.7% | |
| Fees: investment management | $10,232,004 | - | $10,232,004 | - | 0.6% | |
| Travel | $9,062,416 | $8,554,353 | $359,832 | $148,231 | 0.6% | |
| All other expenses | $8,844,931 | $6,788,390 | $1,841,440 | $215,101 | 0.6% | |
| Office expenses | $8,147,457 | $5,725,370 | $2,106,519 | $315,568 | 0.5% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $5,966,785 | $5,833,321 | $133,157 | $307 | 0.4% |
| Advertising and promotion | $3,713,482 | $3,704,596 | - | $8,886 | 0.2% | |
| Pay: disqualified persons | $3,122,797 | $2,966,377 | $156,420 | - | 0.2% | |
| Fees: legal | $2,837,654 | $1,178,660 | $1,658,994 | - | 0.2% | |
| Insurance | $1,265,997 | $255,254 | $1,006,562 | $4,181 | 0.1% | |
| Royalties | $900,494 | $900,494 | - | - | 0.1% | |
| Fees: accounting | $806,720 | - | $806,720 | - | 0.1% | |
| Grants outside the US | $546,521 | $546,521 | - | - | 0.0% | |
| Fees: lobbying | $248,109 | $236,581 | $11,528 | - | 0.0% | |
| Fees: professional fundraisers | $115,703 | - | - | $115,703 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $48,944 | $94,961 | reported apart | |||
| Total | $1,584,630,058 | 100% |
2022 · Form 990 · $1,459,941,335 spent · pay $1,119,204,102 · grants $59,390,524 · events $9,090,336
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $926,269,582 | $880,929,300 | $41,645,221 | $3,695,061 | 63.4% | |
| Other employee benefits | $74,827,190 | $71,432,160 | $3,139,968 | $255,062 | 5.1% | |
| Fees: other services | $73,121,761 | $61,277,892 | $11,413,351 | $430,518 | 5.0% | |
| Payroll taxes | $50,984,763 | $47,709,102 | $3,006,545 | $269,116 | 3.5% | |
| Pension plan contributions | $50,074,904 | $47,284,836 | $2,561,590 | $228,478 | 3.4% | |
| Grants to US organizations and governments | $43,320,808 | $43,320,808 | - | - | 3.0% | |
| Occupancy | $37,422,542 | $30,305,051 | $7,066,096 | $51,395 | 2.6% | |
| Depreciation and depletion | $33,335,723 | $30,159,172 | $3,062,727 | $113,824 | 2.3% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $23,921,779 | $23,921,779 | - | - | 1.6% |
| Information technology | $20,979,655 | $4,144,450 | $16,585,884 | $249,321 | 1.4% | |
| Grants to US individuals | $15,743,431 | $15,743,431 | - | - | 1.1% | |
| Pay: officers, directors, trustees, key employees | $14,899,962 | $3,986,923 | $9,988,699 | $924,340 | 1.0% | |
| Other (as described) | RESIDENTS & FELLOWS | $11,830,476 | $11,830,476 | - | - | 0.8% |
| Other (as described) | DUES & SUBSCRIPTIONS | $11,146,150 | $10,342,083 | $787,567 | $16,500 | 0.8% |
| All other expenses | $10,950,242 | $8,442,192 | $2,452,002 | $56,048 | 0.8% | |
| Interest | $10,338,884 | $9,408,499 | $930,385 | - | 0.7% | |
| Conferences, conventions and meetings | $9,002,979 | $8,543,279 | $429,873 | $29,827 | 0.6% | |
| Travel | $8,853,283 | $8,420,441 | $263,360 | $169,482 | 0.6% | |
| Office expenses | $8,320,891 | $5,433,003 | $2,644,947 | $242,941 | 0.6% | |
| Fees: investment management | $7,676,276 | - | $7,676,276 | - | 0.5% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $6,957,754 | $6,647,064 | $310,490 | $200 | 0.5% |
| Advertising and promotion | $3,396,968 | $3,396,968 | - | - | 0.2% | |
| Pay: disqualified persons | $2,147,701 | $2,007,138 | $140,563 | - | 0.1% | |
| Fees: legal | $1,486,085 | $617,942 | $868,143 | - | 0.1% | |
| Insurance | $1,332,360 | $276,681 | $1,050,036 | $5,643 | 0.1% | |
| Fees: accounting | $706,484 | - | $706,484 | - | 0.0% | |
| Grants outside the US | $326,285 | $326,285 | - | - | 0.0% | |
| Fees: professional fundraisers | $253,343 | - | - | $253,343 | 0.0% | |
| Fees: lobbying | $244,880 | $236,174 | $8,706 | - | 0.0% | |
| Royalties | $68,194 | $68,194 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $52,790 | $87,357 | reported apart | |||
| Total | $1,459,941,335 | 100% |
2021 · Form 990 · $1,375,096,323 spent · pay $1,061,358,017 · grants $56,555,097 · events $8,775,074
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $877,420,917 | $834,832,691 | $39,509,667 | $3,078,559 | 63.8% | |
| Other employee benefits | $75,432,952 | $71,715,653 | $3,435,680 | $281,619 | 5.5% | |
| Fees: other services | $62,082,418 | $50,327,695 | $11,566,974 | $187,749 | 4.5% | |
| Pension plan contributions | $47,223,489 | $44,543,419 | $2,473,120 | $206,950 | 3.4% | |
| Payroll taxes | $46,639,891 | $43,673,644 | $2,738,672 | $227,575 | 3.4% | |
| Grants to US organizations and governments | $40,550,363 | $40,550,363 | - | - | 2.9% | |
| Depreciation and depletion | $34,206,920 | $31,318,659 | $2,753,063 | $135,198 | 2.5% | |
| Occupancy | $34,038,063 | $28,054,180 | $5,853,829 | $130,054 | 2.5% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $22,555,216 | $22,555,216 | - | - | 1.6% |
| Information technology | $19,329,871 | $3,613,222 | $15,215,204 | $501,445 | 1.4% | |
| Grants to US individuals | $15,337,801 | $15,337,801 | - | - | 1.1% | |
| Pay: officers, directors, trustees, key employees | $12,980,417 | $3,553,770 | $8,714,635 | $712,012 | 0.9% | |
| Other (as described) | RESIDENTS & FELLOWS | $11,811,323 | $11,811,323 | - | - | 0.9% |
| Other (as described) | DUES & SUBSCRIPTIONS | $10,684,346 | $10,023,737 | $654,286 | $6,323 | 0.8% |
| Interest | $10,430,436 | $9,530,088 | $900,348 | - | 0.8% | |
| All other expenses | $9,275,262 | $6,493,893 | $2,769,083 | $12,286 | 0.7% | |
| Fees: investment management | $9,071,647 | - | $9,071,647 | - | 0.7% | |
| Conferences, conventions and meetings | $8,697,057 | $8,456,634 | $222,207 | $18,216 | 0.6% | |
| Office expenses | $8,045,598 | $5,555,269 | $2,355,522 | $134,807 | 0.6% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $6,061,124 | $5,914,649 | $104,287 | $42,188 | 0.4% |
| Travel | $4,118,633 | $3,905,435 | $118,853 | $94,345 | 0.3% | |
| Advertising and promotion | $2,785,551 | $2,785,551 | - | - | 0.2% | |
| Pay: disqualified persons | $1,660,351 | $1,660,351 | - | - | 0.1% | |
| Fees: legal | $1,387,536 | $314,908 | $1,072,628 | - | 0.1% | |
| Insurance | $1,180,800 | $277,062 | $893,453 | $10,285 | 0.1% | |
| Fees: accounting | $942,785 | - | $942,785 | - | 0.1% | |
| Grants outside the US | $666,933 | $666,933 | - | - | 0.0% | |
| Fees: lobbying | $230,998 | $223,494 | $7,504 | - | 0.0% | |
| Fees: professional fundraisers | $191,093 | - | - | $191,093 | 0.0% | |
| Royalties | $56,532 | $56,532 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $29,582 | $78,017 | reported apart | |||
| Total | $1,375,096,323 | 100% |
2020 · Form 990 · $1,287,814,092 spent · pay $999,210,384 · grants $52,645,496 · events $4,165,393
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $826,657,869 | $785,854,837 | $37,834,330 | $2,968,702 | 64.2% | |
| Other employee benefits | $68,815,779 | $64,835,989 | $3,701,744 | $278,046 | 5.3% | |
| Fees: other services | $51,130,171 | $40,271,062 | $10,749,462 | $109,647 | 4.0% | |
| Pension plan contributions | $45,070,934 | $42,149,880 | $2,731,509 | $189,545 | 3.5% | |
| Payroll taxes | $43,457,292 | $40,339,312 | $2,913,059 | $204,921 | 3.4% | |
| Occupancy | $40,005,420 | $31,485,291 | $8,370,821 | $149,308 | 3.1% | |
| Grants to US organizations and governments | $39,147,874 | $39,147,874 | - | - | 3.0% | |
| Depreciation and depletion | $34,350,607 | $31,283,775 | $2,919,351 | $147,481 | 2.7% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $23,731,136 | $23,731,136 | - | - | 1.8% |
| Information technology | $17,704,629 | $4,024,554 | $13,415,771 | $264,304 | 1.4% | |
| Pay: officers, directors, trustees, key employees | $13,343,108 | $3,628,676 | $9,036,837 | $677,595 | 1.0% | |
| Grants to US individuals | $13,020,816 | $13,020,816 | - | - | 1.0% | |
| Interest | $10,659,728 | $9,883,730 | $775,998 | - | 0.8% | |
| Fees: investment management | $10,181,411 | - | $10,181,411 | - | 0.8% | |
| Other (as described) | RESIDENTS & FELLOWS | $9,773,311 | $9,773,311 | - | - | 0.8% |
| Other (as described) | DUES & SUBSCRIPTIONS | $8,666,346 | $7,991,378 | $670,872 | $4,096 | 0.7% |
| Other (as described) | EQUIPMENT & MAINTENANCE | $7,265,986 | $5,824,574 | $1,433,249 | $8,163 | 0.6% |
| Office expenses | $6,961,229 | $4,599,683 | $2,263,519 | $98,027 | 0.5% | |
| All other expenses | $5,449,066 | $3,346,578 | $2,057,918 | $44,570 | 0.4% | |
| Conferences, conventions and meetings | $4,165,393 | $4,106,195 | $56,750 | $2,448 | 0.3% | |
| Advertising and promotion | $2,483,560 | $2,481,416 | - | $2,144 | 0.2% | |
| Pay: disqualified persons | $1,865,402 | $1,865,402 | - | - | 0.1% | |
| Fees: legal | $890,205 | $155,466 | $734,739 | - | 0.1% | |
| Insurance | $809,413 | $180,001 | $629,412 | - | 0.1% | |
| Fees: accounting | $679,392 | - | $679,392 | - | 0.1% | |
| Grants outside the US | $476,806 | $476,806 | - | - | 0.0% | |
| Travel | $435,431 | $390,576 | $26,346 | $18,509 | 0.0% | |
| Royalties | $413,292 | $413,292 | - | - | 0.0% | |
| Fees: lobbying | $202,486 | $195,494 | $6,992 | - | 0.0% | |
| Total | $1,287,814,092 | 100% |
2019 · Form 990 · $1,217,951,862 spent · pay $933,499,516 · grants $47,156,362 · events $8,311,143
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $774,808,228 | $731,793,951 | $40,874,359 | $2,139,918 | 63.6% | |
| Other employee benefits | $61,466,896 | $57,991,888 | $3,318,794 | $156,214 | 5.0% | |
| Fees: other services | $48,101,144 | $38,394,657 | $8,778,388 | $928,099 | 3.9% | |
| Pension plan contributions | $42,097,330 | $39,429,654 | $2,540,304 | $127,372 | 3.5% | |
| Payroll taxes | $41,769,385 | $38,833,495 | $2,790,541 | $145,349 | 3.4% | |
| Depreciation and depletion | $35,885,264 | $32,767,602 | $2,972,141 | $145,521 | 2.9% | |
| Occupancy | $35,247,555 | $27,718,982 | $7,386,279 | $142,294 | 2.9% | |
| Grants to US organizations and governments | $34,436,457 | $34,436,457 | - | - | 2.8% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $20,755,973 | $20,755,973 | - | - | 1.7% |
| Information technology | $16,739,397 | $5,047,715 | $11,426,216 | $265,466 | 1.4% | |
| Pay: officers, directors, trustees, key employees | $12,714,624 | $3,844,959 | $8,156,506 | $713,159 | 1.0% | |
| Grants to US individuals | $12,222,670 | $12,222,670 | - | - | 1.0% | |
| Interest | $10,690,765 | $9,876,389 | $814,376 | - | 0.9% | |
| Other (as described) | RESIDENTS & FELLOWS | $9,372,611 | $9,372,611 | - | - | 0.8% |
| Other (as described) | DUES & SUBSCRIPTIONS | $9,100,772 | $8,412,498 | $679,270 | $9,004 | 0.7% |
| All other expenses | $8,358,133 | $6,137,795 | $2,170,234 | $50,104 | 0.7% | |
| Office expenses | $7,995,065 | $5,401,033 | $2,478,398 | $115,634 | 0.7% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $7,868,180 | $4,875,368 | $2,992,085 | $727 | 0.6% |
| Conferences, conventions and meetings | $7,728,795 | $7,437,269 | $253,374 | $38,152 | 0.6% | |
| Travel | $7,326,537 | $7,132,154 | $174,585 | $19,798 | 0.6% | |
| Fees: investment management | $6,300,566 | - | $6,300,566 | - | 0.5% | |
| Advertising and promotion | $2,482,737 | $2,469,230 | - | $13,507 | 0.2% | |
| Fees: legal | $1,448,908 | $884,241 | $564,667 | - | 0.1% | |
| Fees: accounting | $776,107 | - | $776,107 | - | 0.1% | |
| Insurance | $663,743 | $148,803 | $514,940 | - | 0.1% | |
| Pay: disqualified persons | $643,053 | $643,053 | - | - | 0.1% | |
| Grants outside the US | $497,235 | $497,235 | - | - | 0.0% | |
| Fees: lobbying | $225,802 | $220,797 | $5,005 | - | 0.0% | |
| Royalties | $187,442 | $187,442 | - | - | 0.0% | |
| Fees: professional fundraisers | $40,488 | - | - | $40,488 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $222,243 | $582,348 | reported apart | |||
| Total | $1,217,951,862 | 100% |
2018 · Form 990 · $1,179,626,265 spent · pay $899,840,559 · grants $40,544,988 · events $8,854,664
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $743,002,532 | $698,114,382 | $42,371,572 | $2,516,578 | 63.0% | |
| Other employee benefits | $64,917,456 | $60,792,963 | $3,884,730 | $239,763 | 5.5% | |
| Fees: other services | $45,828,996 | $36,717,149 | $7,723,360 | $1,388,487 | 3.9% | |
| Payroll taxes | $39,476,195 | $36,456,645 | $2,827,269 | $192,281 | 3.3% | |
| Pension plan contributions | $39,159,477 | $36,438,304 | $2,543,788 | $177,385 | 3.3% | |
| Occupancy | $36,603,076 | $29,863,282 | $6,597,186 | $142,608 | 3.1% | |
| Depreciation and depletion | $35,306,775 | $27,318,423 | $7,860,366 | $127,986 | 3.0% | |
| Grants to US organizations and governments | $28,298,671 | $28,298,671 | - | - | 2.4% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $22,066,636 | $22,066,636 | - | - | 1.9% |
| Information technology | $14,376,739 | $4,329,382 | $9,865,006 | $182,351 | 1.2% | |
| Pay: officers, directors, trustees, key employees | $12,275,864 | $3,998,153 | $7,525,128 | $752,583 | 1.0% | |
| Grants to US individuals | $11,626,179 | $11,626,179 | - | - | 1.0% | |
| Travel | $10,602,507 | $10,308,241 | $256,108 | $38,158 | 0.9% | |
| Interest | $10,434,847 | $9,335,263 | $1,099,584 | - | 0.9% | |
| Office expenses | $9,992,027 | $6,907,836 | $2,930,543 | $153,648 | 0.8% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $9,684,485 | $9,037,912 | $631,516 | $15,057 | 0.8% |
| Other (as described) | RESIDENTS & FELLOWS | $8,862,177 | $8,862,177 | - | - | 0.8% |
| All other expenses | $8,256,279 | $4,024,820 | $4,147,731 | $83,728 | 0.7% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $8,163,797 | $5,128,169 | $2,997,276 | $38,352 | 0.7% |
| Conferences, conventions and meetings | $8,156,032 | $7,731,414 | $340,589 | $84,029 | 0.7% | |
| Fees: investment management | $5,767,457 | - | $5,767,457 | - | 0.5% | |
| Advertising and promotion | $1,964,555 | $1,961,060 | - | $3,495 | 0.2% | |
| Fees: legal | $1,736,503 | $869,172 | $867,331 | - | 0.1% | |
| Pay: disqualified persons | $1,009,035 | $1,009,035 | - | - | 0.1% | |
| Grants outside the US | $620,138 | $620,138 | - | - | 0.1% | |
| Fees: accounting | $596,162 | - | $596,162 | - | 0.1% | |
| Insurance | $488,746 | $13,623 | $475,123 | - | 0.0% | |
| Fees: lobbying | $278,006 | $272,133 | $5,873 | - | 0.0% | |
| Fees: professional fundraisers | $40,447 | - | - | $40,447 | 0.0% | |
| Royalties | $34,469 | $34,469 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $249,710 | $698,632 | reported apart | |||
| Total | $1,179,626,265 | 100% |
2017 · Form 990 · $1,116,060,114 spent · pay $858,032,127 · grants $40,710,283 · events $7,905,228
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $713,546,035 | $663,152,570 | $47,745,754 | $2,647,711 | 63.9% | |
| Other employee benefits | $58,530,497 | $53,956,534 | $4,333,658 | $240,305 | 5.2% | |
| Fees: other services | $40,745,104 | $32,012,885 | $7,746,650 | $985,569 | 3.7% | |
| Payroll taxes | $37,227,089 | $33,734,589 | $3,331,042 | $161,458 | 3.3% | |
| Pension plan contributions | $36,852,080 | $33,692,425 | $2,999,921 | $159,734 | 3.3% | |
| Occupancy | $35,123,138 | $29,741,299 | $5,151,259 | $230,580 | 3.1% | |
| Depreciation and depletion | $31,583,181 | $24,895,110 | $6,572,292 | $115,779 | 2.8% | |
| Grants to US organizations and governments | $29,755,638 | $29,755,638 | - | - | 2.7% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $20,018,446 | $20,018,446 | - | - | 1.8% |
| Information technology | $14,297,283 | $5,351,777 | $8,819,861 | $125,645 | 1.3% | |
| Pay: officers, directors, trustees, key employees | $10,863,933 | $2,765,965 | $7,305,852 | $792,116 | 1.0% | |
| Grants to US individuals | $10,509,563 | $10,509,563 | - | - | 0.9% | |
| Travel | $9,820,559 | $9,363,942 | $403,516 | $53,101 | 0.9% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $9,695,272 | $5,690,696 | $3,982,032 | $22,544 | 0.9% |
| Other (as described) | DUES & SUBSCRIPTIONS | $8,686,131 | $8,276,625 | $396,151 | $13,355 | 0.8% |
| Office expenses | $8,673,789 | $4,902,547 | $3,642,577 | $128,665 | 0.8% | |
| Interest | $8,266,659 | $7,025,197 | $1,241,462 | - | 0.7% | |
| Conferences, conventions and meetings | $7,307,705 | $6,745,290 | $552,202 | $10,213 | 0.7% | |
| Other (as described) | RESIDENTS & FELLOWS | $6,910,851 | $6,910,851 | - | - | 0.6% |
| All other expenses | $6,020,565 | $4,476,647 | $1,495,961 | $47,957 | 0.5% | |
| Fees: investment management | $5,599,542 | - | $5,599,542 | - | 0.5% | |
| Advertising and promotion | $1,933,759 | $1,928,960 | - | $4,799 | 0.2% | |
| Fees: legal | $1,073,707 | $474,791 | $598,916 | - | 0.1% | |
| Pay: disqualified persons | $1,012,493 | $1,012,493 | - | - | 0.1% | |
| Fees: accounting | $578,277 | - | $578,277 | - | 0.1% | |
| Insurance | $551,472 | $1,465 | $550,007 | - | 0.0% | |
| Grants outside the US | $445,082 | $445,082 | - | - | 0.0% | |
| Fees: lobbying | $277,538 | $271,652 | $5,886 | - | 0.0% | |
| Royalties | $114,021 | $114,021 | - | - | 0.0% | |
| Fees: professional fundraisers | $40,705 | - | - | $40,705 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $187,841 | $597,523 | reported apart | |||
| Total | $1,116,060,114 | 100% |
2016 · Form 990 · $1,061,080,967 spent · pay $799,621,120 · grants $38,712,784 · events $8,442,384
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $661,305,937 | $616,071,464 | $42,736,819 | $2,497,654 | 62.3% | |
| Other employee benefits | $57,233,933 | $52,712,494 | $4,203,384 | $318,055 | 5.4% | |
| Fees: other services | $46,162,252 | $35,741,569 | $9,519,329 | $901,354 | 4.4% | |
| Occupancy | $36,931,244 | $31,644,760 | $5,032,960 | $253,524 | 3.5% | |
| Pension plan contributions | $34,614,139 | $31,793,518 | $2,684,608 | $136,013 | 3.3% | |
| Payroll taxes | $34,372,236 | $31,324,552 | $2,912,664 | $135,020 | 3.2% | |
| Depreciation and depletion | $29,455,480 | $23,677,062 | $5,740,025 | $38,393 | 2.8% | |
| Grants to US organizations and governments | $28,935,500 | $28,935,500 | - | - | 2.7% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $20,361,733 | $20,361,733 | - | - | 1.9% |
| Information technology | $11,986,388 | $5,088,645 | $6,708,142 | $189,601 | 1.1% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $11,174,018 | $6,406,097 | $4,766,713 | $1,208 | 1.1% |
| Office expenses | $9,891,200 | $5,943,778 | $3,817,278 | $130,144 | 0.9% | |
| Pay: officers, directors, trustees, key employees | $9,843,072 | $2,635,381 | $6,458,139 | $749,552 | 0.9% | |
| All other expenses | $9,410,208 | $7,295,762 | $2,107,573 | $6,873 | 0.9% | |
| Grants to US individuals | $9,202,231 | $9,202,231 | - | - | 0.9% | |
| Travel | $9,127,949 | $8,684,296 | $394,830 | $48,823 | 0.9% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $8,254,373 | $7,751,478 | $495,761 | $7,134 | 0.8% |
| Conferences, conventions and meetings | $7,955,294 | $7,270,234 | $644,511 | $40,549 | 0.7% | |
| Interest | $6,151,151 | $5,204,440 | $946,711 | - | 0.6% | |
| Other (as described) | RESIDENTS & FELLOWS | $5,642,301 | $5,642,301 | - | - | 0.5% |
| Fees: investment management | $5,477,380 | - | $5,477,380 | - | 0.5% | |
| Pay: disqualified persons | $2,251,803 | $2,251,803 | - | - | 0.2% | |
| Advertising and promotion | $1,762,994 | $1,756,147 | - | $6,847 | 0.2% | |
| Fees: legal | $1,296,826 | $695,902 | $600,924 | - | 0.1% | |
| Insurance | $662,754 | - | $662,754 | - | 0.1% | |
| Grants outside the US | $575,053 | $575,053 | - | - | 0.1% | |
| Fees: accounting | $573,566 | - | $573,566 | - | 0.1% | |
| Fees: lobbying | $275,940 | $275,940 | - | - | 0.0% | |
| Royalties | $153,362 | $153,362 | - | - | 0.0% | |
| Fees: professional fundraisers | $40,650 | - | - | $40,650 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $203,342 | $487,090 | reported apart | |||
| Total | $1,061,080,967 | 100% |
2015 · Form 990 · $993,553,543 spent · pay $740,540,906 · grants $34,918,016 · events $6,110,906
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $611,102,599 | $566,464,721 | $42,367,737 | $2,270,141 | 61.5% | |
| Other employee benefits | $54,696,124 | $50,180,517 | $4,286,055 | $229,552 | 5.5% | |
| Fees: other services | $43,614,459 | $35,739,003 | $7,520,857 | $354,599 | 4.4% | |
| Occupancy | $34,208,748 | $29,027,682 | $4,937,064 | $244,002 | 3.4% | |
| Pension plan contributions | $33,168,332 | $30,122,250 | $2,891,425 | $154,657 | 3.3% | |
| Payroll taxes | $31,124,646 | $28,024,926 | $2,954,487 | $145,233 | 3.1% | |
| Depreciation and depletion | $28,450,537 | $23,015,875 | $5,425,363 | $9,299 | 2.9% | |
| Grants to US organizations and governments | $25,298,629 | $25,298,629 | - | - | 2.5% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $19,440,609 | $19,440,609 | - | - | 2.0% |
| All other expenses | $14,939,344 | $11,707,057 | $3,226,990 | $5,297 | 1.5% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $11,285,860 | $6,188,610 | $5,094,205 | $3,045 | 1.1% |
| Other (as described) | LOSS ON DEBT EXTINGUISHMENT | $9,478,911 | $8,021,739 | $1,457,172 | - | 1.0% |
| Office expenses | $9,412,708 | $5,511,736 | $3,774,054 | $126,918 | 0.9% | |
| Information technology | $8,961,748 | $4,684,731 | $4,238,566 | $38,451 | 0.9% | |
| Grants to US individuals | $8,837,059 | $8,837,059 | - | - | 0.9% | |
| Pay: officers, directors, trustees, key employees | $8,701,645 | $3,002,253 | $4,951,020 | $748,372 | 0.9% | |
| Travel | $8,106,181 | $7,729,442 | $350,524 | $26,215 | 0.8% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $8,060,535 | $7,546,239 | $506,856 | $7,440 | 0.8% |
| Interest | $6,913,162 | $5,874,056 | $1,039,106 | - | 0.7% | |
| Conferences, conventions and meetings | $5,850,629 | $5,225,861 | $609,255 | $15,513 | 0.6% | |
| Fees: investment management | $5,076,739 | - | $5,076,739 | - | 0.5% | |
| Pay: disqualified persons | $1,747,560 | $1,718,330 | $29,230 | - | 0.2% | |
| Advertising and promotion | $1,343,821 | $1,338,921 | - | $4,900 | 0.1% | |
| Fees: legal | $1,206,189 | $385,872 | $820,317 | - | 0.1% | |
| Grants outside the US | $782,328 | $782,328 | - | - | 0.1% | |
| Insurance | $626,402 | - | $626,402 | - | 0.1% | |
| Fees: accounting | $533,230 | - | $533,230 | - | 0.1% | |
| Royalties | $285,328 | $285,328 | - | - | 0.0% | |
| Fees: lobbying | $258,463 | $258,463 | - | - | 0.0% | |
| Fees: professional fundraisers | $41,018 | - | - | $41,018 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $181,459 | $260,277 | reported apart | |||
| Total | $993,553,543 | 100% |
2014 · Form 990 · $928,128,669 spent · pay $698,373,250 · grants $37,797,830 · events $5,260,101
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $570,129,674 | $528,935,245 | $39,308,304 | $1,886,125 | 61.4% | |
| Other employee benefits | $56,772,657 | $52,149,249 | $4,430,991 | $192,417 | 6.1% | |
| Fees: other services | $35,438,488 | $28,905,113 | $6,518,455 | $14,920 | 3.8% | |
| Occupancy | $33,119,603 | $28,049,586 | $4,871,994 | $198,023 | 3.6% | |
| Pension plan contributions | $32,124,744 | $29,139,021 | $2,855,435 | $130,288 | 3.5% | |
| Payroll taxes | $29,617,429 | $26,691,623 | $2,805,615 | $120,191 | 3.2% | |
| Grants to US organizations and governments | $28,876,341 | $28,876,341 | - | - | 3.1% | |
| Depreciation and depletion | $28,270,289 | $24,098,453 | $4,158,525 | $13,311 | 3.0% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $18,017,024 | $18,017,024 | - | - | 1.9% |
| Information technology | $10,080,135 | $4,242,678 | $5,784,124 | $53,333 | 1.1% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $9,586,447 | $6,197,212 | $3,388,619 | $616 | 1.0% |
| Office expenses | $8,520,893 | $4,939,239 | $3,495,846 | $85,808 | 0.9% | |
| Grants to US individuals | $8,324,801 | $8,324,801 | - | - | 0.9% | |
| Interest | $8,160,581 | $7,011,372 | $1,149,209 | - | 0.9% | |
| Travel | $7,845,831 | $7,478,700 | $348,572 | $18,559 | 0.8% | |
| Pay: officers, directors, trustees, key employees | $7,769,946 | $2,579,931 | $4,522,310 | $667,705 | 0.8% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $7,257,461 | $6,734,652 | $516,182 | $6,627 | 0.8% |
| All other expenses | $7,256,584 | $5,495,119 | $1,757,196 | $4,269 | 0.8% | |
| Other (as described) | RESIDENTS & FELLOWS | $5,032,763 | $5,032,763 | - | - | 0.5% |
| Conferences, conventions and meetings | $5,011,333 | $4,391,531 | $568,950 | $50,852 | 0.5% | |
| Fees: investment management | $4,646,302 | - | $4,646,302 | - | 0.5% | |
| Pay: disqualified persons | $1,958,800 | $1,958,800 | - | - | 0.2% | |
| Advertising and promotion | $1,405,703 | $1,398,420 | - | $7,283 | 0.2% | |
| Grants outside the US | $596,688 | $596,688 | - | - | 0.1% | |
| Royalties | $555,343 | $555,343 | - | - | 0.1% | |
| Fees: accounting | $507,227 | - | $507,227 | - | 0.1% | |
| Fees: legal | $500,381 | $228,166 | $272,215 | - | 0.1% | |
| Insurance | $435,424 | - | $435,424 | - | 0.0% | |
| Fees: lobbying | $252,892 | $252,892 | - | - | 0.0% | |
| Fees: professional fundraisers | $56,885 | - | - | $56,885 | 0.0% | |
| Fundraising events Event | direct expenses; gross income $227,577 | $248,768 | reported apart | |||
| Total | $928,128,669 | 100% |
2013 · Form 990 · $915,251,004 spent · pay $691,256,111 · grants $38,138,093 · events $4,890,715
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $552,383,717 | $513,014,846 | $37,850,893 | $1,517,978 | 60.4% | |
| Other employee benefits | $67,991,086 | $62,803,600 | $4,973,979 | $213,507 | 7.4% | |
| Fees: other services | $34,968,768 | $29,355,713 | $5,584,496 | $28,559 | 3.8% | |
| Pension plan contributions | $32,887,819 | $30,251,182 | $2,531,388 | $105,249 | 3.6% | |
| Occupancy | $31,319,965 | $27,216,539 | $3,915,109 | $188,317 | 3.4% | |
| Payroll taxes | $29,489,273 | $26,960,087 | $2,434,796 | $94,390 | 3.2% | |
| Grants to US organizations and governments | $28,834,002 | $28,834,002 | - | - | 3.2% | |
| Depreciation and depletion | $27,841,818 | $24,009,194 | $3,816,071 | $16,553 | 3.0% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $16,933,402 | $16,933,402 | - | - | 1.9% |
| Information technology | $12,625,868 | $4,285,684 | $8,295,243 | $44,941 | 1.4% | |
| Interest | $8,776,430 | $7,506,164 | $1,270,266 | - | 1.0% | |
| Office expenses | $8,686,843 | $5,273,731 | $3,314,813 | $98,299 | 0.9% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $8,506,434 | $5,906,788 | $2,599,540 | $106 | 0.9% |
| Grants to US individuals | $8,127,337 | $8,127,337 | - | - | 0.9% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $7,149,406 | $6,724,540 | $424,284 | $582 | 0.8% |
| Travel | $7,061,666 | $6,720,545 | $325,833 | $15,288 | 0.8% | |
| Pay: officers, directors, trustees, key employees | $6,949,049 | $2,384,070 | $3,969,724 | $595,255 | 0.8% | |
| Other (as described) | RESIDENTS & FELLOWS | $5,302,374 | $5,302,374 | - | - | 0.6% |
| All other expenses | $4,727,996 | $4,137,302 | $569,673 | $21,021 | 0.5% | |
| Conferences, conventions and meetings | $4,606,578 | $4,223,729 | $342,554 | $40,295 | 0.5% | |
| Fees: investment management | $4,469,302 | - | $4,469,302 | - | 0.5% | |
| Pay: disqualified persons | $1,555,167 | $1,555,167 | - | - | 0.2% | |
| Grants outside the US | $1,176,754 | $1,176,754 | - | - | 0.1% | |
| Advertising and promotion | $997,240 | $996,240 | - | $1,000 | 0.1% | |
| Fees: legal | $626,992 | $409,951 | $217,041 | - | 0.1% | |
| Fees: accounting | $533,073 | - | $533,073 | - | 0.1% | |
| Insurance | $409,349 | - | $409,349 | - | 0.0% | |
| Fees: lobbying | $249,224 | $249,224 | - | - | 0.0% | |
| Fees: professional fundraisers | $36,403 | - | - | $36,403 | 0.0% | |
| Royalties | $27,669 | $27,669 | - | - | 0.0% | |
| Fundraising events Event | direct expenses; gross income $244,659 | $284,137 | reported apart | |||
| Total | $915,251,004 | 100% |
2012 · Form 990 · $902,540,629 spent · pay $672,053,382 · grants $36,227,542 · events $5,464,302
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $530,608,004 | $493,942,342 | $35,212,231 | $1,453,431 | 58.8% | |
| Other employee benefits | $72,495,888 | $66,777,794 | $5,492,152 | $225,942 | 8.0% | |
| Occupancy | $39,815,476 | $35,540,633 | $4,083,954 | $190,889 | 4.4% | |
| Pension plan contributions | $31,827,805 | $29,261,896 | $2,467,008 | $98,901 | 3.5% | |
| Payroll taxes | $28,646,129 | $26,166,088 | $2,391,071 | $88,970 | 3.2% | |
| Depreciation and depletion | $27,778,040 | $24,048,203 | $3,713,405 | $16,432 | 3.1% | |
| Grants to US organizations and governments | $26,456,768 | $26,456,768 | - | - | 2.9% | |
| Fees: other services | $24,791,505 | $21,976,254 | $2,744,069 | $71,182 | 2.7% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $24,605,465 | $24,605,465 | - | - | 2.7% |
| Information technology | $14,446,389 | $5,028,944 | $9,342,228 | $75,217 | 1.6% | |
| Office expenses | $9,257,264 | $6,187,690 | $2,974,656 | $94,918 | 1.0% | |
| Interest | $8,505,553 | $7,305,857 | $1,199,696 | - | 0.9% | |
| Grants to US individuals | $8,222,131 | $8,222,131 | - | - | 0.9% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $8,192,355 | $5,893,784 | $2,294,541 | $4,030 | 0.9% |
| Other (as described) | DUES & SUBSCRIPTIONS | $7,837,656 | $7,396,673 | $435,675 | $5,308 | 0.9% |
| Travel | $6,787,495 | $6,486,813 | $283,300 | $17,382 | 0.8% | |
| Pay: officers, directors, trustees, key employees | $6,504,074 | $2,273,814 | $3,752,054 | $478,206 | 0.7% | |
| Other (as described) | RESIDENTS & FELLOWS | $5,570,250 | $5,570,250 | - | - | 0.6% |
| All other expenses | $5,295,610 | $3,695,186 | $1,588,017 | $12,407 | 0.6% | |
| Conferences, conventions and meetings | $5,166,460 | $4,671,152 | $473,908 | $21,400 | 0.6% | |
| Fees: investment management | $4,040,482 | - | $4,040,482 | - | 0.4% | |
| Pay: disqualified persons | $1,971,482 | $1,971,482 | - | - | 0.2% | |
| Grants outside the US | $1,548,643 | $1,548,643 | - | - | 0.2% | |
| Fees: legal | $534,370 | $278,415 | $255,955 | - | 0.1% | |
| Fees: accounting | $515,955 | - | $515,955 | - | 0.1% | |
| Advertising and promotion | $510,615 | $487,290 | $22,325 | $1,000 | 0.1% | |
| Insurance | $364,318 | $18,180 | $346,138 | - | 0.0% | |
| Fees: lobbying | $156,493 | $156,493 | - | - | 0.0% | |
| Royalties | $53,225 | $53,225 | - | - | 0.0% | |
| Fees: professional fundraisers | $34,729 | - | - | $34,729 | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $297,842 | reported apart | |||
| Total | $902,540,629 | 100% |
2011 · Form 990 · $901,934,512 spent · pay $648,683,494 · grants $35,121,338 · events $4,997,719
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $509,269,853 | $476,070,787 | $31,741,858 | $1,457,208 | 56.5% | |
| Other employee benefits | $73,160,725 | $67,664,877 | $5,251,324 | $244,524 | 8.1% | |
| Occupancy | $40,809,737 | $35,966,354 | $4,660,989 | $182,394 | 4.5% | |
| Pension plan contributions | $30,433,951 | $28,133,480 | $2,198,987 | $101,484 | 3.4% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $29,788,148 | $29,788,148 | - | - | 3.3% |
| Payroll taxes | $27,397,879 | $25,143,086 | $2,163,370 | $91,423 | 3.0% | |
| Depreciation and depletion | $26,736,578 | $23,911,507 | $2,810,378 | $14,693 | 3.0% | |
| Grants to US organizations and governments | $25,761,988 | $25,761,988 | - | - | 2.9% | |
| Other (as described) | BAD DEBT | $24,992,674 | $24,992,674 | - | - | 2.8% |
| Fees: other services | $21,418,482 | $17,865,553 | $3,541,356 | $11,573 | 2.4% | |
| Information technology | $15,156,643 | $4,943,078 | $10,174,209 | $39,356 | 1.7% | |
| All other expenses | $11,118,698 | $8,173,703 | $2,932,359 | $12,636 | 1.2% | |
| Office expenses | $9,679,380 | $6,331,812 | $3,260,871 | $86,697 | 1.1% | |
| Grants to US individuals | $8,475,183 | $8,475,183 | - | - | 0.9% | |
| Interest | $8,086,259 | $7,128,769 | $957,490 | - | 0.9% | |
| Pay: officers, directors, trustees, key employees | $7,435,650 | $3,175,392 | $3,776,579 | $483,679 | 0.8% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $7,144,020 | $6,738,549 | $403,748 | $1,723 | 0.8% |
| Travel | $6,659,598 | $6,336,985 | $307,258 | $15,355 | 0.7% | |
| Other (as described) | RESIDENTS & FELLOWS | $5,465,504 | $5,465,504 | - | - | 0.6% |
| Conferences, conventions and meetings | $4,695,784 | $4,266,002 | $399,148 | $30,634 | 0.5% | |
| Fees: investment management | $3,550,363 | - | $3,550,363 | - | 0.4% | |
| Pay: disqualified persons | $985,436 | $516,243 | $469,193 | - | 0.1% | |
| Grants outside the US | $884,167 | $884,167 | - | - | 0.1% | |
| Advertising and promotion | $757,792 | $675,852 | $72,504 | $9,436 | 0.1% | |
| Fees: legal | $633,774 | $416,869 | $216,905 | - | 0.1% | |
| Fees: accounting | $517,250 | - | $517,250 | - | 0.1% | |
| Insurance | $373,001 | $12,349 | $360,652 | - | 0.0% | |
| Fees: management | $288,387 | - | $288,387 | - | 0.0% | |
| Fees: lobbying | $178,077 | $178,077 | - | - | 0.0% | |
| Royalties | $45,560 | $45,560 | - | - | 0.0% | |
| Fees: professional fundraisers | $33,971 | - | - | $33,971 | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $301,935 | reported apart | |||
| Total | $901,934,512 | 100% |
2010 · Form 990 · $872,807,244 spent · pay $624,414,923 · grants $35,655,716 · events $4,439,777
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $491,258,583 | $459,397,592 | $30,447,636 | $1,413,355 | 56.3% | |
| Other employee benefits | $70,687,955 | $65,448,073 | $4,999,595 | $240,287 | 8.1% | |
| Occupancy | $39,547,249 | $34,394,597 | $4,976,495 | $176,157 | 4.5% | |
| Pension plan contributions | $29,736,395 | $27,519,812 | $2,115,637 | $100,946 | 3.4% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $28,890,006 | $28,890,006 | - | - | 3.3% |
| Depreciation and depletion | $27,078,503 | $24,623,216 | $2,441,137 | $14,150 | 3.1% | |
| Payroll taxes | $26,455,380 | $24,305,550 | $2,059,669 | $90,161 | 3.0% | |
| Grants to US organizations and governments | $25,719,461 | $25,719,461 | - | - | 2.9% | |
| Other (as described) | BAD DEBT | $25,291,490 | $25,291,490 | - | - | 2.9% |
| Fees: other services | $17,525,928 | $14,814,910 | $2,702,361 | $8,657 | 2.0% | |
| Information technology | $13,383,097 | $4,700,544 | $8,651,222 | $31,331 | 1.5% | |
| Office expenses | $10,193,821 | $6,429,986 | $3,657,522 | $106,313 | 1.2% | |
| Grants to US individuals | $8,756,525 | $8,756,525 | - | - | 1.0% | |
| Interest | $8,203,611 | $7,214,260 | $989,351 | - | 0.9% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $6,988,284 | $5,145,148 | $1,838,597 | $4,539 | 0.8% |
| Other (as described) | DUES & SUBSCRIPTIONS | $6,720,544 | $6,429,322 | $288,797 | $2,425 | 0.8% |
| Travel | $6,463,014 | $6,139,405 | $294,965 | $28,644 | 0.7% | |
| Pay: officers, directors, trustees, key employees | $6,276,610 | $2,172,751 | $3,620,565 | $483,294 | 0.7% | |
| All other expenses | $6,078,571 | $4,456,654 | $1,615,676 | $6,241 | 0.7% | |
| Other (as described) | RESIDENTS & FELLOWS | $5,504,868 | $5,504,868 | - | - | 0.6% |
| Conferences, conventions and meetings | $4,200,218 | $3,743,968 | $428,850 | $27,400 | 0.5% | |
| Fees: investment management | $3,399,730 | - | $3,399,730 | - | 0.4% | |
| Grants outside the US | $1,179,730 | $1,179,730 | - | - | 0.1% | |
| Fees: legal | $949,900 | $631,757 | $318,143 | - | 0.1% | |
| Advertising and promotion | $765,884 | $674,768 | $81,068 | $10,048 | 0.1% | |
| Fees: accounting | $551,971 | - | $551,971 | - | 0.1% | |
| Insurance | $325,037 | $9,557 | $315,480 | - | 0.0% | |
| Fees: management | $296,000 | - | $296,000 | - | 0.0% | |
| Fees: lobbying | $174,752 | $174,752 | - | - | 0.0% | |
| Royalties | $157,055 | $157,055 | - | - | 0.0% | |
| Fees: professional fundraisers | $47,072 | - | - | $47,072 | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $239,559 | reported apart | |||
| Total | $872,807,244 | 100% |
2009 · Form 990 · $818,319,669 spent · pay $586,262,872 · grants $33,335,829 · events $4,496,422
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $462,019,504 | $432,508,271 | $28,104,459 | $1,406,774 | 56.5% | |
| Other employee benefits | $66,563,087 | $61,658,440 | $4,662,863 | $241,784 | 8.1% | |
| Occupancy | $39,096,668 | $34,249,073 | $4,680,448 | $167,147 | 4.8% | |
| Other (as described) | MEDICAL & RESEARCH SUPPLIES | $27,607,486 | $27,607,486 | - | - | 3.4% |
| Depreciation and depletion | $27,039,550 | $24,114,222 | $2,915,751 | $9,577 | 3.3% | |
| Pension plan contributions | $27,021,791 | $24,932,102 | $1,991,344 | $98,345 | 3.3% | |
| Payroll taxes | $24,526,716 | $22,481,516 | $1,955,873 | $89,327 | 3.0% | |
| Grants to US organizations and governments | $22,839,840 | $22,839,840 | - | - | 2.8% | |
| Other (as described) | BAD DEBT | $22,809,501 | $22,809,501 | - | - | 2.8% |
| Fees: other services | $17,001,769 | $13,496,966 | $3,479,283 | $25,520 | 2.1% | |
| Information technology | $11,251,293 | $3,696,702 | $7,543,954 | $10,637 | 1.4% | |
| Office expenses | $9,055,366 | $6,239,575 | $2,702,593 | $113,198 | 1.1% | |
| Grants to US individuals | $8,284,715 | $8,284,715 | - | - | 1.0% | |
| Interest | $7,631,341 | $6,535,459 | $1,095,882 | - | 0.9% | |
| Other (as described) | EQUIPMENT & MAINTENANCE | $6,213,398 | $4,862,844 | $1,348,305 | $2,249 | 0.8% |
| Pay: officers, directors, trustees, key employees | $6,131,774 | $2,228,199 | $3,210,097 | $693,478 | 0.7% | |
| Other (as described) | RESIDENTS & FELLOWS | $5,979,441 | $5,979,441 | - | - | 0.7% |
| Travel | $5,915,042 | $5,670,829 | $220,943 | $23,270 | 0.7% | |
| Other (as described) | DUES & SUBSCRIPTIONS | $5,850,249 | $5,683,407 | $162,344 | $4,498 | 0.7% |
| Conferences, conventions and meetings | $4,240,931 | $3,684,129 | $522,841 | $33,961 | 0.5% | |
| All other expenses | $3,381,920 | $2,622,791 | $756,614 | $2,515 | 0.4% | |
| Fees: investment management | $2,758,076 | - | $2,758,076 | - | 0.3% | |
| Grants outside the US | $2,211,274 | $2,211,274 | - | - | 0.3% | |
| Advertising and promotion | $750,723 | $666,388 | $76,427 | $7,908 | 0.1% | |
| Fees: legal | $667,270 | $503,987 | $163,283 | - | 0.1% | |
| Fees: accounting | $573,041 | - | $573,041 | - | 0.1% | |
| Fees: management | $303,000 | - | $303,000 | - | 0.0% | |
| Insurance | $248,320 | - | $248,320 | - | 0.0% | |
| Royalties | $167,780 | $167,780 | - | - | 0.0% | |
| Fees: lobbying | $134,083 | $134,083 | - | - | 0.0% | |
| Fees: professional fundraisers | $44,720 | - | - | $44,720 | 0.0% | |
| Fundraising events Event | direct expenses; gross income - | $255,491 | reported apart | |||
| Total | $818,319,669 | 100% |
Federal lobbying
Lobbying Disclosure Act reports naming a client or registrant with this organization's name and state. Spent: what lobbying for it cost (firm income plus its own reported expenses). Earned: income it reported as a lobbying firm.
| Year | Spent | Earned | Reports |
|---|---|---|---|
| 2026 | $140,000 | 3 | |
| 2025 | $220,000 | 4 | |
| 2024 | $190,000 | 4 | |
| 2023 | $140,000 | 4 | |
| 2022 | $140,000 | 4 | |
| 2021 | $130,000 | 4 | |
| 2020 | $130,000 | 4 | |
| 2019 | $130,000 | 8 | |
| 2018 | $40,000 | 4 | |
| 2017 | $40,000 | 4 | |
| 2016 | $90,000 | 5 | |
| 2015 | $110,000 | 4 | |
| 2014 | $100,000 | 4 | |
| 2013 | $80,000 | 4 | |
| 2012 | $80,000 | 5 |
Issues: Defense, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Taxation/Internal Revenue Code, Veterans, Education, Financial Institutions/Investments/Securities
Firms hired: VAN SCOYOC ASSOCIATES, CAPSTONE NATIONAL PARTNERS
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2027 | $0 | $761,870 | 2 |
| 2026 | $140,700,836 | $7,310,570 | 378 |
| 2025 | $121,290,797 | $9,300,602 | 370 |
| 2024 | $126,074,706 | $9,951,805 | 425 |
| 2023 | $135,336,684 | $16,706,133 | 362 |
| 2022 | $120,555,139 | $10,524,127 | 382 |
| 2021 | $126,623,217 | $7,589,725 | 354 |
| 2020 | $118,749,639 | $7,015,859 | 335 |
| 2019 | $118,482,871 | $7,588,009 | 336 |
| 2018 | $106,699,221 | $9,174,332 | 313 |
| 2017 | $80,831,658 | $8,330,725 | 308 |
| 2016 | $99,260,847 | $10,022,488 | 228 |
| 2015 | $89,248,734 | $8,743,399 | 238 |
| 2014 | $89,692,193 | $10,075,447 | 238 |
| 2013 | $93,540,789 | $7,103,036 | 247 |
| 2012 | $106,182,296 | $8,835,874 | 245 |
| 2011 | $100,047,216 | $9,043,993 | 257 |
| 2010 | $112,131,345 | $9,908,225 | 324 |
| 2009 | $114,689,423 | $9,296,977 | 309 |
| 2008 | $52,184,452 | $12,691,812 | 148 |
| 2007 | $62,612,347 | $8,217,875 | 184 |
Largest awards · 200 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2027 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | IMPLEMENTING EO 14398 DEI DISCRIMINATION THERAPEUTIC MEDICAL PHYSICISTS | $755,646 |
| 2027 | Department of Veterans Affairs | Contract | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) 541715 | RESEARCH ACADEMIC AFFILIATE - CORE CONTRACT EO 14398 | $6,224 |
| 2026 | National Institutes of Health | Grant or other assistance | CONSTRUCTION SUPPORT 93.352 | BRF: RENOVATION OF THE BIOPHYSICS RESEARCH RESOURCES AT THE MEDICAL COLLEGE OF WISCONSIN - PROJECT SUMMARY RENOVATION OF THE BIOPHYSICS RESEARCH RESOURCES AT TH | $8,000,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | A DATA RESOURCE FOR ANALYZING BLOOD AND MARROW TRANSPLANTS | $7,515,416 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK DATA COORDINATING CENTER | $7,335,388 |
| 2026 | Health Resources and Services Administration | Contract | ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES 541990 | STEM CELL THERAPEUTIC OUTCOMES DATABASE (SCTOD) - ESTABLISH AND MAINTAIN A SCIENTIFIC DATABASE OF INFORMATION RELATING TO PATIENTS WHO HAVE BEEN RECIPIENTS OF A | $6,251,953 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CURE SICKLE CELL | $4,805,861 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | TRANSLATIONAL COORDINATION AND DISSEMINATION CENTER FOR THE SCGE CONSORTIUM - PROJECT SUMMARY THE GOAL OF THE NIH COMMON FUND’S SOMATIC CELL GENOME EDITING (SCG | $3,504,228 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | ADDRESSING KEY SOCIAL-STRUCTURAL RISK FACTORS FOR RACIAL DISPARITIES IN MATERNAL MORBIDITY IN SOUTHEASTERN WISCONSIN (ASCEND WI) - PROJECT SUMMARY/ABSTRACT: OVE | $2,975,021 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CELLULAR AND MOLECULAR MECHANISMS OF CARDIOMETABOLIC CONTROL BY ANGIOTENSIN IN THE BRAIN: ROLE OF AT1 RECEPTORS AND BIASED SIGNALING - OVERALL PROGRAM: SUMMARY | $2,753,400 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MOLECULAR MECHANISMS OF CALCIFICATION: ROLES AND OPPORTUNITIES IN DISEASES OF AGING - OVERALL SUMMARY MOLECULAR MECHANISMS OF CALCIFICATION: ROLES AND OPPORTUNI | $2,605,267 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | RAT GENOME DATABASE | $1,897,128 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | MULTI-COHORT VALIDATION OF MACHINE LEARNING RADIOGENOMIC MODELS (ML-RGX) TO PREDICT LATE TOXICITY IN PROSTATE CANCER - PROJECT SUMMARY RADIOTHERAPY IS A CORNER | $1,758,386 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | CONGRESSIONAL DIRECTIVES 93.493 | HRSA COMMUNITY PROJECT FUNDING / CONGRESSIONALLY DIRECTED SPENDING / PURCHASE OF PET/CT FOR MEDICAL COLLEGE OF WI - EARLY DETECTION IS ONE OF THE MOST EFFECTIVE | $1,600,000 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | ORBITRAP ASCEND TRIBRID MASS SPECTROMETER SYSTEM FOR ADVANCING PROTEOMICS RESEARCH IN SOUTHEASTERN WISCONSIN - THIS RESUBMISSION REQUESTS FUNDS UNDER THE NIH S1 | $1,533,926 |
| 2026 | Health Resources and Services Administration | Grant or other assistance | COORDINATED SERVICES AND ACCESS TO RESEARCH FOR WOMEN, INFANTS, CHILDREN, AND YOUTH 93.153 | RYAN WHITE TITLE IV WOMEN, INFANTS, CHILDREN, YOUTH AND AFFECTED FAMILY MEMBERS AIDS HEALTHCARE | $1,077,889 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | REDEFINING INDICATIONS OF EGFR INHIBITORS IN CANCERS THAT HARBOR MUTANT RAS - BACKGROUND: ANTI-EGFR AGENTS HAVE BEEN SHOWN TO BENEFIT COLORECTAL CANCER PATIENTS | $1,070,550 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | INTERSECTION OF THE PPARΓ-RHOBTB1-CULLIN-3 PATHWAY AND RENIN-ANGIOTENSIN SYSTEM IN BLOOD PRESSURE, VASCULAR FUNCTION AND ARTERIAL STIFFNESS - SUMMARY/ABSTRACT A | $1,070,160 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS OF NEUTROPHIL EXTRACELLULAR TRAP FORMATION AND CONTRIBUTION TO BILIARY FIBROSIS IN BILIARY ATRESIA - PROJECT SUMMARY/ABSTRACT BILIARY ATRESIA (BA) IS | $1,065,496 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MEDICAL SCIENTIST TRAINING PROGRAM - THE MEDICAL COLLEGE OF WISCONSIN (MCW), A FREE-STANDING, PRIVATE MEDICAL SCHOOL IN MILWAUKEE, WISCONSIN, HAS SUPPORTED MD-P | $1,003,841 |
| 2026 | Centers for Disease Control and Prevention | Grant or other assistance | INJURY PREVENTION AND CONTROL RESEARCH AND STATE AND COMMUNITY BASED PROGRAMS 93.136 | CE24-001, ICRC, MCW CIC CENTER GRANT: WORKING TOWARDS HEALTH EQUITY IN INJURY PREVENTION | $850,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE ROLE OF TPA IN REDUCING LP(A) ASSEMBLY - EPIDEMIOLOGICAL, GENOME-WIDE ASSOCIATION, AND MENDELIAN RANDOMIZATION STUDIES HAVE DEMONSTRATED THAT LIPOPROTEIN (A | $812,747 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CELL-FREE NUCLEIC ACID AS A PREDICTOR OF SEVERITY OF ILLNESS AND OUTCOME IN COMPLEX CONGENITAL HEART SURGERY - PROJECT SUMMARY/ABSTRACT DESPITE ADVANCES IN PERI | $792,011 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | HYBRID RAT DISCOVERY PROGRAM – A RENEWABLE GENETIC RESOURCE - PROJECT SUMMARY THE GOAL OF THIS R24 RESOURCE PROGRAM IS TO ENSURE THAT THE HYBRID RAT DISCOVERY P | $777,972 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | OPTIMIZATION OF CHRONIC NEUROMODULATION IN TREATING NEUROGENIC BLADDER DYSFUNCTION - PROJECT SUMMARY LOWER URINARY TRACT DYSFUNCTION IS A SIGNIFICANT IMPAIRMENT | $751,694 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS AND OPTIMIZATION OF TIBIAL NERVE STIMULATION IN TREATING NEUROGENIC BLADDER DYSFUNCTION - PROJECT SUMMARY LOWER URINARY TRACT DYSFUNCTION IS ONE OF | $747,444 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | SYMPTOM MONITORING USING PATIENT-REPORTED OUTCOMES TO OPTIMIZE MEDICATION USE (SYMPTOM) - PROJECT SUMMARY FOR THE MORE THAN 200,000 WOMEN WHO DEVELOP HORMONE RE | $740,099 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | GATA2-TGF BETA-TAL1 PATHWAY AS A CRITICAL MEDIATOR OF NK CELL DEVELOPMENT - ABSTRACT (SIGNIFICANCE) GATA2 IS AN OBLIGATORY TRANSCRIPTION FACTOR FOR HUMAN NK CEL | $738,193 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | VALIDATING CAUSALITY OF DISPUTED MITOCHONDRIAL VARIANTS IN INBORN ERRORS OF METABOLISM - PROJECT SUMMARY PRIMARY MITOCHONDRIAL DISEASE (PMD) ENCOMPASSES MULTI-S | $714,964 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | THE ROLES OF LYME SPIROCHETE ADHESINS IN HEMATOGENOUS DISSEMINATION - UPON TRANSMISSION BY A VECTOR TICK BITE, LYME DISEASE SPIROCHETES, PRIMARILY B. BURGDORFER | $711,443 |
| 2026 | National Institutes of Health | Grant or other assistance | ENVIRONMENTAL HEALTH 93.113 | GEGOO MYAAJYANG GKENDMANG (KNOWING WHAT WE EAT): REDUCING EXPOSURE TO DIETARY CONTAMINANT MIXTURES BY SUPPORTING GREAT LAKES SUBSISTENCE FOOD PROGRAMS - ABSTRAC | $706,420 |
| 2026 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | ABDOMINAL/BODY, INTERVENTIONAL, AND NUCLEAR MEDICINE RADIOLOGY SERVICES FOR THE CLEMENT J. ZABLOCKI VA MEDICAL CENTER | $703,349 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE ROLE OF LDL IN HEMOSTASIS - HEMOPHILIA A IS A HEREDITARY BLEEDING DISORDER RESULTING FROM THE ABSENCE OR DEFICIENCY OF COAGULATION FACTOR VIII (FVIII). MORE | $701,402 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CYTOMEGALOVIRUS MANIPULATION OF FUNCTIONAL CORTICAL TISSUE DEVELOPMENT - PROJECT SUMMARY HUMAN CYTOMEGALOVIRUS (HCMV) INFECTS MUCH OF THE WORLD’S POPULATION AND | $696,198 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THE ROLE OF O-GLCNACYLATION IN CORTICOTROPH PHYSIOLOGY AND DISEASE - PROJECT SUMMARY/ABSTRACT CUSHING’S DISEASE (CD), CAUSED BY ACTH-SECRETING PITUITARY ADENOMA | $694,092 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | DEVELOPMENT OF STEROL CARRIER PROTEIN 2 INHIBITORS AS ANXIOLYTICS - ACCORDING TO THE NIMH, APPROXIMATELY ONE IN FIVE AMERICANS SUFFERED FROM AN ANXIETY DISORDER | $693,299 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | CRE-DRIVER RAT RESOURCE PROJECT R24 - PROJECT SUMMARY THIS R24 RESOURCE GRANT WILL LEVERAGE OUR EXISTING INFRASTRUCTURE: PERSONNEL, EXPERTISE IN RAT TRANSGENESI | $691,556 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISM OF CHEMOTHERAPY INDUCED MICROVASCULAR DYSFUNCTION IN CANCER SURVIVORS - PROJECT ABSTRACT EVERY YEAR 255,000 NEW CASES OF BREAST CANCER ARE DIAGNOSED | $683,643 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | CHRONIC STRESS-INDUCED REDD1 EXPRESSION IN PREFRONTAL CORTEX AND COGNITIVE INFLEXIBILITY - PROJECT SUMMARY FLEXIBLE BEHAVIOR-- THE ABILITY TO ADAPT BEHAVIOR IN | $680,178 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | THE ROLE OF STRUCTURAL RACISM ON DISPARITIES IN CLINICAL OUTCOMES FOR DIABETES: A MIXED METHODS STUDY - APPROXIMATELY 37.1 MILLION ADULTS 18 YEARS OR OLDER (14. | $678,598 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MOLECULAR MECHANISMS OF POLYMODAL TRP CHANNELS IN REGULATION OF MICROVASCULAR ENDOTHELIAL FUNCTION - TRANSIENT RECEPTOR POTENTIAL (TRP) CHANNELS, WHICH CAN INTE | $676,961 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | AUGMENTING REGULATORY T CELL RECONSTITUTION DURING GVHD - GRAFT VERSUS HOST DISEASE (GVHD) IS THE MAJOR COMPLICATION ASSOCIATED WITH ALLOGENEIC HEMATOPOIETIC ST | $675,405 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | RADIOPAQUE BIOABSORBABLE METAL COMPOSITE WIRES FOR INTRAVASCULAR DEVICES - PROJECT SUMMARY THE LONG-TERM GOAL OF THIS RESEARCH PROGRAM IS TO PROVIDE THE ENDOVAS | $668,030 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | HUMAN CORONARY ARTERY PLAQUE TRANSCRIPTOMES AND CARDIOVASCULAR RISK ASSESSMENT - ATHEROSCLEROTIC CORONARY ARTERY DISEASE REMAINS A LEADING CAUSE OF MORBIDITY AN | $665,481 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | RADIOPATHOMIC MODELING OF GLIOMA HETEROGENEITY THROUGHOUT A PATIENT'S DISEASE TRAJECTORY - PROJECT ABSTRACT THE INFILTRATIVE NATURE OF GLIOMAS MAKES IT DIFFICUL | $663,952 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PCPE2 IN ADIPOSE TISSUE EXPANSION AND LIPOPROTEIN METABOLISM - INCREASED PREVALENCE OF OBESITY IN THE US POPULATION CONTINUES TO DRIVE GREATER RISK FOR DEVELOPI | $655,834 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | EXPERIMENTAL AND COMPUTATIONAL ANALYSIS OF MECHANISMS OF MITOCHONDRIAL-CELLULAR ROS CROSSTALK IN THE KIDNEY IN SALT-SENSITIVE HYPERTENSION - PROJECT SUMMARY SAL | $655,193 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | SELF-SAMPLING TO OPTIMIZE ANAL LESION OUTCOMES (SOLO) - HUMAN PAPILLOMAVIRUS CAUSES SQUAMOUS CELL CARCINOMA OF THE ANUS (SCCA) WHICH HAS A HETEROGENOUS INCIDENC | $651,765 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | MCW NCTN LEAD ACADEMIC PARTICIPATING SITE | $651,764 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | CONFORMATION AND FUNCTIONAL DYNAMICS OF CLASS B PBPS IN ENTEROCOCCAL ANTIMICROBIAL RESISTANCE - PROJECT SUMMARY THE CONTINUED AND INEVITABLE EMERGENCE OF ANTIBI | $649,014 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH AND TRAINING IN COMPLEMENTARY AND INTEGRATIVE HEALTH 93.213 | GROUP SINGING OR SOLO SINGING TO IMPROVE VASCULAR HEALTH IN OLDER ADULTS WITH CORONARY ARTERY DISEASE (GOT VOICE): A FEASIBILITY STUDY - CARDIOVASCULAR DISEASE | $648,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MEMBRANE PROTEIN EFFECTORS OF PATHOGEN INTERACTIONS WITH HOST | $647,400 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | KERATINOCYTE SIGNALING MEDIATES NEUROPATHIC PAIN - PROJECT SUMMARY: PAINFUL PERIPHERAL NEUROPATHY OCCURS IN UP TO 80% OF PATIENTS RECEIVING CHEMOTHERAPY AND IS | $647,147 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | TARGETING THE MUSCLE METABOREFLEX TO OPTIMIZE EXERCISE CAPACITY IN STROKE SURVIVORS - STROKE SURVIVORS ARE UNABLE TO ADEQUATELY INCREASE AND SUSTAIN CARDIOVASCU | $646,406 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MICROBIAL AND NEUROVASCULAR PREDICTORS FOR SUBTYPES OF PRODROMAL ALZHEIMER'S DISEASE - PROJECT SUMMARY ALZHEIMER'S DISEASE (AD) REMAINS THE MOST PREVALENT FORM | $645,037 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | EVERY DAY COUNTS: A LIFESTYLE PROGRAM FOR WOMEN METASTATIC BREAST CANCER - THE COMMUNITY OF WOMEN WITH METASTATIC BREAST CANCER (MBC) IS GROWING DUE TO GREATER | $644,067 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | MOVING FORWARD WITH MULTIPLE MYELOMA - PROJECT SUMMARY MULTIPLE MYELOMA (MM) IS THE SECOND MOST COMMON HEMATOLOGICAL MALIGNANCY IN THE U.S., TYPICALLY DIAGNOSED | $643,831 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | MECHANICALLY SENSITIVE REGULATORS OF HUMAN AMNION AND PRIMORDIAL GERM CELL FORMATION FROM A COMMON PROGENITOR - PROJECT SUMMARY INFERTILITY IS A COMPLEX DISEASE | $639,854 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | BASOLATERAL BRAIN ENDOTHELIAL CILIA AND ITS ROLE IN PROMOTING VASCULAR STABILITY - PROJECT SUMMARY ENDOTHELIAL CILIA ARE NORMALLY CONSIDERED TO BE PRESENT ON TH | $635,206 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ROLE OF LIVER KINASE B1 IN THE DECREASED ANGIOGENESIS IN BRONCHOPULMONARY DYSPLASIA - PROJECT SUMMARY BRONCHOPULMONARY DYSPLASIA (BPD) IS THE MOST COMMON COMPLI | $632,540 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | GALLIUM MALTOLATE FOR THE TREATMENT OF DIFFICULT-TO-TREAT HIGH-GRADE PEDIATRIC BRAIN TUMORS - PROJECT ABSTRACT/SUMMARY NEOPLASMS OF THE CENTRAL NERVOUS SYSTEM ( | $632,314 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | ROLE AND REGULATION OF INTRACELLULAR SIGNALING IN ENTEROCOCCAL ANTIMICROBIAL RESISTANCE - PROJECT SUMMARY THE CONTINUED AND INEVITABLE EMERGENCE OF ANTIBIOTIC R | $630,730 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | REPURPOSING FOSAMPRENAVIR TO ADDRESS PPI-REFRACTORY GERD IN OLDER ADULTS - ABSTRACT GASTROESOPHAGEAL REFLUX DISEASE (GERD) DISPROPORTIONATELY AFFECTS OLDER ADUL | $628,335 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | NOCICEPTIVE MECHANISMS UNDERLYING SICKLE CELL PAIN | $626,038 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | ALDO-KETO REDUCTASE’S MECHANISM IN BRAIN INJURY FROM HYPOXIA-ISCHEMIA AND TETRAHYDROBIOPTERIN DEFICIENCY - PROJECT SUMMARY/ABSTRACT CONGENITAL TETRAHYDROBIOPTER | $625,792 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | INTERACTION BETWEEN LEPTIN AND ANGIOTENSIN IN THE PATHOGENESIS OF OBESITY-HYPERTENSION | $625,666 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | STRUCTURE-BASED INHIBITION OF CHEMOKINE SIGNALING IN THE INFLAMED PANCREAS - MODIFIED PROJECT SUMMARY/ABSTRACT SECTION THE GOAL OF THIS PROJECT IS TO ESTABLISH | $624,128 |
| 2026 | National Institutes of Health | Grant or other assistance | NURSING RESEARCH 93.361 | TESTING THE EFFICACY OF TWO INTERVENTIONS TO IMPROVE HEALTH OUTCOMES AND QUALITY OF LIFE AMONG RURAL OLDER ADULTS LIVING WITH HIV - MORE THAN 55,000 PEOPLE LIVI | $623,338 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | BLOOD FLOW REGULATION AND NEUROMUSCULAR FUNCTION POST-STROKE - INCREASED NEUROMUSCULAR FATIGABILITY (THE ACUTE, EXERCISE INDUCED REDUCTION IN FORCE) IS AN UNDER | $623,134 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MECHANISM OF ENDOTHELIAL SENESCENCE IN TISSUE REGENERATION AND REPAIR - PROJECT SUMMARY ANGIOGENESIS, THE FORMATION OF NEW BLOOD CAPILLARIES PLAYS A KEY ROLE IN | $618,354 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | DUAL FUNCTIONALITY OF CERAMIDE IN HUMAN MICROVASCULAR ENDOTHELIAL FUNCTION - PROJECT SUMMARY ELEVATED LEVELS OF PLASMA CERAMIDE ARE AN INDEPENDENT RISK FACTOR F | $613,509 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ROLE OF TIP60 ACETYLTRANSFERASE IN CARDIAC REGENERATION AND REPAIR - ISCHEMIC HEART DISEASE REMAINS THE LEADING CAUSE OF DEATH WORLDWIDE, PRIMARILY DUE TO IRREV | $610,494 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | PASTA KINASE SIGNALING AND ENTEROCOCCAL CELL WALL STRESS - PROJECT SUMMARY PASTA KINASES ARE A FAMILY OF BACTERIAL TRANSMEMBRANE (TM) SER/THR KINASES WIDELY CON | $609,348 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | REDUCING THE RISK OF CHRONIC HYPERTENSION AND IMPROVING VASCULAR FUNCTION FOLLOWING PREECLAMPSIA - PROJECT ABSTRACT/SUMMARY HYPERTENSIVE DISORDER OF PREGNANCY ( | $605,492 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | POST-TRANSCRIPTIONAL REGULATION OF VASCULAR HOMEOSTASIS BY RNA-BINDING PROTEINS - PROJECT SUMMARY VASCULAR HOMEOSTASIS IS ESSENTIAL FOR HUMAN HEALTH AS ENDOTHEL | $602,810 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | LONGITUDINAL RADIO-PATHOMIC MAPPING OF NON-ENHANCING TUMOR GROWTH IN GLIOBLASTOMA - PROJECT SUMMARY GLIOBLASTOMA (GBM) REMAINS THE MOST AGGRESSIVE PRIMARY BRAIN | $602,121 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | CHRONIC SLEEP DEFICIENCY AS A CAUSE OF BONE LOSS IN AGING - MORE THAN 35% OF ADULTS IN THE U.S. UNDERGO CHRONIC SLEEP RESTRICTION (SR) WHICH IS ASSOCIATED WITH | $601,313 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ROLE OF INTERLEUKIN 23 IN GASTROINTESTINAL GVHD | $595,963 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | CELLULAR MECHANISMS OF MYO7A IN THE RETINA - PROJECT SUMMARY / ABSTRACT PROPOSED EXPERIMENTS IN THIS MULTIPLE-PI APPLICATION ADDRESS THE RETINAL FUNCTIONS OF MY | $590,839 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | DEFINING THE ROLE OF GATA6 IN SMA PATHOLOGY - PROJECT SUMMARY OUR RESEARCH GOAL IS TO IDENTIFY NOVEL THERAPEUTIC TARGETS TO SUPPLEMENT AND ENHANCE THE EFFICACY | $588,303 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANOSENSITIVE MECHANISM OF ANGIOGENESIS IN THE LUNG - PROJECT SUMMARY ANGIOGENESIS PLAYS IMPORTANT ROLES IN ORGAN REGENERATION. COMPENSATORY LUNG GROWTH IS I | $584,625 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | MECHANISMS UNDERLYING THE INFLUENCE OF STRESS ON DRUG-SEEKING BEHAVIOR - PROJECT SUMMARY/ABSTRACT THE EFFECTIVE MANAGEMENT OF SUBSTANCE USE DISORDERS (SUDS) REQ | $581,740 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IMPACT OF B CELL SUBPOPULATIONS ON OVARIAN CANCER PROGRESSION - PROJECT SUMMARY IMMUNOTHERAPIES FOR HIGH-GRADE SEROUS OVARIAN CANCER (HGSOC), WHICH ACCOUNTS FOR | $580,985 |
| 2026 | National Institutes of Health | Grant or other assistance | HUMAN GENOME RESEARCH 93.172 | THE ETHICS OF ENGAGEMENT IN PATIENT-FOCUSED DRUG DEVELOPMENT FOR RARE DISEASES - PROJECT SUMMARY: PATIENT AND FAMILY GROUPS (PFGS) HAVE LONG SUPPORTED RARE DISE | $575,916 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | COAGULATION-INFLAMMATION CROSSTALK IN PLACENTAL ABRUPTION - PROJECT SUMMARY/ABSTRACT: PLACENTAL ABRUPTION IS A LIFE-THREATENING PREGNANCY COMPLICATION WHERE THE | $575,724 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PATHOGENIC ROLE OF IL-39/IL-39R SIGNALING IN GRAFT-VERSUS-HOST DISEASE - ABSTRACT GRAFT-VERSUS-HOST DISEASE (GVHD) REMAINS A SIGNIFICANT SOURCE OF TRANSPLANT-RE | $574,479 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | MOLECULAR MARKERS FOR TUMORS ASSOCIATED WITH EXTRACHROMOSOMAL HPV - 3URMHFW 6XPPDU IN THE CLASSICAL PARADIGM FOR CERVICAL CANCER, KERATINOCYTES ARE INFECTED W | $574,118 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | STAND UP FOR YOUR HEALTH: A RANDOMIZED STUDY - ABSTRACT: SEDENTARY BEHAVIOR IS BECOMING INCREASINGLY PREVALENT WITH THE EXPANSION OF A ‘WORK FROM HOME’ CULTURE, | $569,147 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | ASSESSING PHOTORECEPTOR STRUCTURE AND FUNCTION IN NORMAL AND DISEASED RETINA | $567,195 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ELUCIDATING MOLECULAR MECHANISMS OF GPCR SIGNALING WITH NOVEL EPR TECHNOLOGIES - PROJECT SUMMARY/ABSTRACT THIS PROJECT FOLLOWS TWO COMPLEMENTARY AVENUES OF INVE | $566,169 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PATIENT-REPORTED OUTCOMES TO UNDERSTAND INFANT TO EARLY CHILDHOOD TRANSITION OF INFANTS WITH BRONCHOPULMONARY DYSPLASIA - PROJECT SUMMARY/ABSTRACT THE GOAL OF T | $565,595 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | PRIOR EXPERIENCE SHAPES SELECTIVITY WITHIN HUMAN VENTRAL TEMPORAL CORTEX - PROJECT SUMMARY RAPID VISUAL RECOGNITION IS CRUCIAL FOR GUIDING HUMAN BEHAVIOR IN DYN | $564,849 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PLATELET-DERIVED FVIII GENE THERAPY OF HEMOPHILIA A | $561,352 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | A SELF-ORGANIZING EMBRYOID MODEL OF PERI-IMPLANTATION HUMAN DEVELOPMENT | $559,891 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | LEVERAGING MOBILE TOOLS TO INVESTIGATE EMOTION DYNAMICS AND BEHAVIOR IN AUTISTIC YOUTH WITH DEPRESSION - ABSTRACT: AUTISM SPECTRUM DISORDER IS A COMMON NEURODEV | $555,440 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | EVOLUTION AND DESIGN OF METAMORPHIC FOLD-SWITCHING PROTEINS - PROJECT SUMMARY/ABSTRACT THE GOALS OF THIS PROJECT ARE TO UNDERSTAND HOW AND WHY A METAMORPHIC PRO | $554,302 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | GASTROSCHISIS OUTCOMES OF DELIVERY (GOOD) STUDY - GASTROSCHISIS IS THE MOST COMMON CONGENITAL ABDOMINAL WALL DEFECT IN WHICH THE INTESTINES HERNIATE OUTSIDE THE | $546,057 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | SPINAL CORD STRUCTURE-FUNCTION RELATIONSHIPS IN DEGENERATIVE CERVICAL MYELOPATHY - ABSTRACT: DEGENERATIVE CERVICAL MYELOPATHY (DCM) IS THE COMMONEST CAUSE OF SP | $544,282 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CARBONIC ANHYDRASE AS A CARDIOPROTECTIVE TARGET IN ANTHRACYCLINE-INDUCED CARDIOTOXICITY - PROJECT SUMMARY HEART DISEASE IS A LEADING CAUSE OF MORTALITY AMONG CA | $541,272 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING PIM-2 KINASE FOR IMPROVING CANCER IMMUNOTHERAPY - ABSTRACT THE ADAPTIVE IMMUNE SYSTEM HAS THE CAPACITY TO RECOGNIZE AND KILL MALIGNANT CELLS. HOWEVER, | $538,587 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | MITIGATION OF MULTI-ORGAN DELAYED EFFECTS OF ACUTE RADIATION EXPOSURE (DEARE) WITH ACE2 AGONIST DIMINAZENE ACETURATE. - SUMMARY WITH THE ADVENT OF HEMATOPOIETIC | $536,993 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MECHANISMS OF MORBIDITY AFTER CORRECTING AORTIC COARCTATIONS OF VARYING SEVERITY | $536,108 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | SEX-DIFFERENCES IN ACE2 REGULATE NORMAL TISSUE TOXICITY DURING GASTROINTESTINAL ACUTE RADIATION SYNDROME - SUMMARY OUR LABORATORY HAS RECENTLY REPORTED SEX-DIFF | $525,658 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | NKA/CD36 SIGNALING IN ADIPOCYTES PROMOTES OXIDATIVE STRESS AND DRIVES CHRONIC INFLAMMATION IN ATHEROSCLEROSIS - ATHEROSCLEROSIS (AS) IS A CHRONIC INFLAMMATORY D | $523,513 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | THE ROLE OF MIDBRAIN MTOR SIGNALING IN HYPERACTIVITY AND IMPULSIVITY - PROJECT SUMMARY THE MECHANISTIC TARGET OF RAPAMYCIN (MTOR) IS A SERINE/THREONINE-PROTEIN | $521,266 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MODULATORS OF CARDIOMYOCYTE STRUCTURE TO PROMOTE FUNCTIONAL RECOVERY DURING CARDIAC REGENERATION AND REPAIR - PROJECT SUMMARY THE GOVERNING PREMISE OF THIS APPL | $519,906 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | GAMMAHERPESVIRUS PROTEIN KINASE: A MASTER MANIPULATOR OF THE HOST DURING CHRONIC INFECTION. - GAMMAHERPESVIRUSES ESTABLISH LIFE-LONG INFECTIONS IN >95% OF ADULT | $519,342 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | UROTHELIAL CELLS AND SENSORY SIGNALING - PROJECT SUMMARY UROTHELIAL CELLS PLAY AN ACTIVE ROLE IN BLADDER PHYSIOLOGY BY RESPONDING TO PHYSICAL/CHEMICAL STIMULI A | $518,532 |
| 2026 | National Institutes of Health | Grant or other assistance | NURSING RESEARCH 93.361 | PERCEIVED IMMIGRATION LAWS AND INFECTIOUS DISEASE CONTROL MEASURES - OVER 44 MILLION IMMIGRANTS LIVE IN THE US, AND NEARLY HALF (44%) ARE LATINX. HISTORICALLY, | $517,203 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | STRUCTURE-BASED DESIGN OF SELECTIVE SEROTONIN BIASED AGONISTS AS CHEMICAL PROBES FOR PSYCHEDELIC POTENTIAL - PROJECT SUMMARY: PSYCHEDELICS HAVE SHOWN EXTRAORDIN | $516,972 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | THE ROLE OF HEPATOCYTE TPA IN HEPATIC VLDL PRODUCTION. - ATHEROSCLEROSIS IS INITIATED AND PROMOTED BY THE ARTERIAL ACCUMULATION OF APOLIPOPROTEIN B (APOB)-CONTA | $509,499 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | REGULATION OF CHEMOKINE RECEPTOR SIGNALING - PROJECT SUMMARY G PROTEIN-COUPLED RECEPTOR (GPCR) SIGNALING PLAYS AN ESSENTIAL ROLE IN MANY PHYSIOLOGICAL PROCESSES | $507,000 |
| 2026 | Centers for Disease Control and Prevention | Grant or other assistance | CENTERS FOR DISEASE CONTROL AND PREVENTION INVESTIGATIONS AND TECHNICAL ASSISTANCE 93.283 | SICKLE CELL DATA COLLECTION PROGRAM IN WISCONSIN (SCDC-WI) | $500,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | GESTATIONAL DIABETES AND PHARMACOTHERAPY (GAP) ? A RANDOMIZED CONTROLLED TRIAL INVESTIGATING TIMING OF PHARMACOTHERAPY INITIATION FOR PATIENTS WITH GESTATIONAL | $496,232 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | UNRAVELING THE IMPACT OF EXTRACELLULAR VESICLE-LOADED FXR1 MRNA ON RE-EDUCATING CANCER MICROENVIRONMENT - ABSTRACT THIS STUDY FOCUSES ON OVARIAN CANCER, A SIGNI | $494,160 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | IDENTIFICATION OF TARGETS OF THE ANTIPARASITIC DRUG PRAZIQUANTEL | $493,670 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ELICITING CARDIOMYOCYTE PROLIFERATION BY UN-BLOCKING MITOTIC TRANSIT - PROJECT SUMMARY ADULT ISCHEMIC HEART INJURY CAUSES SIGNIFICANT LOSS OF CARDIOMYOCYTES (C | $492,809 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | APPLICATIONS OF LESION-DEFICIT MAPPING TO UNRESOLVED PROBLEMS IN APHASIA - PROJECT SUMMARY A DETAILED MODEL OF HOW FOCAL DAMAGE TO THE BRAIN AFFECTS LONG-TERM L | $488,906 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | INVESTIGATIONS INTO 5-HT2A SIGNALING MECHANISMS OF PSYCHEDELIC DRUGS FOR THE TREATMENT OF STIMULANT USE DISORDER - PROJECT SUMMARY STIMULANT USE DISORDERS AND O | $480,492 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MECHANISMS OF IMPROVING FECAL CONTINENCE MUSCLES MOTOR FUNCTION IN HEALTH AND DISEASE - ABSTRACT THE OVERALL AIM OF THIS PROPOSAL IS AN IN-DEPTH INVESTIGATION O | $475,963 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | BICUSPID AORTIC VALVE BIOMECHANICS AND CALCIFICATION - PROJECT ABSTRACT CALCIFIC AORTIC STENOSIS (CAS) IS THE MOST PREVALENT HEART VALVE DISORDER AFFECTING UP T | $474,515 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | IDENTIFICATION AND INTERROGATION OF GLIAL GENE SIGNATURES IN VOLITIONAL OPIOID SEEKING - PROJECT SUMMARY DRUG ADDICTION REMAINS A PERVASIVE PUBLIC HEALTH CRISIS | $468,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | PULMONARY VAGAL SENSORY NEURONS IN CHRONIC LUNG DISEASE - PROJECT SUMMARY PRETERM INFANTS ARE BORN WITH IMMATURE LUNGS AND IMMATURE NEURAL CONTROL OF BREATHING. | $467,332 |
| 2026 | National Institutes of Health | Grant or other assistance | TRANS-NIH RESEARCH SUPPORT 93.310 | A UNIQUE DEVICE TO MEASURE RADIATION DOSE AND HOMOGENEITY OF EXPOSURE FOLLOWING A LARGE-SCALE IONIZING RADIATION EVENT - ABSTRACT: OUR PROJECT WILL DELIVER A FI | $466,764 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THERAPEUTICALLY LEVERAGING METABOLIC VULNERABILITIES IN BREAST CANCER - PROJECT SUMMARY: ANTI-CANCER DRUG TREATMENTS OFTEN DO NOT COMPLETELY ERADICATE ALL CANCE | $466,407 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | MOLECULAR PATHWAYS OF CALCIUM PYROPHOSPHATE DEPOSITION DISEASE - CALCIUM PYROPHOSPHATE DEPOSITION DISEASE (CPDD) IS A COMMON TYPE OF ARTHRITIS DEFINED BY THE PR | $460,379 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | OTITIS MEDIA DIAGNOSIS AND TREATMENT - PROJECT SUMMARY/ABSTRACT OTITIS MEDIA (OM) IS THE MOST COMMON DIAGNOSIS IN PEDIATRIC PATIENTS SEEN FOR ILLNESS IN THE UNI | $445,624 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | P66SHC IN CEREBROVASCULAR IMPAIRMENT IN ALZHEIMER’S DISEASE - AGE-RELATED COGNITIVE IMPAIRMENT IS OFTEN ASSOCIATED WITH VASCULAR CHANGES WHICH ACCOMPANY OR PREC | $441,460 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | STRUCTURAL BASIS FOR CHEMOKINE FUNCTION | $436,247 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | MOLECULAR MECHANISMS OF AXENFELD-RIEGER SYNDROME | $436,099 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | REGULATION OF CELL STATE PLASTICITY IN BREAST TUMORIGENESIS - CANCER IS FUELED BY ACQUIRED CELL PLASTICITY, YET THE MOLECULAR PROCESSES CONTROLLING PLASTICITY T | $434,995 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | IDENTIFYING GUT MICROBIOME MEDIATED MECHANISMS FOR DIASTOLIC DYSFUNCTION IMPROVEMENT AFTER BARIATRIC SURGERY - PROJECT SUMMARY SLEEVE GASTRECTOMY (SG), IS A TYP | $431,830 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | THE ROLE OF MORTALIN IN THYROID CANCER - THE GOAL OF THIS PROJECT IS TO ELUCIDATE THE MECHANISM BY WHICH MORTALIN IS UPREGULATED IN THYROID CANCER, DETERMINE TH | $431,406 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | HEALTH OUTCOMES FOLLOWING ENROLLMENT IN MEDICARE AMONG OLDER PEOPLE WITH HIV - EFFECTIVE ANTIRETROVIRAL THERAPY (ART ) HAS TRANSFORMED HIV INTO A MANAGEABLE CHR | $429,001 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | DEFINING THE ROLE OF HSA21 GENE OVEREXPRESSION IN AGING-ASSOCIATED AND AΒ-INDUCED NEURODEGENERATION IN C. ELEGANS - PROJECT SUMMARY DOWN SYNDROME (DS), CAUSED B | $429,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | SUCRALOSE AT THE MATERNAL/FETAL INTERFACE - PROJECT SUMMARY/ABSTRACT NON-NUTRITIVE SWEETENERS (NNS) HAVE BEEN COMMONLY USED AS FOOD ADDITIVES IN THE UNITED STAT | $429,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | FUNCTIONAL DYNAMICS OF ESSENTIAL BACTERIAL PROTEINS AND EPR TECHNOLOGY DEVELOPMENT - PROJECT SUMMARY/ABSTRACT PROTEINS ARE VITAL TO ALL BIOLOGICAL PROCESSES, DR | $429,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | CLARIFYING ENGINEERED BIOABSORBABLE METALS TISSUE-BIOMATERIAL INTERFACE AND REGENERATION - THE LONG-TERM GOAL OF RESEARCH IN MY LABORATORY IS TO DEVELOP A TECHN | $429,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | THE CRITICAL JOURNEY: THE ROLE OF CLADE AND AN ADHESIN IN LEPTOSPIRA KIDNEY COLONIZATION - PROJECT SUMMARY LEPTOSPIROSIS IS THE MOST WIDESPREAD ZOONOTIC DISEASE | $429,000 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | MECHANISTIC ASSESSMENT OF RETINAL GANGLION CELL GENESIS - PROJECT SUMMARY/ABSTRACT RETINAL GANGLION CELLS (RGCS) CONNECT THE EYES TO THE BRAIN. THEY ARE ESSENTI | $428,349 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ENLISTING HPV INTEGRATION EVENTS TO ILLUMINATE DRIVERS AND TARGET TREATMENT IN INVASIVE CERVICAL CANCER - PROJECT SUMMARY INVASIVE CERVICAL CANCER (ICC) KILLS N | $426,162 |
| 2026 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | THERAPEUTIC MEDICAL PHYSICISTS SERVICES (MILWAUKEE VAMC) | $423,008 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MOLECULAR MECHANISMS OF G PROTEIN-COUPLED RECEPTOR BIASED SIGNALING | $421,200 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | AUTONOMIC REACTIVITY TO RESTORE A DYSREGULATED BRAIN-GUT AXIS VIA TARGETED THERAPY - PROJECT SUMMARY/ABSTRACT DISORDERS OF GUT-BRAIN INTERACTION (DGBI) AFFECT U | $420,508 |
| 2026 | National Institutes of Health | Grant or other assistance | DRUG USE AND ADDICTION RESEARCH PROGRAMS 93.279 | A NOVEL THERAPEUTIC STRATEGY FOR BRONCHOPULMONARY DYSPLASIA - PROJECT SUMMARY BRONCHOPULMONARY DYSPLASIA (BPD) IS THE MOST COMMON COMPLICATION OF PREMATURE BIRT | $418,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | PLASMA PERSULFIDES EXPLAIN CULTURE-NEGATIVE NEONATAL SEPSIS - PROJECT SUMMARY SEPSIS IN NEWBORNS, PARTICULARLY PREMATURE NEWBORNS, CAN LEAD TO INJURY TO THE BRA | $418,000 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PROTEIN INTERACTIONS THAT CONTROL CALCIUM OXALATE STONE FORMATION - KIDNEY STONES REMAIN AN ENIGMATIC DISEASE DESPITE DECADES OF WORK BY MANY INVESTIGATORS WITH | $417,040 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | INTEGRATED PHYSIOLOGY TRAINING: MOLECULE TO ORGANISM | $416,841 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | INDUCING NEUROPLASTICITY WITH A WIRELESS CRANIAL IMPLANT TO IMPROVE GLIOMA SURGERY OUTCOMES - PROJECT SUMMARY/ABSTRACT FOR INDIVIDUALS WITH PRIMARY BRAIN TUMORS | $413,808 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | NEURAL REPRESENTATION OF LEXICAL CONCEPTS - PROJECT SUMMARY/ABSTRACT APPROXIMATELY TWO MILLION PEOPLE IN THE U.S. SUFFER FROM ACQUIRED LANGUAGE DISORDERS, KNOW | $411,951 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | REGULATING FOXA-MEDIATED TRANSCRIPTION DURING LIVER DEVELOPMENT - PROJECT SUMMARY THE GOAL OF THIS PROPOSAL IS TO DETERMINE MECHANISMS OF FOXA1 AND 2 REGULATION | $406,985 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | STRUCTURAL DYNAMICS OF GPCR OLIGOMERIZATION: IMPACT ON LOCALIZATION AND SIGNALING - ABSTRACT G PROTEIN-COUPLED RECEPTORS (GPCRS) ARE CRUCIAL IN CELLULAR SIGNALI | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ARPC3-MEDIATED ACTIN REMODELING IN INSULIN GRANULE EXOCYTOSIS AND DIABETES - PROJECT SUMMARY INSULIN SECRETION DEFICIENCY IS A HALLMARK OF DIABETES. IN THIS PRO | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | METABOLIC REGULATION OF IMMUNITY IN C. ELEGANS - PROJECT SUMMARY DYSREGULATION OF FUNDAMENTAL SIGNALING PATHWAYS DUE TO PERTURBATIONS OF CELLULAR METABOLITES CA | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ORAL DISEASES AND DISORDERS RESEARCH 93.121 | LEVERAGING SINGLE-CELL CO-CULTURE AND GENE EXPRESSION PROFILING TO IDENTIFY TUMOR ANTIGEN-SPECIFIC T CELLS IN ORAL CANCER - PROJECT ABSTRACT ORAL SQUAMOUS CELL | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ONTOGENY AND KINETICS OF INNATE IMMUNE CELLS IN HEALTH AND DISEASE - PROJECT SUMMARY TISSUE-RESIDENT MACROPHAGES ARE FOUND WITHIN EVERY TISSUE IN AN ORGANISM AN | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | UNDERSTANDING THE DEGENERATION OF AXON AND NERVE TERMINALS IN ALZHEIMER'S DISEASE AND RELATED DEMENTIA BRAIN - PROJECT SUMMARY A REMARKABLE BRAIN ATTRIBUTE IS A | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | BIOCHEMICAL MECHANISMS OF BETA CELL PROTECTION THROUGH BROMODOMAIN INHIBITION | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | ADVANCING GENOMIC INTERPRETATION FOR CHROMATIN REMODELING ENZYMES - PROJECT SUMMARY/ABSTRACT THE FUNCTIONAL INTERPRETATION OF HUMAN GENETIC VARIATION NEEDS TO C | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRANSCRIPTOMICS OF ADHERENT ENDOTHELIAL CELLS FOR IMPROVED ENDOTHELIALIZATION OF SMALL-DIAMETER VASCULAR GRAFTS - PROJECT SUMMARY THE LONG-TERM OBJECTIVE OF TH | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | INS AND OUTS OF ABSCISSION CHECKPOINT SIGNALING: MOLECULAR MECHANISMS SAFEGUARDING ABSCISSION - PROJECT SUMMARY: CYTOKINETIC ABSCISSION IS THE PHYSICAL SEPARATI | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | RETINOID SIGNALING AND HOMEOSTASIS IN THE EYE - SUMMARY THIS PROPOSAL DESCRIBES EXPERIMENTS TO INVESTIGATE THE ROLE PLAYED BY STRA6 IN MODULATING TRANSCRIPTION | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | DISCOVERING AND EXPLOITING SELECTIVITY WITHIN TANDEM BROMODOMAINS | $390,000 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | MITOCHONDRIA AND ANESTHETIC-INDUCED DEVELOPMENTAL NEUROTOXICITY - PROJECT SUMMARY MILLIONS OF CHILDREN RECEIVE GENERAL ANESTHETICS (GAS) FOR SURGICAL PROCEDURES | $385,920 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | A PRECISION MEDICINE BASIS FOR ESTROGEN THERAPY FOR ADVANCED BREAST CANCER | $379,383 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | THE ROLE OF CYTOMEGALOVIRUS IN THE PHYSIOLOGICAL AND CLINICAL EFFECTS OF CONCUSSION - PROJECT SUMMARY/ABSTRACT SPORT-RELATED CONCUSSION (SRC) IS A MAJOR PUBLIC | $371,213 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ROLE OF EXOSOMAL SPHK1 IN OVARIAN CANCER PROGRESSION - PROJECT SUMMARY IMMUNOTHERAPIES, INCLUDING THOSE THAT INVOLVE IMMUNE CHECKPOINT INHIBITORS AGAINST PROGRA | $364,532 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | GENETIC MAPPING OF BREAST CANCER RISK IN THE TUMOR MICROENVIRONMENT | $356,850 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | UNCOVERING THE BASIS AND IMPLICATIONS OF LINEAGE PLASTICITY IN BREAST CANCER - TUMORIGENESIS INVOLVES THE ACCUMULATION OF GENETIC ABERRATIONS, LEADING TO THE EM | $356,850 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | TARGETING THE CANCER STEM CELLS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMOR - PROJECT SUMMARY MALIGNANT PERIPHERAL NERVE SHEATH TUMOR (MPNST) IS A TYPE OF SOFT T | $356,850 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | VIRAL-MEDIATED OPTOGENETIC TECHNIQUES FOR PERIPHERAL NERVE STIMULATION OF MOTOR FUNCTION - PROJECT SUMMARY/ABSTRACT THIS PROJECT SEEKS TO IMPROVE THE UTILITY OF | $351,840 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | REGULATION OF SUCCESSFUL OPTIC NERVE REGENERATION BY THE MEVALONATE/CHOLESTEROL PATHWAY - PROJECT SUMMARY LOSS OF VISION DUE TO OPTIC NEUROPATHIES, LIKE GLAUCOM | $351,000 |
| 2026 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | BONE-DERIVED NANOPARTICLES FOR TARGETED RHBMP2 DELIVERY TO RESTORE FUNCTION AND PROMOTE OSTEOGENIC DIFFERENTIATION IN RADIATION-DAMAGED BONE MARROW STEM CELLS - | $349,413 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | BIOBEHAVIORAL ONCOLOGY TRAINING PROGRAM - ABSTRACT THIS NEW T32 RESUBMISSION APPLICATION SUPPORTS A POSTDOCTORAL RESEARCH TRAINING PROGRAM IN BIOBEHAVIORAL ONCO | $337,790 |
| 2026 | Department of Veterans Affairs | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | PERFUSION SERVICES MILWAUKEE VAMC | $335,998 |
| 2026 | National Institutes of Health | Grant or other assistance | CHILD HEALTH AND HUMAN DEVELOPMENT EXTRAMURAL RESEARCH 93.865 | PLACENTAL HORMONES AND O-GLCNACYLATION IN GESTATIONAL DIABETES - PROJECT SUMMARY/ ABSTRACT EVERY YEAR, ABOUT 18 MILLION BABIES ARE BORN FROM MOTHERS WITH GESTAT | $328,354 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | EMERGENT TECHNOLOGY FOR STUDYING THE STRUCTURE/FUNCTION RELATIONSHIP OF ENZYMES USING ELECTRON PARAMAGNETIC RESONANCE - PROJECT SUMMARY/ABSTRACT: ELECTRON PARAM | $327,600 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | STUDENT-CENTERED PATHWAY TO ADVANCE RESEARCH AND CANCER CAREERS - THERE IS A PRESSING NEED TO INCREASE THE NUMBER OF SKILLED PROFESSIONALS IN CANCER RESEARCH TO | $324,000 |
| 2026 | National Highway Traffic Safety Administration | Contract | OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES 541690 | MEDICAL COLLEGE OF WISCONSIN CIREN OPEN ENROLLMENT | $322,082 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | PUERTO RICAN OBESITY INTERVENTION FOR MEN - ABSTRACT OVERWEIGHT AND OBESITY ARE AMONG THE MOST PREVALENT AND PRESSING HEALTH ISSUES AFFECTING LATINO MEN, WITH R | $306,749 |
| 2026 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE OF ANGIOTENSIN II IN BLADDER DYSFUNCTION - INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME (IC/BPS) IS ASSOCIATED WITH INCREASED VOIDING FREQUENCY, NOCTURIA, B | $280,438 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | EARLY DIAGNOSIS OF LIGHT CHAIN AMYLOIDOSIS - PROJECT SUMMARY LIGHT CHAIN (AL) AMYLOIDOSIS IS A RECALCITRANT AND DEADLY HEMATOLOGIC DISEASE CHARACTERIZED BY ORGA | $273,000 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH RELATED TO DEAFNESS AND COMMUNICATION DISORDERS 93.173 | ADVANCING SURGEON-SCIENTISTS THROUGH CAREER EDUCATION AND NETWORKED TRAINING IN OTOLARYNGOLOGY (ASCENT-OTO) - PROJECT SUMMARY SURGEON-SCIENTISTS ARE UNIQUELY PO | $269,453 |
| 2026 | National Institutes of Health | Grant or other assistance | ALLERGY AND INFECTIOUS DISEASES RESEARCH 93.855 | UTILIZING PLATELET-TARGETED GENE THERAPY TO INDUCE IMMUNE TOLERANCE IN FOOD ALLERGY - PROJECT SUMMARY FOOD ALLERGY IS A GROWING PUBLIC HEALTH CONCERN WITH NO CU | $249,632 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRPC6 INHIBITION THERAPY TO RESCUE CARDIAC MUSCLE DYSFUNCTION IN MUSCULAR DYSTROPHY - THIS PROPOSAL TESTS THE EFFICACY AND MECHANISMS BY WHICH A RECENTLY DEVELO | $249,000 |
| 2026 | National Institutes of Health | Grant or other assistance | MENTAL HEALTH RESEARCH GRANTS 93.242 | ESTRADIOL-MEDIATED GENE SIGNATURES IN HIPPOCAMPAL MEMORY - PROJECT SUMMARY THE SEX-STEROID HORMONE 17-ESTRADIOL (E2) HAS A WELL-ESTABLISHED ROLE IN MEDIATING | $248,999 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | ROLE OF AUTOPHAGY IN TYPE 2 DIABETES MICROVASCULAR DYSFUNCTION - PROJECT SUMMARY THIS K99/R00 APPLICATION PROPOSES A COMPREHENSIVE CAREER DEVELOPMENT PLAN AND A | $248,999 |
| 2026 | National Institutes of Health | Grant or other assistance | EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS 93.853 | UNDERSTANDING SPINAL NEUROPEPTIDE SIGNALING IN ITCH - PROJECT SUMMARY/ABSTRACT CHRONIC ITCH DISORDERS ARE THE PRIMARY REASON FOR VISITS TO DERMATOLOGISTS AND HA | $248,999 |
| 2026 | National Institutes of Health | Grant or other assistance | ALCOHOL RESEARCH PROGRAMS 93.273 | RECIPROCAL LONGITUDINAL ASSOCIATIONS BETWEEN BRAIN FUNCTION AND ALCOHOL USE TRAJECTORIES IN ADOLESCENTS AND YOUNG ADULTS - PROJECT SUMMARY/ABSTRACT ALCOHOL USE | $248,964 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | OPTIMAL DONOR SELECTION FOR HEMATOPOIETIC CELL TRANSPLANT IN THE CYCLOPHOSPHAMIDE PROPHYLAXIS ERA BY BAYESIAN MACHINE LEARNING WITH PROGRESSIVE ILLNESS-DEATH DA | $238,710 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | SINGLE-CELL DISSECTION OF CELLULAR AND TRANSCRIPTIONAL DYNAMICS DRIVING POST-TRANSPLANT RELAPSE IN MYELODYSPLASTIC SYNDROMES - ABSTRACT ALLOGENEIC HEMATOPOIETIC | $234,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | CORE CLINICAL CENTERS FOR THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK | $234,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | TRAINING IN SIGNATURE TRANSDISCIPLINARY CARDIOVASCULAR SCIENCES | $225,318 |
| 2026 | National Institutes of Health | Grant or other assistance | VISION RESEARCH 93.867 | RESEARCH TRAINING PROGRAM IN VISION SCIENCE | $218,692 |
| 2026 | Department of the Navy | Contract | COLLEGES, UNIVERSITIES, AND PROFESSIONAL SCHOOLS 611310 | TUITION AND FEES | $214,798 |
| 2026 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | UNDERSTANDING BREAST CANCER RISK AND SCREENING IN TRANSGENDER PERSONS THROUGH A PILOT BREAST CANCER SCREENING PROGRAM - PROJECT SUMMARY/ABSTRACT IN THE U.S., AN | $210,130 |
| 2026 | National Institutes of Health | Grant or other assistance | RESEARCH INFRASTRUCTURE PROGRAMS 93.351 | ENH13 MUTANT RATS FOR INVESTIGATION OF XX VS. XY DIFFERENCES IN PHENOTYPES - PROJECT SUMMARY THE LONG-TERM OBJECTIVES ARE TO DEVELOP AND VALIDATE RAT MODELS OF | $195,000 |
| 2026 | National Institutes of Health | Grant or other assistance | AGING RESEARCH 93.866 | VOICE-ACTIVATED AND TOUCHSCREEN-CONTROLLED SMART SPEAKER INTERVENTION FOR ADULTS AGED 50 YEARS AND OLDER WITH POORLY CONTROLLED TYPE 2 DIABETES - ADULTS AGED 50 | $195,000 |
| 2026 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | MEDICAL COLLEGE OF WISCONSIN PHYSICIAN SCIENTIST IMMERSION PROGRAM - WE HAVE A UNIQUE OPPORTUNITY TO RECRUIT, TRAIN, AND RETAIN PROMISING PHYSICIAN-SCIENTIST CA | $191,864 |
| 2026 | National Institutes of Health | Grant or other assistance | BIOMEDICAL RESEARCH AND RESEARCH TRAINING 93.859 | SPECIALIZED TRAINING IN ANESTHESIOLOGY TEAM SCIENCE - PROJECT SUMMAY/ABSTRACT THE MAIN GOAL OF THE SPECIALIZED TRAINING IN ANESTHESIOLOGY TEAM SCIENCE (STAT) PR | $186,882 |
State business registration
- THE MEDICAL COLLEGE OF WISCONSIN, INC. WI, Employee benefit plan sponsor (Form 5500), Filed for plan year 2025
- THE MEDICAL COLLEGE OF WISCONSIN, INC. FL, Foreign nonprofit corporation (FORNP), Inactive, formed 2016-07-29
- THE MEDICAL COLLEGE OF WISCONSIN, INC. FL, Foreign nonprofit corporation (FORNP), Active, formed 2021-07-20
The same business name in the same state, from the state’s official registry data.
Patents
153 US patents filed in the last 20 years.
- The Medical College of Wisconsin, Inc. 153 patents, 2009-12-29 to 2026-09-29 EXACT high confidence: identical full name and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12747441 | Riboswitch modulated gene therapy for retinal diseases | 2026-09-29 | PTBLXML, file of 2026-09-29 |
| US 12691114 | Compositions for inhibition of herpesviruses | 2026-07-28 | PTBLXML, file of 2026-07-28 |
| US 12678453 | Aerosolized formulations of HIV protease inhibitors for the treatment of airway reflux | 2026-07-14 | PTBLXML, file of 2026-07-14 |
| US 12622976 | Targeting CLPTM1L for treatment and prevention of cancer | 2026-05-12 | PTBLXML, file of 2026-05-12 |
| US 12616562 | Systems and methods for continence training | 2026-05-05 | PTBLXML, file of 2026-05-05 |
| US 12611464 | Modified clostridial neurotoxins as vaccine and conjugate vaccine platforms | 2026-04-28 | PTBLXML, file of 2026-04-28 |
| US 12594283 | Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug | 2026-04-07 | PTBLXML, file of 2026-04-07 |
| US 12565643 | Alpha-galactosidase protein for enzyme replacement therapy (ERT) and methods of use | 2026-03-03 | PTBLXML, file of 2026-03-03 |
| US 12555496 | Apparatus and method for teaching wound debridement | 2026-02-17 | PTBLXML, file of 2026-02-17 |
| US 12542214 | Medical image segmentation using deep learning models trained with random dropout and/or standardized inputs | 2026-02-03 | PTBLXML, file of 2026-02-03 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Trademarks
21 US trademarks, 18 live.
- The Medical College of Wisconsin, Inc. 21 marks, WI EXACT high confidence: identical full name and state
| Mark | Serial | Filed | Status | Source |
|---|---|---|---|---|
| A | 98349196 | 2024-01-09 | Registered | TRTYRAP, file of 2026-04-03 |
| A AUDAXITY | 98349191 | 2024-01-09 | Registered | TRTYRAP, file of 2026-04-03 |
| AUDAXITY | 98343435 | 2024-01-05 | Registered | TRTYRAP, file of 2026-04-03 |
| MCW SHE CENTER | 98260355 | 2023-11-08 | Registered | TRTYRAP, file of 2026-04-03 |
| WINS | 97545221 | 2022-08-11 | Registered | TRTYRAP, file of 2026-04-03 |
| MDFUSION | 97461591 | 2022-06-16 | Abandoned | TRTYRAP, file of 2026-04-03 |
| FUSIONMD | 97461588 | 2022-06-16 | Abandoned | TRCFECO2, file of 2024-03-27 |
| MCWFUSION | 97461585 | 2022-06-16 | Registered | TRTYRAP, file of 2026-04-03 |
| PROJECT WONDER | 97336431 | 2022-03-29 | Registered | TRCFECO2, file of 2024-03-27 |
| PROJECT WONDER THE ART OF SCIENCE AT MCW | 97336426 | 2022-03-29 | Registered | TRCFECO2, file of 2024-03-27 |
The newest marks of the trademark owners above, matched to this record by name (and state).
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | THE MEDICAL COLLEGE OF WISCONSIN, INC. | WI | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Payment recipient | MEDICAL COLLEGE OF WISCONSIN | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Medical College of Wisconsin, Inc | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | MEDICAL COLLEGE OF WISCONSIN INC | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | MEDICAL COLLEGE OF WISCONSIN, INC. | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | Medical College Of Wisconsin, Incorporated | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | THE MEDICAL COLLEGE OF WISCONSIN | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | The Medical College of Wisconsin, Inc | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | The Medical College of Wisconsin, Inc. | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | The Medical College Of Wisconsin,inc | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | The Medical College Of Wisconsin Inc. | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | THE MEDICAL COLLEGE OF WISCONSIN INC | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | THE MEDICAL COLLEGE OF WISCONSIN INC . | WI | Open Payments (drug and device company payments) | name and state |
| Payment recipient | THE MEDICAL COLLEGE OF WISCONSIN| INC | WI | Open Payments (drug and device company payments) | name and state |
Matched by name (and state) or EIN only; a shared name is not proof of the same person or organization.
Comments